NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Molecular Imaging and Contrast Agent Database (MICAD)
MICAD is a key component of the NIH Common Fund (formerly NIH Roadmap); it is developed by the National Center for Biotechnology Information (NCBI), at the National Institutes of Health (NIH). More about MICAD »
After June 30 of 2013, new and revised chapters will no longer be uploaded to the MICAD website. However, the current chapters remain available online.
1444 agents currently listed. Latest update: June 27, 2013.
MICAD available through PubMed: MICAD chapters are now accessible through PubMed. To retrieve a list of all MICAD records, query PubMed for "Molecular Imaging and Contrast Agent Database (MICAD)"[book].
FDA Approved Contrast Agents: Download a list of FDA approved contrast agents (Latest update: January 2013).
Molecular Imaging Probes and Contrast Agents List: The MICAD staff has created the Molecular Imaging Probes and Contrast Agents List (MIP & CA List) by screening the PubMed/MedLine databases and other appropriate sources of such information. Only agents used in animal or human studies yielding in vivo data were selected for inclusion in the list. Although great care has been taken to accurately present all and only those imaging and contrast agents that fulfill the in vivo data criteria, this list is by no means considered complete. No one imaging modality has been given preference over the others and the omission of any agent(s) or the introduction of any errors in the list is purely unintentional. The MIP & CA List is subject to the same copyright and disclaimers as the rest of the MICAD content. Please read carefully the complete disclaimer information for MICAD before using the list. Download the list (Latest update: January 2013).
Contents
- About MICAD
- MRI
- 13C
- Hyperpolarized [1,4-13C2]fumarate as an imaging agent of tumor cell death in vivo [PDF Version][1,4-13C2]FumarateLiang Shan.Created: January 15, 2010; Last Update: April 12, 2010.
- Hyperpolarized [1-13C]dehydroascorbic acid [PDF Version][1-13C]DHAKam Leung.Created: September 15, 2011; Last Update: December 15, 2011.
- Hyperpolarized [13C]-2-hydroxyethylpropionate [PDF Version]HP[13C]HEPPHuiming Zhang.Created: January 31, 2008; Last Update: March 5, 2008.
- Hyperpolarized 13C-labeled bicarbonate (H13CO3-) for in vivo pH measurement with 13C magnetic resonance spectroscopy [PDF Version]Hyperpolarized H13CO3-Liang Shan.Created: January 25, 2010; Last Update: April 12, 2010.
- Hyperpolarized sodium 1-[13C]pyruvate [PDF Version]HP[13C]PyrHuiming Zhang.Created: January 29, 2008; Last Update: February 28, 2008.
- Hyperpolarized α-keto[1-13C]isocaproate as a 13C magnetic resonance spectroscopic agent for profiling branched chain amino acid metabolism in tumors [PDF Version][1-13C]KICLiang Shan.Created: January 15, 2010; Last Update: May 19, 2010.
- Hyperpolarized [1,4-13C2]fumarate as an imaging agent of tumor cell death in vivo [PDF Version]
- 19F
- 6-Fluoropyridoxol [PDF Version]6-FPOLKenneth T. Cheng.Created: May 9, 2006; Last Update: March 25, 2008.
- Aqueous colloidal nanoemulsion of perfluorocarbon polymers [PDF Version]CS-1000Liang Shan.Created: February 24, 2011; Last Update: March 31, 2011.
- Perfluoro-15-crown-5 ether-labeled dendritic cells [PDF Version]PFPE-DCsHuiming Zhang.Created: August 1, 2008; Last Update: September 3, 2008.
- Perfluoropolyethylene glycol–labeled BDC2.5 T cells [PDF Version]PFPE-BTCsHuiming Zhang.Created: August 8, 2008; Last Update: September 16, 2008.
- VHPKQHRGGSKGC-liquid perfluorocarbon nanoparticles [PDF Version]VCAM-1-targeted NPsKam Leung.Created: February 28, 2010; Last Update: April 1, 2010.
- 6-Fluoropyridoxol [PDF Version]
- Cu
- Au3Cu1 Nanoparticles [PDF Version]Au3Cu1-NPsKam Leung.Created: June 26, 2008; Last Update: August 18, 2008.
- Au3Cu1 Nanoparticles [PDF Version]
- Europium
- Eu-1,7-Bis(2-(methylene benzyloxy ether)-acetic acid) acetamide-4,10-bis(acetamidoacetic acid)-1,4,7,10- tetraazacyclododecane [PDF Version]Eu-DOTA-OBZ2-Gly2Mark Pagel and Kam Leung.Created: February 19, 2009; Last Update: March 10, 2009.
- Eu-1,7-Bis(2-(methylene benzyloxy ether)-acetic acid) acetamide-4,10-bis(acetamidoacetic acid)-1,4,7,10- tetraazacyclododecane [PDF Version]
- Fe
- BM3h-8C8 Mutant of the heme domain of the bacterial cytochrome P450-BM3 (Bacillus megaterium) [PDF Version]BM3h-8C8Liang Shan.Created: December 17, 2010; Last Update: January 18, 2011.
- BM3h-8C8 Mutant of the heme domain of the bacterial cytochrome P450-BM3 (Bacillus megaterium) [PDF Version]
- Gadolinium
- (1-(2-(β-Galactopyranosyloxy)propyl)-4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane) gadolinium(III) [PDF Version]EGadMeHuiming Zhang.Created: January 14, 2008; Last Update: February 20, 2008.
- (Gd-chelate)2-Phe-His-Cys-Pro(OH)-Tyr(2-Cl)-Asp-Leu-Cys-His-Ile-Leu-(Gd-chelate)2 [PDF Version]4GdpeptideHuiming Zhang.Created: November 15, 2007; Last Update: January 8, 2008.
- [(Biotin-Ala-Ser-Lys-Lys-Pro-Lys-Arg-Asn-Ile-Lys-Ala)4-dendrimer]-streptavidin-[biotin-gadolinium 1,4,7-tris(carboxymethyl)-10-(2’-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-loaded apoferritin] [PDF Version]C3d-SA-GdAFHuiming Zhang.Created: December 27, 2007; Last Update: February 4, 2008.
- 4,5-Diethyl-10,23-dimethyl-9,24-bis(3-hydroxypropyl)-16,-17-bis(3,hydroxypropyl)oxy-13,20,25,26,27—pentaazapentacyclo-[20.2.1.13,6.19,11.014,19]heptacosa-3,5,8,10,12,14,16,18,20,22,24-undecaene gadolinium hydrates [PDF Version]MGdHuiming Zhang.Created: December 6, 2007; Last Update: January 8, 2008.
- Anti-c-Met monoclonal antibody linked to biotinylated bovine serum albumin and gadolinium [PDF Version]Anti-c-Met-Gd-albuminArvind Chopra.Created: December 4, 2008; Last Update: January 7, 2009.
- Anti-intercellular adhesion molecule 1 antibody–conjugated gadolinium diethylenetriaminepentaacetic acid [PDF Version]Gd-DTPA-anti-ICAM-1 antibodyThe MICAD Research Team.Created: July 12, 2007; Last Update: August 13, 2007.
- Anti-malondialdehyde-modified low-density lipoprotein MDA2 monoclonal antibody gadolinium-labeled micelles [PDF Version]MDA2 micellesKam Leung.Created: August 15, 2009; Last Update: October 22, 2009.
- Anti-vascular endothelial growth factor polylactic acid-polyethylene glycol-poly-L-Lys/gadolinium-diethylenetriamine pentaacetic acid nanoparticles [PDF Version]Anti-VEGF PLA-PEG-PLL-DTPA-Gd NPsKam Leung.Created: May 5, 2012; Last Update: July 19, 2012.
- Avidin-gadolinium [PDF Version]Avidin-GdArvind Chopra.Created: December 1, 2008; Last Update: December 26, 2008.
- Biotinylated bovine serum albumin linked to gadolinium diethylenetriaminepentaacetic acid [PDF Version]Biotin-BSA-GdDTPAArvind Chopra.Created: December 9, 2008; Last Update: December 26, 2008.
- Dimeric Gd-tetraazacyclododecanetetraacetic acid-folate [PDF Version]P866Kam Leung.Created: January 17, 2009; Last Update: May 3, 2009.
- Evans Blue-diethylenetriamine-N,N,N”,N”-pentaacetic acid-gadolinium [PDF Version]EB-DTPA-GdArvind Chopra.Created: October 25, 2007; Last Update: December 19, 2007.
- Folate-polyethylene glycol-ultrasmall superparamagnetic iron oxide nanoparticles [PDF Version]P1133Kam Leung.Created: May 9, 2011; Last Update: July 14, 2011.
- Gadobenate [PDF Version]Gd-BOPTAKenneth T. Cheng.Created: November 28, 2005; Last Update: December 3, 2007.
- Gadobutrol [PDF Version]Gd-DO3A-butrolKenneth T. Cheng.Created: February 15, 2006; Last Update: October 18, 2007.
- Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-cinnamoyl-Phe-D-Leu-Phe-D-Leu-Phe-Lys-NH2 [PDF Version]Gd-DOTA-cFlFlFKKam Leung.Created: May 1, 2013; Last Update: June 6, 2013.
- Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-G3 nanoglobule-CGLIIQKNEC (CLT1) [PDF Version]Gd-DOTA-G3-CLT1Kam Leung.Created: October 1, 2012; Last Update: December 6, 2012.
- Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Lys-polyethylene glycol-CGLIIQKNEC (CLT1) [PDF Version]CLT1-dL-(Gd-DOTA)4Kam Leung.Created: September 15, 2012; Last Update: December 6, 2012.
- Gadolinium-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-icosahedral closo-borane12 scaffold conjugated with Glu-{Glu-[cyclo(Arg-Gly-Asp-d-Phe-Lys)]2}2 [PDF Version]CA-12Kam Leung.Created: April 11, 2013; Last Update: May 30, 2013.
- Gadolinium-1,4,7,10-tetraazacyclododecane-N,N’,N’,N’”-tetraacetic-monoamide-24-cascade-polymer [PDF Version]24GdDOTACPHuiming Zhang.Created: October 17, 2007; Last Update: December 4, 2007.
- Gadolinium-1,4,7,10-tetraazacyclododecane-N',N'',N''',N''''-tetraacetic acid-Gly-Pro-D-Leu-D-Ala-NHOH [PDF Version]P947Kam Leung.Created: December 15, 2008; Last Update: February 24, 2009.
- Gadolinium-1,4,7,10-tetraazacyclododecane-N',N'',N''',N''''-tetraacetic acid-Pro-Leu-Ala-Leu-Lys-Arg-Asp-Arg [PDF Version]Gd-DOTA-PCA7Kam Leung.Created: June 15, 2008; Last Update: July 15, 2008.
- Gadolinium 1-((11-S)-3,10-diaza-13-carboxamido-11-carboxy-2,9-dioxotridecyl)-N,N’,N”-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane [PDF Version]Gd-DOTAMA-GlnHuiming Zhang.Created: November 20, 2007; Last Update: January 3, 2008.
- Gadolinium-anti-neutrophil gelatinase-associated lipocalin 2 24p3 antibody-conjugated micelles [PDF Version]NGAL/24p3-Targeted micellesKam Leung.Created: January 15, 2011; Last Update: June 16, 2011.
- Gadolinium-bis-5-hydroxytriptamide-diethylenetriamine pentaacetic acid [PDF Version]Gd-bis-5-HT-DTPAArvind Chopra.Created: August 30, 2011; Last Update: October 28, 2011.
- Gadolinium-diethylenetriamine pentaacetic acid-24-cascade-polymer [PDF Version]24GdDTPACPHuiming Zhang.Created: October 2, 2007; Last Update: December 4, 2007.
- Gadolinium diethylenetriamine pentaacetic acid-Arg-Gly-Asp peptidomimetic [PDF Version]Gd-DTPA-g-mimRGDKam Leung.Created: June 15, 2008; Last Update: July 18, 2008.
- Gadolinium-diethylenetriamine pentaacetic acid-carboxymethylarabinogalactan [PDF Version]Gd-DTPA-CMAG-A2Kam Leung.Created: November 15, 2008; Last Update: January 6, 2009.
- Gadolinium-diethylenetriamine pentaacetic acid-GKWHCTTKFPHHYCLY [PDF Version]EP-3533Kam Leung.Created: November 15, 2008; Last Update: January 6, 2009.
- Gadolinium-Diethylenetriamine pentaacetic acid-Leu-Ile-Lys-Lys-Pro-Phe [PDF Version]Gd-DTPA-g-R826Kam Leung.Created: October 26, 2009; Last Update: March 11, 2010.
- Gadolinium-Diethylenetriamine pentaacetic acid-poly(lactic-co-glycolic acid) microbubbles [PDF Version]Gd-DTPA-PLGAKam Leung.Created: October 11, 2010; Last Update: December 9, 2010.
- Gadolinium-diethylenetriamine tetraacetic acid-icosahedral closo-borane12 scaffold [PDF Version]CA-9Kam Leung.Created: April 11, 2013; Last Update: May 30, 2013.
- Gadolinium-Hexyl-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid-progesterone [PDF Version]ProGloKam Leung.Created: May 1, 2012; Last Update: August 9, 2012.
- Gadolinium-HU-308-incorporated micelles [PDF Version]CB2R-Targeted micellesKam Leung.Created: March 15, 2011; Last Update: April 21, 2011.
- Gadolinium-incorporated mesoporous silica nanoparticles [PDF Version]Gd2O3@SiO2Liang Shan.Created: July 11, 2011; Last Update: August 10, 2011.
- Gadolinium-labeled diethylenetriamine pentaacetic acid-CGLIIQKNEC [PDF Version]Gd-DTPA-CLT1Kam Leung.Created: July 15, 2009; Last Update: September 11, 2009.
- Gadolinium-reconstituted high-density liproprotein-[palmitoyl-WK(palmitoyl)G(LRKLRKRLLR)2-NH2] nanoparticles [PDF Version]rHDL-P2A2Kam Leung.Created: August 15, 2009; Last Update: September 9, 2009.
- Gadolinium-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-Cys-Asn-Asn-Ser-Lys-Ser-His-Thr-Cys [PDF Version]Gd-DOTA-R832Kam Leung.Created: October 29, 2009; Last Update: March 18, 2010.
- Gadolinium-tetraazacyclododecane tetraacetic acid coupled with folate via bis(aminoethyl)ethylene glycol linker [PDF Version]Gd.DOTA.FolateLiang Shan.Created: March 12, 2011; Last Update: April 19, 2011.
- Gadoteridol Gd-HP-DO3A [PDF Version]Kenneth T. Cheng.Created: October 7, 2005; Last Update: November 5, 2007.
- GadoversetamideGd-DTPA-BMEA [PDF Version]Kenneth T. Cheng.Created: November 7, 2007; Last Update: December 10, 2007.
- Gadoxetate [PDF Version]Gd-EOB-DTPAKenneth T. Cheng.Created: May 14, 2007; Last Update: April 10, 2008.
- Gd@C82 Fullerenol [PDF Version]Gd@C82(OH)40Huiming Zhang.Created: October 31, 2008; Last Update: December 1, 2008.
- Gd-Diethylenetriaminepentaacetic acid-polylysyl-N-glutaryl-phosphatidyl ethanolamine-2C5 liposomes [PDF Version]Gd-DTPA-PLL-NGPE-2C5 liposomesKam Leung.Created: May 17, 2009; Last Update: June 9, 2009.
- Gd-DOTA-anti-Aβ42-F(ab’)2-antibody fragment (putrescine)n [PDF Version]GdAβ42Huiming Zhang.Created: November 7, 2008; Last Update: December 22, 2008.
- Gd-DOTA-c(Cys-Arg-Gly-Asp-Cys) [PDF Version]P975Kam Leung.Created: June 27, 2010; Last Update: September 3, 2010.
- Gd-DOTA-G-NH(CH2)11CO-RSPAYYTAA-(CH2CH2O)8-R [PDF Version]GdPCA2Huiming Zhang.Created: December 22, 2008; Last Update: January 14, 2009.
- Gd-DTPA-Bz-poly(α,L-glutamic acid) [PDF Version]GdLPGHuiming Zhang.Created: January 9, 2009; Last Update: January 26, 2009.
- Gd-DTPA-Cystine diethyl ester copolymers [PDF Version]GDCEPKam Leung.Created: September 22, 2006; Last Update: November 21, 2007.
- Gd-DTPA l-Cystine bisamide copolymers [PDF Version]GCACKenneth T. Cheng, Zheng-Rong Lu, and Todd Kaneshiro.Created: November 8, 2007; Last Update: January 22, 2008.
- Gd-DTPA l-Cystine bisisopropyl amide copolymers [PDF Version]GCICKenneth T. Cheng, Zheng-Rong Lu, and Todd Kaneshiro.Created: February 7, 2008; Last Update: March 3, 2008.
- Gd-DTPA l-Cystine bispropyl amide copolymers [PDF Version]GCPCKenneth T. Cheng, Zheng-Rong Lu, and Todd Kaneshiro.Created: January 30, 2008; Last Update: February 25, 2008.
- GKVLAK–(Gadolinium-(1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid t-butyl ester)-10-acetic acid monoamide))–GGGGTVQQEL [PDF Version]Gd-DCCP16Liang Shan.Created: March 29, 2011; Last Update: April 26, 2011.
- Mouse anti-cMet monoclonal antibody linked to gadolinium diethylenetriamine pentaacetic acid conjugated to biotinylated bovine serum albumin [PDF Version]Anti-c-Met-Gd-DTPA-albuminArvind Chopra.Created: September 15, 2009; Last Update: October 26, 2009.
- Poly(ethylene glycol)-b-poly(L-lysine)-gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid micelle [PDF Version]PEG-P(Lys-DOTA-Gd)Liang Shan.Created: May 31, 2011; Last Update: June 23, 2011.
- Polyion complex micelles of poly(ethylene glycol)-b-poly(L-lysine)-gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-dextran sulfate [PDF Version]PIC micellesLiang Shan.Created: May 31, 2011; Last Update: June 23, 2011.
- Pyridine-tetra-acetate-gadolinium(III) (PTA-Gd) conjugated to 17β-estradiol (EPTA-Gd) or tamoxifen (TPTA-Gd) [PDF Version]EPTA-Gd; TPTA-GdArvind Chopra.Created: January 23, 2012; Last Update: February 23, 2012.
- TAMRA-IL-13-Conjugated functionalized gadolinium metallofullerene (Gd3N@C80(OH)-26(CH2CH2COOH)-16) [PDF Version]TAMRA-IL-13-f-Gd3N@C80Kam Leung.Created: September 4, 2011; Last Update: November 17, 2011.
- Transferrin-coated gadolinium-labeled human serum albumin nanoparticles [PDF Version]Gd-HSA-Tf-NPArvind Chopra.Created: April 30, 2013; Last Update: May 23, 2013.
- Tri-gadolinium nitride PEGylated-hydroxylated endohedral metallofullerene [PDF Version]Gd3N@C80[DiPEG5000(OH)x]Huiming Zhang.Created: October 28, 2008; Last Update: December 1, 2008.
- Trisodium-[(2-(R)-[(4,4-diphenylcyclohexyl)phosphono-oxymethyl]-diethylenetriaminepentaacetato)(aquo)gadolinium(III)Gadofosveset [PDF Version]Huiming Zhang.Created: October 24, 2007; Last Update: January 3, 2008.
- (1-(2-(β-Galactopyranosyloxy)propyl)-4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane) gadolinium(III) [PDF Version]
- Iron oxide
- Amine-modified silica-coated polyhedral superparamagnetic iron oxide nanoparticle–labeled rabbit bone marrow–derived mesenchymal stem cells [PDF Version]SPIO@SiO2-NH2-labeled MSCsLiang Shan.Created: December 11, 2009; Last Update: January 28, 2010.
- Anti-ligand–induced binding sites (LIBS) antibody conjugated to microparticles of iron oxide [PDF Version]LIBS-MPIOsKam Leung.Created: June 21, 2010; Last Update: September 3, 2010.
- Anti-malondialdehyde-modified low-density lipoprotein MDA2 monoclonal antibody–labeled lipid-coated superparamagnetic iron oxide nanoparticles [PDF Version]MDA2 LSPIOsKam Leung.Created: May 15, 2012; Last Update: August 2, 2012.
- Anti-malondialdehyde-modified low-density lipoprotein MDA2 monoclonal antibody–labeled lipid-coated ultra-small superparamagnetic iron oxide nanoparticles [PDF Version]MDA2 LUSPIOsKam Leung.Created: May 10, 2012; Last Update: August 2, 2012.
- Anti-vascular cell adhesion molecule antibody M/K-2.7 and anti-P-selectin antibody RB40.34 conjugated microparticles of iron oxide [PDF Version]VCAM-MPIO-P-selectinKam Leung.Created: March 8, 2008; Last Update: April 21, 2008.
- Anti-vascular cell adhesion molecule antibody M/K-2.7–conjugated microparticles of iron oxide [PDF Version]VCAM-MPIOKam Leung.Created: January 28, 2011; Last Update: April 14, 2011.
- Avidin-coated baculoviral vectors-biotinylated ultra-small superparamagnetic iron oxide nanoparticles [PDF Version]Baavi-bUSPIOHuiming Zhang.Created: March 31, 2008; Last Update: April 30, 2008.
- Citrate-coated (184th variant) very small superparamagnetic iron oxide particles [PDF Version]VSOP-C184The MICAD Research Team.Created: September 1, 2006; Last Update: September 27, 2006.
- CLIO-(H-2Kd)-Lys-Tyr-Asp-Lys-Ala-Asp-Val-Phe-Leu [PDF Version]CLIO-NRP-V7Huiming Zhang.Created: August 15, 2008; Last Update: September 16, 2008.
- Complement receptor type 2–conjugated superparamagnetic iron oxide nanoparticles [PDF Version]CR2-Fc-SPIOKam Leung.Created: July 23, 2010; Last Update: December 29, 2010.
- Cross-linked iron oxide–transactivator transcription [PDF Version]CLIO-TatThe MICAD Research Team.Created: July 18, 2006; Last Update: August 7, 2006.
- Cyclo(Arg-Gly-Asp-D-Try-Glu) conjugated to ultrasmall superparamagnetic iron oxide nanoparticles [PDF Version]c(RGDyE)-USPIOKam Leung.Created: February 16, 2008; Last Update: April 30, 2008.
- Doxorubicin-loaded poly(ethylene oxide)-trimellitic anhydride chloride-folate superparamagnetic iron oxide nanoparticles [PDF Version]YCC-DOXArvind Chopra.Created: July 16, 2010; Last Update: September 23, 2010.
- Ferumoxides [PDF Version]SSPIOKam Leung.Created: November 1, 2004; Last Update: December 12, 2007.
- Ferumoxsil [PDF Version]Large SPIOKam Leung.Created: November 1, 2004; Last Update: December 12, 2007.
- Ferumoxtran [PDF Version]USPIOKam Leung.Created: November 1, 2004; Last Update: December 12, 2007.
- FluidMAG iron nanoparticle-labeled mesenchymal stem cells for tracking cell homing to tumors [PDF Version]FluidMAG iron nanoparticle-labeled MSCsLiang Shan.Created: December 23, 2009; Last Update: February 16, 2010.
- Glycol chitosan/heparin-immobilized gold-deposited iron oxide nanoparticles [PDF Version]Composite NPsLiang Shan.Created: July 28, 2011; Last Update: August 18, 2011.
- H18/7 F(ab’)2 E-selectin monoclonal antibody conjugated to cross-linked iron oxide nanoparticles [PDF Version]CLIO-H18/7 F(ab’)2Kam Leung.Created: March 26, 2007; Last Update: April 20, 2007.
- Iron oxide–ferritin nanocages [PDF Version]Fn-Fe nanocagesKam Leung.Created: June 4, 2011; Last Update: August 27, 2012.
- Iron oxide nanoparticles-poly-L-lysine complex [PDF Version]SPIO-PLLHuiming Zhang.Created: February 20, 2008; Last Update: March 26, 2008.
- Lactoferrin-conjugated poly(ethylene glycol)-coated Fe3O4 nanoparticles [PDF Version]Fe3O4-LfLiang Shan.Created: September 25, 2012; Last Update: October 24, 2012.
- Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles [PDF Version]Lf-SPIONsLiang Shan.Created: September 25, 2012; Last Update: October 24, 2012.
- Magnetic iron microbeads coupled with HEA-125 monoclonal antibody against epithelial cell adhesion molecule [PDF Version]EpCAM microbeadsLiang Shan.Created: February 24, 2011; Last Update: March 29, 2011.
- MES-1 F(ab’)2 E-selectin monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticle [PDF Version]MES-1-USPIOKam Leung.Created: February 8, 2007; Last Update: March 15, 2007.
- Monoclonal antibody against antigen A7 coupled to ferromagnetic lignosite particles [PDF Version]A7-FMLArvind Chopra.Created: November 20, 2008; Last Update: December 17, 2008.
- N-Alkyl-polyethylenimine 2 kDa–stabilized superparamagnetic iron oxide nanoparticles for MRI cell tracking [PDF Version]Alkyl-PEI2k/SPIOLiang Shan.Created: January 13, 2011; Last Update: February 22, 2011.
- Octreotide conjugated to pegylated ultrasmall superparamagnetic iron oxide nanoparticle [PDF Version]USPIO-PEG-OCTKam Leung.Created: November 5, 2009; Last Update: February 4, 2010.
- Ovarian cancer antigen 183B2 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles [PDF Version]OCMab183B2-USPIOKam Leung.Created: January 5, 2011; Last Update: April 14, 2011.
- Poly(N,N-dimethylacrylamide)-coated maghemite nanoparticles for labeling and tracking mesenchymal stem cells [PDF Version]PDMAAm-coated γ-Fe2O3-labeled MSCsLiang Shan.Created: December 23, 2009; Last Update: February 16, 2010.
- Polyethylene glycol–coated and folic acid–conjugated superparamagnetic iron oxide nanoparticles [PDF Version]SPIO-PEG-FALiang Shan.Created: September 30, 2009; Last Update: November 12, 2009.
- Saposin C-dioleylphosphatidylserine nanovesicles coupled with iron oxides [PDF Version]SapC-DOPS-IOLiang Shan.Created: June 20, 2011; Last Update: July 18, 2011.
- Sialy Lewisx mimetic conjugated to pegylated ultrasmall superparamagnetic iron oxide nanoparticles [PDF Version]USPIO-PEG-sLeXKam Leung.Created: November 5, 2009; Last Update: February 4, 2010.
- Sialy Lewisx mimetic conjugated to ultrasmall superparamagnetic iron oxide nanoparticles [PDF Version]USPIO-g-sLeXKam Leung.Created: March 5, 2007; Last Update: March 20, 2007.
- Single-chain anti-epidermal growth factor receptor antibody fragment conjugated to magnetic iron oxide nanoparticles [PDF Version]ScFvEGFR-IOArvind Chopra.Created: January 26, 2009; Last Update: March 11, 2009.
- Superparamagnetic iron oxide nanoparticles (SPION) stabilized by alginate [PDF Version]SPION-alginateLiang Shan.Created: October 13, 2009; Last Update: November 30, 2009.
- Thermally cross-linked superparamagnetic iron oxide nanoparticle-A10 RNA aptamer-doxorubicin conjugate [PDF Version]TCL-SPION-Apt(Dox)Huiming Zhang.Created: August 29, 2008; Last Update: October 8, 2008.
- Thiol-modified poly(ethylene glycol)-conjugated gold/superparamagnetic iron oxide nanoparticles [PDF Version]PEG-S-Au/SPIOKam Leung.Created: July 23, 2010; Last Update: December 29, 2010.
- Trastuzumab-dextran iron oxide nanoparticles [PDF Version]Trastuzumab-dextran NPArvind Chopra.Created: November 4, 2008; Last Update: December 17, 2008.
- Trastuzumab-manganese–doped iron oxide nanoparticles [PDF Version]Trastuzumab-MnMEIO nanoparticlesKam Leung.Created: April 19, 2007; Last Update: May 21, 2007.
- Ultrasmall superparamagnetic iron oxide-anti-CD20 monoclonal antibody [PDF Version]USPIO-anti-CD20 MAbKenneth T. Cheng.Created: May 21, 2007; Last Update: February 12, 2008.
- Ultrasmall superparamagnetic iron oxide-cyclo(Cys-Asn-Asn-Ser-Lys-Ser-His-Thr-Cys) [PDF Version]USPIO-R832Kam Leung.Created: March 3, 2013; Last Update: May 9, 2013.
- Ultrasmall superparamagnetic iron oxide-Leu-Ile-Lys-Lys-Pro-Phe [PDF Version]USPIO-R826Kam Leung.Created: February 26, 2013; Last Update: May 16, 2013.
- Ultrasmall superparamagnetic iron oxide nanoparticles conjugated with Ile-Pro-Leu-Pro-Phe-Tyr-Asn [PDF Version]USPIO-PHOKam Leung.Created: February 23, 2010; Last Update: March 25, 2010.
- ZHER2:342 Affibody-polyethylene glycol-superparamagnetic iron oxide nanoparticles [PDF Version]IO-PEG-ZHER2:342Kam Leung.Created: July 16, 2012; Last Update: October 18, 2012.
- Amine-modified silica-coated polyhedral superparamagnetic iron oxide nanoparticle–labeled rabbit bone marrow–derived mesenchymal stem cells [PDF Version]
- Manganese ferrite
- Anti-malondialdehyde-modified low-density lipoprotein MDA2 murine monoclonal antibody manganese-micelles [PDF Version]MDA2-Mn micellesKam Leung.Created: May 10, 2012; Last Update: August 27, 2012.
- Manganese(II)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-G3 nanoglobule-CGLIIQKNEC (CLT1) [PDF Version]Mn-DOTA-G3-CLT1Kam Leung.Created: September 15, 2012; Last Update: December 6, 2012.
- Vascular endothelial growth factor A isoform 121-gelonin fusion protein–conjugated manganese ferrite nanoparticles [PDF Version]VEGF121/rGel-MNPsLiang Shan.Created: July 6, 2011; Last Update: August 17, 2011.
- Anti-malondialdehyde-modified low-density lipoprotein MDA2 murine monoclonal antibody manganese-micelles [PDF Version]
- Nitroxide
- 15N-Labeled 4-oxo-2,2,6,6-tetramethyl-piperidine-1-oxyl [PDF Version][15N]TEMPONEHuiming Zhang.Created: April 30, 2008; Last Update: June 9, 2008.
- 3-Carbamoyl-2,2,5,5-tetramethyl-1-pyrrolidinyl-N-oxyl [PDF Version]3CPHuiming Zhang.Created: April 30, 2008; Last Update: June 9, 2008.
- 3-Carboxy-2,2,5,5-tetramethyl-pyrrolidinyl-N-oxyl [PDF Version]3CxPHuiming Zhang.Created: April 30, 2008; Last Update: June 9, 2008.
- 15N-Labeled 4-oxo-2,2,6,6-tetramethyl-piperidine-1-oxyl [PDF Version]
- Nitroxide
- 17O-Labeled water [PDF Version]H217OKam Leung.Created: May 27, 2010; Last Update: August 5, 2010.
- 17O-Oxygen [PDF Version]17O2Kam Leung.Created: May 17, 2010; Last Update: August 5, 2010.
- 17O-Labeled water [PDF Version]
- Tm3+
- Tm-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-acetamidoacetic acid [PDF Version]Tm-DOTA-GlyMark Pagel and Kam Leung.Created: February 19, 2009; Last Update: March 10, 2009.
- Tm-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-acetamidoacetic acid [PDF Version]
- Yb
- Ytterbium chelated to 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid,10-orthoaminoanilide [PDF Version]Yb-DO3A-oAAMark Pagel and Arvind Chopra.Created: November 26, 2011; Last Update: January 5, 2012.
- Ytterbium chelated to 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid,10-orthoaminoanilide [PDF Version]
- 13C
- Multimodal
- 111In, 68Ga
- 111In/68Ga-Labeled anti-epidermal growth factor receptor, native chemical ligation cyclized Affibody ZHER2:342min [PDF Version][111In/68Ga]ZHER2:342minArvind Chopra.Created: April 3, 2013; Last Update: May 23, 2013.
- 111In/68Ga-Labeled DOTA-conjugated cyclo[γ-d-Glu-Ala-Tyr-d-Lys]-Trp-Met-Asp-Phe-NH2 (cyclo-MG1), a minigastrin analog [PDF Version][111In/68Ga]-DOTA-cyclo-MG1Arvind Chopra.Created: May 17, 2012; Last Update: July 12, 2012.
- 111In/68Ga-Labeled DOTA conjugated cyclo[γ-d-Glu-Ala-Tyr-d-Lys]-Trp-Nle-Asp-Phe-NH2 (cyclo-MG2), a minigastrin analog [PDF Version][111In/68Ga]-DOTA-cyclo-MG2Arvind Chopra.Created: May 17, 2012; Last Update: July 26, 2012.
- 111In/68Ga-Labeled anti-epidermal growth factor receptor, native chemical ligation cyclized Affibody ZHER2:342min [PDF Version]
- 111In, Cy5.5
- 111In-Labeled multifunctional single-attachment-point reagent-c[RGDfK] [PDF Version]111In-MSAP-RGDLiang Shan.Created: July 13, 2012; Last Update: August 21, 2012.
- 111In-Labeled multifunctional single-attachment-point reagent-c[RGDfK] [PDF Version]
- 111In, Cy7
- 111In-Labeled annexin A5-polyethylene glycol–coated core-cross-linked polymeric micelle-Cy7 [PDF Version]111In-A5-CCPMKam Leung.Created: November 30, 2011; Last Update: January 19, 2012.
- 111In-Labeled-TNYLFSPNGPIARAW (TNYL-RAW)-polyethylene glycol–coated core-cross-linked polymeric micelle-Cy7 [PDF Version]111In-TNYL-RAW-CCPMKam Leung.Created: September 18, 2011; Last Update: January 19, 2012.
- 111In-Labeled annexin A5-polyethylene glycol–coated core-cross-linked polymeric micelle-Cy7 [PDF Version]
- 111In, CyAL5.5
- 111In-Labeled Ac-TZ14011 peptide (a chemokine receptor 4 antagonist) conjugated to CyAL5.5 (a fluorescent dye) through a multifunctional single-attachment point (MSAP) reagent [PDF Version][111In]Ac-TZ14011-MSAPArvind Chopra.Created: November 29, 2012; Last Update: December 27, 2012.
- 111In-Labeled Ac-TZ14011 peptide (a chemokine receptor 4 antagonist) conjugated to CyAL5.5 (a fluorescent dye) through a multifunctional single-attachment point (MSAP) reagent [PDF Version]
- 111In and IRDye800
- 111In-Diethylenetriaminepentaacetic acid-benzyl-succinamido-Lys-IRDye800-c(Arg-Gly-Asp-D-Phe-Lys) [PDF Version]111In-DTPA-Bz-SA-Lys-IRDye800-c(RGDfK)Kam Leung.Created: October 4, 2008; Last Update: November 17, 2008.
- 111In-Diethylenetriaminepentaacetic acid-benzyl-succinamido-Lys-IRDye800-c(Arg-Gly-Asp-D-Phe-Lys) [PDF Version]
- 111In and IRDye 800CW
- 111In-(Diethylenetriamine pentaacetic acid)n-trastuzumab-(IRDye 800CW)m [PDF Version]111In-(DTPA)n-trastuzumab-(IRDye 800CW)mArvind Chopra.Created: January 5, 2009; Last Update: April 5, 2009.
- 111In-(Diethylenetriamine pentaacetic acid)n-trastuzumab-(IRDye 800CW)m [PDF Version]
- 123I, 124I
- Radioiodinated T84.66 minibody [PDF Version]123/124I-T84.66 minibodyKam Leung.Created: February 2, 2008; Last Update: April 3, 2008.
- Radioiodinated T84.66 minibody [PDF Version]
- 124I, 125I
- 124I/125I-Fibril-reactive monoclonal antibody [PDF Version]124I/125I-11-1F4 MAbKenneth T. Cheng.Created: December 7, 2006; Last Update: January 2, 2008.
- 124I/125I-Fibril-reactive monoclonal antibody [PDF Version]
- 177Lu, cypate
- 177Lu-DOTA-Tyr3-c(Cys-Tyr-Trp-Lys-Thr-Cys)-Thr-Lys(cypate)-NH2 [PDF Version]177Lu-LS172Huiming Zhang.Created: March 20, 2008; Last Update: April 22, 2008.
- 177Lu-DOTA-Tyr3-c(Cys-Tyr-Trp-Lys-Thr-Cys)-Thr-Lys(cypate)-NH2 [PDF Version]
- 64Cu, Cy5.5
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-Lys(Cy5.5)-Gly-Gly-Tyr-knottin 2.5D [PDF Version]64Cu-DOTA/Cy5.5-2.5DKam Leung.Created: September 28, 2010; Last Update: January 7, 2011.
- BBQ650-Pro-Leu-Gly-Val-Arg-Lys(Cy5.5)-Glu-Lys(64Cu-DOTA)-OH [PDF Version]BBQ650-PLGVR-K(Cy5.5)-E-K(64Cu-DOTA)-OHKam Leung.Created: January 6, 2013; Last Update: April 11, 2013.
- Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys/Cy5.5-Ferritin 64Cu-loaded nanocages [PDF Version]RGD4C/Cy5.5-Fn-64Cu nanocagesKam Leung.Created: June 23, 2011; Last Update: September 15, 2011.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-Lys(Cy5.5)-Gly-Gly-Tyr-knottin 2.5D [PDF Version]
- 64Cu, cypate
- 64Cu-DOTA-Tyr3-c(Cys-Tyr-Trp-Lys-Thr-Cys)-Thr-Lys(cypate)-NH2 [PDF Version]64Cu-LS172Huiming Zhang.Created: March 20, 2008; Last Update: April 21, 2008.
- 64Cu-DOTA-Tyr3-c(Cys-Tyr-Trp-Lys-Thr-Cys)-Thr-Lys(cypate)-NH2 [PDF Version]
- 64Cu, quantum dot (QD705)
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-quantum dot-vascular endothelial growth factor [PDF Version]64Cu-DOTA-QD-VEGFHuiming Zhang.Created: July 1, 2008; Last Update: August 12, 2008.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-quantum dot-vascular endothelial growth factor [PDF Version]
- 64Cu and Acridine
- 64Cu-Labeled 2,6-bis(dimethylamino)-10-(4-((4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclodo-decan-1-yl)methyl)benzyl)-acridin-10-ium [PDF Version][64Cu]DO3A-xy-ACRArvind Chopra.Created: February 26, 2013; Last Update: April 11, 2013.
- 64Cu-Labeled 2,6-bis(dimethylamino)-10-(4-((4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclodo-decan-1-yl)methyl)benzyl)-acridin-10-ium [PDF Version]
- 64Cu and IRDye800
- 64Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-bevacizumab-IRDye 800CW [PDF Version]64Cu-NOTA-Bev-800CWKam Leung.Created: December 7, 2012; Last Update: March 21, 2013.
- 64Cu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-conjugated IRDye 800CW (a near-infrared fluorescence dye) coupled to mAb7, an anti-epithelial cell adhesion molecule monoclonal antibody [PDF Version][64Cu]DOTA-IRDye 800CW-mAb7Arvind Chopra.Created: March 5, 2013; Last Update: April 11, 2013.
- 64Cu-Labeled NOTA-conjugated anti-CD105 (endoglin) chimeric monoclonal antibody linked to near-infrared dye IRDye 800CW [PDF Version][64Cu]-NOTA-TRC105-800CWArvind Chopra.Created: March 23, 2012; Last Update: May 10, 2012.
- 64Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-bevacizumab-IRDye 800CW [PDF Version]
- 64Cu and LRhodamine
- 64Cu-Labeled DOTA-Lissamine Rhodamine B and derivatives [PDF Version][64Cu]DOTA-LRBArvind Chopra.Created: January 16, 2013; Last Update: January 31, 2013.
- 64Cu-Labeled DOTA-Lissamine Rhodamine B and derivatives [PDF Version]
- 64Cu and quantum dot
- 64Cu-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-quantum dot-c(Arg-Gly-Asp-D-Tyr-Lys) [PDF Version]64Cu-DOTA-QD-c(RGDyK)Kam Leung.Created: March 1, 2008; Last Update: May 21, 2008.
- 64Cu-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-quantum dot-c(Arg-Gly-Asp-D-Tyr-Lys) [PDF Version]
- 66/67/68Ga
- 66/67/68Ga-γ-Deferoxamine-folate [PDF Version]66/67/68Ga-γ-DF-folateKam Leung.Created: September 14, 2006; Last Update: January 30, 2011.
- 66/67/68Ga-γ-Deferoxamine-folate [PDF Version]
- 67Ga, 68Ga
- [NIe4,Asp5,d-Phe7, 67Ga/68Ga-1,4,7,10-tetraazacyclododecane-N,N’,N’’,N’’’-1,4,7,10-tetraacetic acid-Lys11]-α-MSH4-11 [PDF Version]67Ga/68Ga-DOTA-NAPamideKenneth T. Cheng.Created: July 30, 2007; Last Update: November 19, 2007.
- [NIe4,Asp5,d-Phe7, 67Ga/68Ga-1,4,7,10-tetraazacyclododecane-N,N’,N’’,N’’’-1,4,7,10-tetraacetic acid-Lys11]-α-MSH4-11 [PDF Version]
- 89Zr and IRDye 800CW
- 89Zr-Labeled anti-CD105 (endoglin) chimeric monoclonal antibody TRC105 linked to IRDye 800CW [PDF Version][89Zr]TRC105-IRDye800CWArvind Chopra.Created: January 23, 2013; Last Update: January 31, 2013.
- 89Zr-Labeled anti-CD105 (endoglin) chimeric monoclonal antibody TRC105 linked to IRDye 800CW [PDF Version]
- 99mTc, iodine
- 99mTc-Labeled acetylated, 2,3,5-triiodobenzoic acid- and diethylenetriamine pentaacetic acid-conjugated, and PEGylated ethylenediamine-core generation 4 polyamidoamine dendrimers [PDF Version]99mTc-G4-[[[[Ac]-TIBA]-DTPA]-mPEG12]Liang Shan.Created: March 5, 2012; Last Update: April 25, 2012.
- 99mTc-Labeled acetylated, 2,3,5-triiodobenzoic acid- and diethylenetriamine pentaacetic acid-conjugated, and PEGylated ethylenediamine-core generation 4 polyamidoamine dendrimers [PDF Version]
- Alexa Fluor 680, gadolinium
- Alexa Fluor 680-labeled transferrin-cationic (NBD-labeled DOPE-DOTAP) liposome-encapsulated gadopentetate dimeglumine complex [PDF Version]TfNIR-LipNBD-CA complexKenneth T. Cheng, Paul C. Wang, and Liang Shan.Created: October 18, 2007; Last Update: December 17, 2007.
- Alexa Fluor 680-labeled transferrin-cationic (NBD-labeled DOPE-DOTAP) liposome-encapsulated gadopentetate dimeglumine complex [PDF Version]
- Au, gadolinium (Gd)
- Gold nanoparticles coated with dithiolated diethylenetriamine pentaacetic acid-gadolinium chelate [PDF Version]Au@DTDTPA-Gd50Liang Shan.Created: September 24, 2010; Last Update: November 17, 2010.
- Gold nanoparticles functionalized with gadolinium-diethylenetriamine pentaacetic acid-cysteine conjugate [PDF Version]Au@GdLLiang Shan.Created: September 24, 2010; Last Update: November 17, 2010.
- Gold nanoparticles coated with dithiolated diethylenetriamine pentaacetic acid-gadolinium chelate [PDF Version]
- Cy5.5, gadolinium (Gd)
- Annexin A5-Gd-micelles-Cy5.5 [PDF Version]AnxA5-micellesKam Leung.Created: February 27, 2011; Last Update: April 27, 2011.
- Cy5.5-Labeled and gadolinium-chelated chitosan nanoparticles [PDF Version]Cy5.5-CNP-Gd(III)Liang Shan.Created: September 2, 2010; Last Update: October 20, 2010.
- Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid monoamide-G2 nanoglobule-CGLIIQKNEC (CLT1)-Cy5 [PDF Version]CLT1-G2-(Gd-DOTA-MA)-Cy5Kam Leung.Created: April 21, 2013; Last Update: June 13, 2013.
- Gadolinium-G6 dendrimer-Cy5.5 [PDF Version]Gd-G6-Cy5.5Kam Leung.Created: June 19, 2009; Last Update: July 23, 2009.
- Annexin A5-Gd-micelles-Cy5.5 [PDF Version]
- Cy5.5, gadolinium (Gd), gold (Au)
- Gold/silica nanoparticles with a near-infrared fluorescent and PEGylated paramagnetic lipid coating [PDF Version]Au-SiFluPaLCsLiang Shan.Created: May 23, 2011; Last Update: June 23, 2011.
- Gold/silica nanoparticles with a near-infrared fluorescent and PEGylated paramagnetic lipid coating [PDF Version]
- Europium, perfluorocarbon
- Eu-chelate anti-fibrin antibody-conjugated perfluorocarbon nanoparticles [PDF Version]EuPFCHuiming Zhang.Created: January 17, 2008; Last Update: February 20, 2008.
- Eu-chelate anti-fibrin antibody-conjugated perfluorocarbon nanoparticles [PDF Version]
- Gadolinium, Texas Red
- Anti-ICAM-1 antibody-conjugated paramagnetic liposomes [PDF Version]Anti-ICAM ACPLsHuiming Zhang.Created: January 3, 2008; Last Update: February 14, 2008.
- Anti-ICAM-1 antibody-conjugated paramagnetic liposomes [PDF Version]
- Gadolinium (Gd3+), quantum dots (QDs)
- Gadolinium-diethylenetriaminepentaacetic acid-cyclo(Cys-Asn-Gly-Arg-Cys)-Gly-Lys-quantum dots [PDF Version]cNGR-pQDsKam Leung.Created: January 15, 2009; Last Update: March 19, 2009.
- PEGylated paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core [PDF Version]Q-SiPaLCsLiang Shan.Created: May 23, 2011; Last Update: June 23, 2011.
- Gadolinium-diethylenetriaminepentaacetic acid-cyclo(Cys-Asn-Gly-Arg-Cys)-Gly-Lys-quantum dots [PDF Version]
- Gold nanoparticles, Cy5.5
- Cy5.5-Containing matrix metalloproteinase (MMP) activatable peptide conjugated to glycol chitosan (GC)–coated gold nanoparticles (AuNPs) [PDF Version]MMP-GC-AuNPsArvind Chopra.Created: March 6, 2012; Last Update: April 12, 2012.
- Cy5.5-Containing matrix metalloproteinase (MMP) activatable peptide conjugated to glycol chitosan (GC)–coated gold nanoparticles (AuNPs) [PDF Version]
- I (as iohexol); Gd (as gadoteridol)
- PEGylated liposome co-encapsulating iohexol and gadoteridol for multimodal CT and MR imaging [PDF Version]PEGlipo-IG-1Jinzi Zheng, Christine Allen, David Jaffray, and Arvind Chopra.Created: July 29, 2011; Last Update: September 29, 2011.
- PEGylated liposome co-encapsulating iohexol and gadoteridol for multimodal CT and MR imaging [PDF Version]
- IR-783 and 111In
- 111In-DTPA-Bz-NH-SA-K(IR-783-S-Ph-CO)-c(CGRRAGGSC)NH2 [PDF Version]111In-DLIA-IL11RαKam Leung.Created: September 2, 2007; Last Update: November 6, 2007.
- 111In-DTPA-Bz-NH-SA-K(IR-783-S-Ph-CO)-c(CGRRAGGSC)NH2 [PDF Version]
- Iron, GFP
- Bimodal lentiviral vector encoding myc-tagged human ferritin heavy chain and green fluorescent protein (GFP) [PDF Version]Lenti-myc-hFTHLiang Shan.Created: February 2, 2011; Last Update: March 9, 2011.
- Bimodal lentiviral vector encoding myc-tagged human ferritin heavy chain and green fluorescent protein (GFP) [PDF Version]
- Iron oxide, 111In
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-benzyl-ChL6-superparamagnetic iron oxide nanoparticles [PDF Version]111In-DOTA-Bz-ChL6-SPIOKam Leung.Created: August 8, 2008; Last Update: September 3, 2008.
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-benzyl-ChL6-superparamagnetic iron oxide nanoparticles [PDF Version]
- Iron oxide, 124I
- 124I-Serum albumin-manganese-magnetism-engineered iron oxide nanoparticles [PDF Version]124I-SA-MnMEIOKam Leung.Created: February 1, 2009; Last Update: May 3, 2009.
- 124I-Serum albumin-manganese-magnetism-engineered iron oxide nanoparticles [PDF Version]
- Iron oxide, Cy5.5
- Annexin V-cross-linked iron oxide-Cy5.5 [PDF Version]AnxCLIO-Cy5.5Kam Leung.Created: July 27, 2006; Last Update: March 28, 2008.
- Anti-vascular cell adhesion molecule monoclonal antibody M/K-2.7 conjugated cross-linked iron oxide-Cy5.5 nanoparticles [PDF Version]VCAM-NPKam Leung.Created: October 1, 2007; Last Update: October 29, 2007.
- Cross-linked iron oxide-Cy5.5 [PDF Version]CLIO-Cy5.5The MICAD Research Team.Created: July 5, 2006; Last Update: July 21, 2006.
- Cy5.5-Amino-terminal fragment of urokinase-type plasminogen activator conjugated to magnetic iron oxide nanoparticles [PDF Version]Cy5.5-AFT-IOKam Leung.Created: October 7, 2009; Last Update: December 24, 2009.
- Cy5.5-Arg-Arg-Arg-Arg-crosslinked iron oxide nanoparticle [PDF Version]Cy5.5-R4-SC-CLIOKam Leung.Created: May 16, 2005; Last Update: June 2, 2005.
- Gly-Ser-Ser-Lys-(FITC)-Gly-Gly-Gly-Cys-Arg-Gly-Asp-Cys-CLIO-Cy5.5 [PDF Version]cRGD-CLIO(Cy5.5)Huiming Zhang.Created: December 17, 2007; Last Update: January 18, 2008.
- Green fluorescent protein specified small interfering RNA-cross-linked iron oxide nanoparticles-Cy5.5 [PDF Version]siGFP-CLIO-Cy5.5Huiming Zhang.Created: April 17, 2008; Last Update: May 12, 2008.
- IPLVVPLGGSC(Cy5.5-Cross-linked iron oxide)K(Fitc) [PDF Version]IPL-NPKam Leung.Created: August 10, 2008; Last Update: September 16, 2008.
- Lys-Thr-Leu-Leu-Pro-Thr-Pro-cross-linked iron oxide-Cy5.5 [PDF Version]PTP-CLIO-Cy5.5Kam Leung.Created: August 8, 2008; Last Update: February 22, 2011.
- Survivin specified small interfering RNA-CLIO-Cy5.5 [PDF Version]siSurvivin-CLIO-Cy5.5Huiming Zhang.Created: April 17, 2008; Last Update: May 12, 2008.
- VCAM-1 internalizing peptide-28 nanoparticles [PDF Version]VINP-28 NPKam Leung.Created: September 29, 2007; Last Update: December 4, 2007.
- Annexin V-cross-linked iron oxide-Cy5.5 [PDF Version]
- Iron oxide, Cy5.5, FITC
- Bombesin peptide conjugated–cross-linked iron oxide-Cy5.5 [PDF Version]BN-CLIO-Cy5.5The MICAD Research Team.Created: August 1, 2006; Last Update: August 17, 2006.
- Cross-linked iron oxide–C-AHA-AREPPTRTFAYWGK(FITC) [PDF Version]CLIO-EPPTThe MICAD Research Team.Created: July 26, 2006; Last Update: August 14, 2006.
- Bombesin peptide conjugated–cross-linked iron oxide-Cy5.5 [PDF Version]
- Iron oxide, Cy7
- Cys-Arg-Glu-Lys-Ala-superparamagnetic iron oxide-Cy7 nanoparticles [PDF Version]CREKA-SPIO-Cy7Kam Leung.Created: August 8, 2008; Last Update: October 15, 2008.
- Cys-Arg-Glu-Lys-Ala-superparamagnetic iron oxide-Cy7 nanoparticles [PDF Version]
- Iron oxides, RITC
- Multimodal, rhodamine B isothiocyanate-incorporated, silica-coated magnetic nanoparticle–labeled human cord blood–derived mesenchymal stem cells for cell tracking [PDF Version]MNPs@SiO2(RITC)-labeled MSCsLiang Shan.Created: December 11, 2009; Last Update: January 28, 2010.
- Multimodal, rhodamine B isothiocyanate-incorporated, silica-coated magnetic nanoparticle–labeled human cord blood–derived mesenchymal stem cells for cell tracking [PDF Version]
- Iron oxides, VT680, 64Cu
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-iron oxide-c(RGDyK) nanoparticles [PDF Version]64Cu-DOTA-IO-RGDyKKam Leung.Created: October 1, 2009; Last Update: December 3, 2009.
- 64Cu-DTPA-CLIO-VT680 [PDF Version]64Cu-TNPHuiming Zhang.Created: February 8, 2008; Last Update: March 11, 2008.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-iron oxide-c(RGDyK) nanoparticles [PDF Version]
- Microspheres, 166Ho
- [166Ho]-Loaded poly(L-lactic acid) microspheres [PDF Version][166Ho]-PLLA-MSArvind Chopra.Created: August 19, 2010; Last Update: October 14, 2010.
- [166Ho]-Loaded poly(L-lactic acid) microspheres [PDF Version]
- Quantum dot, gadolinium
- Annexin A5-quantum dot-DTPA-gadolinium [PDF Version]AnxA5-QD-GdKam Leung.Created: March 16, 2007; Last Update: March 27, 2008.
- Annexin A5-quantum dot-DTPA-gadolinium [PDF Version]
- 111In, 68Ga
- Optical
- 5-Carboxy-fluorescein
- 5-Carboxy-fluorescein-labeled octreotate [PDF Version]OcFLiang Shan.Created: July 27, 2010; Last Update: August 16, 2010.
- 5-Carboxy-fluorescein-labeled octreotate [PDF Version]
- A15
- A15 (NIRF agent) [PDF Version]The MICAD Research Team.Created: May 4, 2006; Last Update: May 30, 2006.
- A15 (NIRF agent) [PDF Version]
- Alexa Fluor 488
- AlexaFluor 488-conjugated antibody against lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) [PDF Version]Alexa488-Anti-LYVE-1Kam Leung.Created: March 24, 2011; Last Update: July 6, 2011.
- Alexa Fluor 488–conjugated anti-carcinoembryonic antigen monoclonal antibody [PDF Version]Alexa Fluor 488 anti-CEA MAbArvind Chopra.Created: August 11, 2008; Last Update: September 2, 2008.
- AlexaFluor 488-conjugated antibody against lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) [PDF Version]
- Alexa Fluor 647
- Ac-rkkrrorrrGK(QSY21)DEVDAPC(Alexa Fluor 647)-NH2 [PDF Version]TCAPQ647Kenneth T. Cheng and David Piwnica-Worms.Created: January 23, 2008; Last Update: April 22, 2008.
- Ac-rkkrrorrrGK(QSY21)DEVDAPC(Alexa Fluor 647)-NH2 [PDF Version]
- Alexa Fluor 680
- Alexa 680 conjugated to bovine serum albumin [PDF Version]Alexa680-BSAArvind Chopra.Created: March 8, 2012; Last Update: March 29, 2012.
- Alexa Fluor 680-Bevacizumab [PDF Version]Alexa680-BevacizumabKam Leung.Created: October 17, 2008; Last Update: December 16, 2008.
- Alexa Fluor 680-glycylglycylglycine-bombesin[7-14]NH2 peptide [PDF Version]Alexa Fluor 680-G-G-G-BN[7-14]NH2Kenneth T. Cheng, Charles J. Smith, Lixin Ma, Ping Yu, and Timothy J. Hoffman.Created: July 20, 2007; Last Update: August 25, 2007.
- Alexa Fluor 680-NH-CO-CH2-S-CH2-Phe-Pro-Arg-CH2-prothrombin [PDF Version]AF680-ProTLiang Shan.Created: March 15, 2012; Last Update: May 15, 2012.
- Humanized anti–type 1 insulin-like growth factor receptor monoclonal antibody conjugated to Alexa 680 [PDF Version]AVE1642-Alexa 680Arvind Chopra.Created: July 13, 2009; Last Update: August 4, 2009.
- LLP2A-biotin-streptavidin-Alexa Fluor 680 [PDF Version]LLP2A-SA-Alexa680Kam Leung.Created: October 10, 2007; Last Update: December 4, 2007.
- Self-quenching Alexa fluor 680 conjugated to trastuzumab [PDF Version]Tra-Alexa680(SQ)Arvind Chopra.Created: March 5, 2009; Last Update: April 6, 2009.
- Alexa 680 conjugated to bovine serum albumin [PDF Version]
- Alexa Fluor 700
- AlexaFluor 700–Labeled regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-d-Phe-Lys)]4 [PDF Version]A700-RAFT-RGDLiang Shan.Created: July 17, 2012; Last Update: August 29, 2012.
- AlexaFluor 700–Labeled regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-d-Phe-Lys)]4 [PDF Version]
- Alexa Fluor 750
- Alexa Fluor 750-albumin-binding domain-fused-(ZHER2:342)2 Affibody [PDF Version]Alexa750-ABD-fused-(ZHER2:342)2 AffibodyKam Leung.Created: December 16, 2008; Last Update: April 4, 2011.
- Alexa Fluor 750-ZHER2:342 Affibody [PDF Version]Alexa750-ZHER2:342Kam Leung.Created: June 16, 2010; Last Update: March 16, 2011.
- Alexa Fluor 750-albumin-binding domain-fused-(ZHER2:342)2 Affibody [PDF Version]
- AOI987
- AOI987 [PDF Version]The MICAD Research Team.Created: May 17, 2006; Last Update: June 15, 2006.
- AOI987 [PDF Version]
- Au
- Gold-polyethylene glycol nanoshells [PDF Version]Au-PEG-nanoshellsKam Leung.Created: May 26, 2008; Last Update: June 9, 2008.
- Polyethylene glycol–coated gold nanoshells conjugated with anti-VCAM-1 antibody [PDF Version]Kam Leung.Created: February 28, 2013; Last Update: May 16, 2013.
- Ultrasmall near-infrared gold nanoclusters [PDF Version]AuNCsKam Leung.Created: March 19, 2011; Last Update: June 2, 2011.
- Gold-polyethylene glycol nanoshells [PDF Version]
- BODIPY-FL
- BODIPY-FL-neutravidin-biotin-Cetuximab [PDF Version]BODIPY-FL-CetuximabKam Leung.Created: January 15, 2008; Last Update: February 25, 2008.
- BODIPY-FL-neutravidin-biotin-Cetuximab [PDF Version]
- BODIPY TMR-X
- Carbobenzoxy-capped Phe-Lys(BODIPY TMR-X-acyloxymethyl ketone(QSY7) [PDF Version]GB117Liang Shan.Created: May 19, 2010; Last Update: May 25, 2010.
- Carbobenzoxy-capped Phe-Lys(BODIPY TMR-X-acyloxymethyl ketone(QSY7) [PDF Version]
- CellVue Maroon
- CellVue Maroon–labeled saposin C-dioleylphosphatidylserine nanovesicles [PDF Version]CVM-SapC-DOPSLiang Shan.Created: June 20, 2011; Last Update: July 18, 2011.
- CellVue Maroon–labeled saposin C-dioleylphosphatidylserine nanovesicles [PDF Version]
- Cy5
- Carbobenzoxy-capped Phe-Lys(Cy5)-acyloxymethyl ketone [PDF Version]GB123Liang Shan.Created: May 9, 2010; Last Update: May 25, 2010.
- Cbz-Phe-Lys(Cy5)-methyl ketone-2,6,dimethylterephthalic amide-hexyl-QSY 21 [PDF Version]GB137Huiming Zhang.Created: November 24, 2008; Last Update: January 5, 2009.
- Cy5-Glu-Pro-Asp-acyloxymethyl ketone [PDF Version]Cy5-AB50Kam Leung.Created: November 8, 2009; Last Update: December 30, 2009.
- Cy5-labeled aza-peptidyl Pro-Asn epoxide [PDF Version]LP-1Liang Shan.Created: May 12, 2010; Last Update: June 3, 2010.
- Cy5-Regioselectively addressable functionalized template-[cyclo-(RGD-d-Phe-Lys)]4 peptide [PDF Version]Cy5-RAFT-c(-RGDfK-)4Kenneth T. Cheng, Elisabeth Garanger, Veronique Josserand, Zhaohui Jin, Stephanie Foillard, Didier Boturyn, Pr Marie C. Favrot, Pascal Dumy, and Jean-Luc Coll.Created: October 9, 2007; Last Update: December 28, 2007.
- Cy5-Tat-Glu-Pro-Asp-acyloxymethyl ketone [PDF Version]tAB50-Cy5Liang Shan.Created: May 19, 2010; Last Update: June 3, 2010.
- L36-Cy5 anti-laminin trimerbody [PDF Version]L36-Cy5 anti-laminin trimerbodyLiang Shan.Created: June 11, 2009; Last Update: August 18, 2009.
- MFE23-Cy5 anti-carcinoembryonic antigen trimerbody [PDF Version]MFE23-Cy5 anti-CEA trimerbodyLiang Shan.Created: June 11, 2009; Last Update: August 18, 2009.
- Recombinant human erythropoietin coupled to near-infrared fluorescence dye Cy5.5 [PDF Version]Epo-Cy5.5Arvind Chopra.Created: February 2, 2012; Last Update: February 23, 2012.
- Self-quenched-regioselectively addressable functionalized template-[cyclo-(RGD-d-Phe-Lys)]4 peptide-Cy5-fluorescence quencher QSY21 [PDF Version]RAFT-c(-RGDfK-)4-Cy5-SS-QKenneth T. Cheng, Jesus Razkin, Veronique Josserand, Zhaohui Jin, Stephanie Foillard, Didier Boturyn, Pr Marie C. Favrot, Pascal Dumy, and Jean-Luc Coll.Created: October 31, 2007; Last Update: January 21, 2008.
- Carbobenzoxy-capped Phe-Lys(Cy5)-acyloxymethyl ketone [PDF Version]
- Cy5.5
- 2-(1E,3E,5E)-5-3-(R)-1-(1-(R)-2-(R)-2-[2-(4-(Benzo[d]thiazol-2-ylamino)phenyl)\acetamido]-6-(E)-3-(pyridin-3-yl)acrylamido)hexanamido)-5-carboxypentanamido)cyclohexyl)-27-carbamoyl-1,9,13,21,25,33-hexaoxo-5,17-dioxa-2,8,14,20,26,32-hexa-azaheptatriacontan-37-yl)-1,1-dimethyl-6,8-disulfonato-1H-benzo[e]indol-2(3H)-ylid-ene)penta-1,3-dienyl)-3-ethyl-1,1-dimethyl-1H-ben-zo[e]indolium-6,8-disulfonate [PDF Version]Cy5.5-LLP2A-6Kam Leung.Created: June 10, 2009; Last Update: August 12, 2009.
- Chlorotoxin:Cy5.5 [PDF Version]CTX:Cy5.5The MICAD Research Team.Created: July 23, 2007; Last Update: August 30, 2007.
- Cy5.5-3-Benzo[1,3]dioxol-5-yl-5-hydroxy-5-(4-methoxyphenyl)-4-(3,4,5-trimethoxybenzyl)-5H-furan-2-one) [PDF Version]Cy5.5-PD156707Kam Leung.Created: August 12, 2009; Last Update: September 30, 2009.
- Cy5.5-8-Amino-octanoic acid-Ser-Cys-Pro-Pro-Trp-Gln-Glu-Trp-His-Asn-Phe-Met-Pro-Phe-NH2 [PDF Version]Cy5.5-Aoc-EGBPKam Leung.Created: August 21, 2012; Last Update: November 15, 2012.
- Cy5.5-Ac-Cys-ZEGFR:1907 [PDF Version]Cy5.5-ZEGFR:1907Kam Leung.Created: June 21, 2012; Last Update: September 7, 2012.
- Cy5.5-Aminohexanoic acid-RPLALWRS-aminohexanoic acid-C-G4-PAMAM-PEG-AF750 [PDF Version]PB-M7NIRKam Leung.Created: April 26, 2009; Last Update: May 28, 2009.
- Cy5.5-Annexin V [PDF Version]The MICAD Research Team.Created: September 28, 2005; Last Update: October 31, 2005.
- Cy5.5-Anti-ephrin receptor B4 (EphB4) humanized monoclonal antibody hAb47 [PDF Version]Cy5.5-hAb47Kam Leung.Created: March 18, 2013; Last Update: May 9, 2013.
- Cy5.5-Asp-Gly-Glu-Ala (DGEA) [PDF Version]Cy5.5-DGEAKam Leung.Created: January 3, 2012; Last Update: April 5, 2012.
- Cy5.5-Asp-Gly-Glu-Ala-Gly-Lys-(Arg)8-OH [PDF Version]Cy5.5-DGEAGK(R8)-OHKam Leung.Created: January 6, 2012; Last Update: April 5, 2012.
- Cy5.5-c(Lys-Ala-His-Trp-Gly-Phe-Thr-Leu-Asp)NH2 [PDF Version]Cy5.5-C6Kam Leung.Created: March 20, 2010; Last Update: April 15, 2010.
- Cy5.5-CGRRRQRRKKRG-Labeled T lymphocytes [PDF Version]Cy5.5-Tat-T cellsHuiming Zhang.Created: July 10, 2008; Last Update: August 27, 2008.
- Cy5.5-Chitosan-anti-vascular endothelial growth factor receptor 2 monoclonal antibody DC101 [PDF Version]Cy5.5-Chitosan-DC101Kam Leung.Created: September 15, 2011; Last Update: December 15, 2011.
- Cy5.5 conjugated anti-epidermal growth factor receptor monoclonal antibody [PDF Version]Cetuximab-Cy5.5Arvind Chopra.Created: October 18, 2007; Last Update: November 1, 2007.
- Cy5.5-Conjugated anti-epidermal growth factor receptor monoclonal antibody C225 [PDF Version]C225-Cy5.5Arvind Chopra.Created: April 14, 2009; Last Update: July 22, 2009.
- Cy5.5-Conjugated anti-human CD31 monoclonal antibody [PDF Version]Cy5.5-anti-hCD31 MAbArvind Chopra.Created: December 15, 2008; Last Update: January 7, 2009.
- Cy5.5-Conjugated glycol chitosan-5β-cholanic acid nanoparticles [PDF Version]Cy5.5-CNPsArvind Chopra.Created: March 12, 2012; Last Update: May 10, 2012.
- Cy5.5-Conjugated matrix metalloproteinase cleavable peptide nanoprobe [PDF Version]Cy5.5-MMP probeArvind Chopra.Created: March 19, 2012; Last Update: April 12, 2012.
- Cy5.5-Cyclo(CGNSNPKSC) [PDF Version]Cy5.5-GX1Kam Leung.Created: January 30, 2012; Last Update: May 3, 2012.
- Cy5.5-Endostatin [PDF Version]Kam Leung.Created: May 8, 2006; Last Update: February 27, 2012.
- Cy5.5-Epidermal growth factor [PDF Version]Cy5.5-EGFKam Leung.Created: July 15, 2006; Last Update: March 27, 2012.
- Cy5.5-Ferritin nanocages [PDF Version]Cy5.5-Fn nanocagesKam Leung.Created: June 4, 2011; Last Update: August 18, 2011.
- Cy5.5-GGPRQITAGK(Fitc)C-Poly-L-lysine-methoxypolyethylene glycol [PDF Version]Cy5.5-GGPRQITAGK(Fitc)C-PL-MPEGKam Leung.Created: October 10, 2007.
- Cy5.5-GGSGRSANAK(Fitc)C-poly-L-lysine-methoxy polyethylene glycol [PDF Version]Cy5.5-GGSGRSANAK(Fitc)C-PL-MPEGKam Leung.Created: January 5, 2009; Last Update: March 3, 2009.
- Cy5.5-Gly-His-Pro-Gly-Gly-Pro-Gln-Gly-Lys(Fitc)-Cys-Poly-L-lysine-methoxypolyethylene glycol [PDF Version]Cy5.5-GHPGGPQK(Fitc)C-PL-MPEGKam Leung.Created: January 2, 2008; Last Update: January 22, 2008.
- Cy5.5-Gly-Pro-Leu-Gly-Val-Arg-Gly-(TDOPA)3-flower-like gold–Fe3O4 optical nanoparticles [PDF Version]FANPsKam Leung.Created: October 6, 2011; Last Update: January 5, 2012.
- Cy5.5-Gly-Pro-Leu-Gly-Val-Arg-Gly-Cys-Ferritin-black hole quencher-3 nanocages [PDF Version]C/B-Fn nanocagesKam Leung.Created: June 21, 2011; Last Update: September 15, 2011.
- Cy5.5-Gly-Pro-Leu-Gly-Val-Arg-Gly-Cys-gold nanoparticles [PDF Version]Cy5.5-MMP-AuNPsKam Leung.Created: April 26, 2009; Last Update: May 28, 2009.
- Cy5.5-Human serum albumin-tissue inhibitor of matrix metalloproteinase 2 fusion protein [PDF Version]Cy5.5-HSA/TIMP-2Kam Leung.Created: February 4, 2012; Last Update: May 31, 2012.
- Cy5.5-Knottin 2.5D [PDF Version]Cy5.5-Knottin 2.5DArvind Chopra.Created: March 26, 2009; Last Update: May 28, 2009.
- Cy5.5-Knottin 2.5F [PDF Version]Cy5.5-Knottin 2.5FArvind Chopra.Created: March 26, 2009; Last Update: May 28, 2009.
- Cy5.5-labeled pH low insertion peptide (pHLIP) [PDF Version]pHLIP-Cy5.5Liang Shan.Created: August 8, 2009; Last Update: November 12, 2009.
- Cy5.5-Polyethylene glycol-CGS25966 inhibitor of matrix metalloproteinases [PDF Version]Cy5.5-AF489Kam Leung.Created: February 14, 2013; Last Update: May 9, 2013.
- Cy5.5-Poly-L-lysine-methoxypolyethylene glycol [PDF Version]Cy5.5-PL-MPEGKam Leung.Created: November 10, 2007.
- Cy5.5-Rituximab [PDF Version]Cy5.5-RITKam Leung.Created: March 10, 2009; Last Update: June 4, 2009.
- Cy5.5-Single-chain Cys-tagged vascular endothelial growth factor-121 [PDF Version]Cy5.5-scVEGF121Kam Leung.Created: February 17, 2008; Last Update: March 31, 2008.
- Cy5.5-Trastuzumab [PDF Version]Cy5.5-TrastKam Leung.Created: June 15, 2006; Last Update: March 28, 2012.
- Cyclo(Arg-Gly-Asp-d-Tyr-Lys)-Cy5.5 [PDF Version]RGD-Cy5.5Kam Leung.Created: December 27, 2004; Last Update: September 22, 2011.
- Cyclo(Cys-Arg-Gly-Asp-Cys)-Gly-Lys-Cy5.5 [PDF Version]c(CRGDC)-GK-Cy5.5Kam Leung.Created: October 17, 2011; Last Update: February 2, 2012.
- Cyclo(Cys-Asn-Gly-Arg-Cys)-Gly-Lys-Cy5.5 [PDF Version]Cy5.5-cNGRKam Leung.Created: January 15, 2009; Last Update: March 19, 2009.
- Cys-Arg-Lys-Arg-Leu-Asp-Arg-Asn-Cys-glycol chitosan-Cy5.5 nanoparticles [PDF Version]AP-HGC-Cy5.5 NPsKam Leung.Created: April 15, 2009; Last Update: July 7, 2009.
- D-Cys-D-Asp-Gly-HCit-Gly-Pro-Gln-D-Cys-Ebes-Ebes-Lys-Cy5.5 [PDF Version]OA02-Cy5.5Kam Leung.Created: September 6, 2007; Last Update: October 18, 2007.
- D-Cys-D-Asp-Gly-HCit-Gly-Pro-Gln-D-Cys-Ebes-Lys-polyethylene glycol-cholic acids-Cy5.5 telodendrimer nanoparticles [PDF Version]OA02-PEG5k-CA8-Cy5.5 NPsKam Leung.Created: June 1, 2012; Last Update: September 7, 2012.
- D-Cys-D-Asp-Gly-Leu-Gly-ProOH-Asn-D-Cys-biotin-streptavidin-Cy5.5 [PDF Version]LXY1-biotin-SA-Cy5.5Kam Leung.Created: May 6, 2009; Last Update: June 6, 2009.
- D-Cys-D-Asp-Gly-Tyr(3-NO2)-Gly-ProOH-Asn-D-Cys-biotin-streptavidin-Cy5.5 [PDF Version]LXY2-biotin-SA-Cy5.5Kam Leung.Created: May 6, 2009; Last Update: June 8, 2009.
- Fibroblast activation protein α–specific, near-infrared peptide probe (KGPGPNQC) linked to Cy5.5 and a quencher dye, QSY21 [PDF Version]ANPFAPArvind Chopra.Created: October 31, 2012; Last Update: November 21, 2012.
- Mesenchymal-epithelial transition factor binding peptide-8-aminooctanoic acid conjugated to Cy5.5 [PDF Version]cMBP-AOC-Cy5.5Arvind Chopra.Created: July 30, 2009; Last Update: September 10, 2009.
- Mesenchymal-epithelial transition factor binding peptide-Gly-Gly-Gly conjugated to Cy5.5 [PDF Version]cMBP-GGG-Cy5.5Arvind Chopra.Created: July 31, 2009; Last Update: September 10, 2009.
- Sialyl-Lewisx-liposome-Cy5.5 [PDF Version]SLX-Lipo-Cy5.5Kam Leung.Created: April 28, 2009; Last Update: June 5, 2009.
- 2-(1E,3E,5E)-5-3-(R)-1-(1-(R)-2-(R)-2-[2-(4-(Benzo[d]thiazol-2-ylamino)phenyl)\acetamido]-6-(E)-3-(pyridin-3-yl)acrylamido)hexanamido)-5-carboxypentanamido)cyclohexyl)-27-carbamoyl-1,9,13,21,25,33-hexaoxo-5,17-dioxa-2,8,14,20,26,32-hexa-azaheptatriacontan-37-yl)-1,1-dimethyl-6,8-disulfonato-1H-benzo[e]indol-2(3H)-ylid-ene)penta-1,3-dienyl)-3-ethyl-1,1-dimethyl-1H-ben-zo[e]indolium-6,8-disulfonate [PDF Version]
- Cy7
- Cy7-(3S,7S)-26-Amino-5,13,20-trioxo-4,6,12,21-tetraazahexacosane-1,3,7,22-tetracarboxylic acid [PDF Version]Cy7-3Kam Leung.Created: December 27, 2012; Last Update: April 4, 2013.
- Cy7-Bis-dipicolylamine-zinc [PDF Version]Cy7-DPA-ZnKam Leung.Created: October 8, 2008; Last Update: November 12, 2008.
- Cy7-Polyethylene glycol-cinnamoyl-Phe-D-Leu-Phe-D-Leu-Phe-Lys-NH2 [PDF Version]Cy7-PEG-cFlFlFKKam Leung.Created: May 1, 2013; Last Update: June 13, 2013.
- Cy7-Tetrameric arginine-glycine-aspartic acid peptide [PDF Version]Cy7-E{E[c(RGDyK)]2}2Kenneth T. Cheng.Created: March 9, 2007; Last Update: May 13, 2008.
- Cy7-Tyr-d-Glu-Cys-Hyp-Tyr(3-Cl)-Gly-Leu-Cys-Tyr-Ile-Gln-NH2 [PDF Version]Cy7-FTP11Kam Leung.Created: April 27, 2013; Last Update: May 30, 2013.
- Cy7-(3S,7S)-26-Amino-5,13,20-trioxo-4,6,12,21-tetraazahexacosane-1,3,7,22-tetracarboxylic acid [PDF Version]
- Cypate
- Cypate-2-Deoxy-d-glucose [PDF Version]Cypate-2DGKam Leung.Created: August 18, 2012; Last Update: November 15, 2012.
- cypate-d: -(+)-glucosamine (cyp-GlcN), and d: -(+)-glucosamine-cypate-d: -(+)-glucosamine (cyp-2GlcN) [PDF Version]cyp-GlcN and cyp-2GlcNArvind Chopra.Created: August 8, 2012; Last Update: September 13, 2012.
- Cypate-Gly-Arg-Asp-Ser-Pro-Lys [PDF Version]Cyp-GRDSPKKam Leung.Created: September 26, 2005; Last Update: October 12, 2005.
- Cypate-2-Deoxy-d-glucose [PDF Version]
- DiD
- DiD-Labeled anti-EpCAM-directed NK-92-scFv(MOC31) zeta cells [PDF Version]DiD-NK-92-scFv(MOC31) zeta cellsKam Leung.Created: August 28, 2009; Last Update: September 30, 2009.
- DiD-Labeled anti-EpCAM-directed NK-92-scFv(MOC31) zeta cells [PDF Version]
- DiR
- Indotricarbocyanine-loaded AS1411 DNA aptamer- and TGN peptide-modified poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles [PDF Version]DiR-AsTNPLiang Shan.Created: August 10, 2012; Last Update: September 5, 2012.
- Near-infrared fluorescence 1,1-dioctadecyl-3,3,3,3-tetramethylindotricarbocyanine iodide (DiR)-labeled macrophages for cell imaging [PDF Version]DiR-Labeled macrophagesLiang Shan.Created: December 11, 2009; Last Update: January 12, 2010.
- Indotricarbocyanine-loaded AS1411 DNA aptamer- and TGN peptide-modified poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles [PDF Version]
- DY675
- DY-675-g7-Poly(lactic-co-glycolic acid) nanoparticles [PDF Version]DY-g7-PLGA NPsKam Leung.Created: December 1, 2010; Last Update: March 3, 2011.
- DY-675-g7-Poly(lactic-co-glycolic acid) nanoparticles [PDF Version]
- DY682
- DY-682-Albumin-binding domain-fused-ZHER2:342 Affibody [PDF Version]DY-682-ABD-ZHER2:342Kam Leung.Created: June 17, 2010.
- DY-682-Albumin-binding domain-fused-ZHER2:342 Affibody [PDF Version]
- DY750
- DyLight 750-MES-1 E-selectin monoclonal antibody [PDF Version]DyLight 750-MES-1Kam Leung.Created: February 28, 2011; Last Update: June 1, 2011.
- DyLight 750-MES-1 E-selectin monoclonal antibody [PDF Version]
- Fluorescein
- Fluorescein-conjugated human serum albumin [PDF Version]FLS-HSAThe MICAD Research Team.Created: July 26, 2007; Last Update: August 30, 2007.
- Fluorescein-conjugated human serum albumin [PDF Version]
- Fluorescein isothiocyanate (FITC)
- 4-[2-(3,4,5,6-Tetrahydropyrimidin-2-ylamino)ethyloxy]benzoyl-2-(S)-[N-3-amino-neopenta-1-carbamyl)]-aminoethylsulfonylamino-β-alanine fluorescein thiourea [PDF Version]FITC-IACKenneth T. Cheng, Narasimhan Danthi, and Jianwu Xie.Created: October 9, 2007; Last Update: January 2, 2008.
- Fluorescein-conjugated cyclic decapeptides, CGLIIQKNEC (CLT1) and CNAGESSKNC (CLT2) [PDF Version]Fluorescent CLT peptidesLiang Shan.Created: July 28, 2011; Last Revision: August 28, 2012.
- 4-[2-(3,4,5,6-Tetrahydropyrimidin-2-ylamino)ethyloxy]benzoyl-2-(S)-[N-3-amino-neopenta-1-carbamyl)]-aminoethylsulfonylamino-β-alanine fluorescein thiourea [PDF Version]
- Green fluorescence protein
- Recombinant adenovirus with enhanced green fluorescent protein [PDF Version]Ad-E3-EGFPArvind Chopra.Created: December 9, 2007; Last Update: January 2, 2008.
- Recombinant adenovirus with enhanced green fluorescent protein [PDF Version]
- Green fluorescence protein (GFP), luciferin
- HSV1-TK/GFP/Fluc [PDF Version]TGLHuiming Zhang.Created: October 21, 2008; Last Update: December 1, 2008.
- HSV1-TK/GFP/Fluc [PDF Version]
- HiLyte Fluor 647
- HiLyte Fluor 647-hyaluronic acid-gold nanoparticles [PDF Version]HHAuNPsKam Leung.Created: December 26, 2008; Last Update: February 24, 2009.
- HiLyte Fluor 647-hyaluronic acid-gold nanoparticles [PDF Version]
- IANBD
- Annexin B12 Cys101,Cys260-N,N'-dimethyl-N-(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine [PDF Version]pSIVAmLiang Shan.Created: May 22, 2010; Last Update: June 30, 2010.
- Annexin B12 Cys101,Cys260-N,N'-dimethyl-N-(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine [PDF Version]
- Indocyanine green
- Anti-human sperm protein 17 monoclonal antibody-indocyanine green derivative 02 [PDF Version]Anti-Sp17-ICG-Der-02Kam Leung.Created: September 8, 2012; Last Update: December 20, 2012.
- Bovine serum albumin–stabilized gold nanoclusters conjugated with folate and indocyanine green derivative 02 [PDF Version]Au-FA-MPAKam Leung.Created: October 4, 2012; Last Update: January 24, 2013.
- Bovine serum albumin–stabilized gold nanoclusters conjugated with l-methionine and indocyanine green derivative 02 [PDF Version]Au-Met-MPAKam Leung.Created: October 1, 2012; Last Update: January 24, 2013.
- Daclizumab complexed to near-infrared fluorophore indocyanine green [PDF Version]Dac-ICGArvind Chopra.Created: February 17, 2009; Last Update: March 4, 2009.
- Folic acid-indocyanine green-poly(d,l-lactide-coglycolide)-lipid nanoparticles [PDF Version]FA-ICG-PLGA-lipid NPsArvind Chopra.Created: August 30, 2012; Last Update: September 27, 2012.
- Indocyanine green derivative 02-2-deoxy-d-glucose [PDF Version]ICG-Der-02-2DGKam Leung.Created: September 17, 2012; Last Update: December 20, 2012.
- Indocyanine green derivative 02-Glu-c(RGDyK)2 [PDF Version]ICG-Der-02-c(RGDyK)2Kam Leung.Created: September 24, 2012; Last Update: December 28, 2012.
- Indocyanine green–doped calcium phosphate nanoparticles [PDF Version]ICG-CPNPsKam Leung.Created: March 17, 2010; Last Update: April 15, 2010.
- Indocyanine green-polyethylene glycol-folate [PDF Version]fPI-01Kam Leung.Created: January 19, 2011; Last Update: April 20, 2011.
- l-Methyl-methionine-indocyanine green derivative 02 [PDF Version]Met-ICG-Der-02Kam Leung.Created: September 27, 2012; Last Update: December 28, 2012.
- Quenched indocyanine green-anti-prostate-specific membrane antigen antibody J591 [PDF Version]ICG-J591Kam Leung.Created: December 8, 2011; Last Update: March 1, 2012.
- Trastuzumab complexed to near-infrared fluorophore indocyanine green [PDF Version]Tra-ICGArvind Chopra.Created: February 11, 2009; Last Update: March 4, 2009.
- Anti-human sperm protein 17 monoclonal antibody-indocyanine green derivative 02 [PDF Version]
- Indocyanine green and Alexa Fluor680
- Activatable Alexa Fluor680-conjugated panitumumab and indocyanine green-conjugated trastuzumab cocktail [PDF Version]Pan-Alexa680 and Tra-ICG cocktailLiang Shan.Created: May 16, 2012; Last Update: July 10, 2012.
- Activatable Alexa Fluor680-conjugated panitumumab and indocyanine green-conjugated trastuzumab cocktail [PDF Version]
- IR-783
- 2-[2-[2-Chloro-3-[2-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium [PDF Version]IR-783Kam Leung.Created: July 12, 2010; Last Update: October 20, 2010.
- Hyaluronan conjugated with IR-783 [PDF Version]IR783-HAKam Leung.Created: May 24, 2011; Last Update: July 21, 2011.
- IR-783-Glucosamine [PDF Version]IR-2Kam Leung.Created: August 2, 2008; Last Update: May 11, 2009.
- 2-[2-[2-Chloro-3-[2-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium [PDF Version]
- IR-786
- Hoechst 33258-polyethylene glycol-IR-786 [PDF Version]Hoechst-IRKam Leung.Created: September 29, 2011; Last Update: December 29, 2011.
- IR-786 perchlorate [PDF Version]IR-786Kam Leung.Created: January 3, 2005; Last Update: October 5, 2011.
- Hoechst 33258-polyethylene glycol-IR-786 [PDF Version]
- IR-820
- Protoporphyrin IX and IR-820 fluorophore–encapsulated organically modified silica nanoparticles [PDF Version]PpIX/IR-820–doped ORMOSIL NPsLiang Shan.Created: June 29, 2012; Last Update: August 7, 2012.
- Protoporphyrin IX and IR-820 fluorophore–encapsulated organically modified silica nanoparticles [PDF Version]
- IR-820 and FITC
- N'-Fluorescein-N''-[4-O-(β-d-glucopyranuronic acid)-3-difluoromethylphenyl]-S-methylthiourea (FITC-TrapG) and N'-(p-aminophenyl)thioether of IR-820-N''-[4-O-(β-d-glucopyranuronic acid)-3-difluoromethylphenyl]-S-methylthiourea (NIR-TrapG) [PDF Version]FITC-TrapG and NIR-TrapGArvind Chopra.Created: April 10, 2012; Last Update: May 10, 2012.
- N'-Fluorescein-N''-[4-O-(β-d-glucopyranuronic acid)-3-difluoromethylphenyl]-S-methylthiourea (FITC-TrapG) and N'-(p-aminophenyl)thioether of IR-820-N''-[4-O-(β-d-glucopyranuronic acid)-3-difluoromethylphenyl]-S-methylthiourea (NIR-TrapG) [PDF Version]
- IRDye700DX
- IRDye 700DX-Labeled annexin V [PDF Version]NIR700-Annexin VArvind Chopra.Created: October 27, 2009; Last Update: December 17, 2009.
- IRDye 700DX-Labeled annexin V [PDF Version]
- IRDye78
- GPI-78 [PDF Version]Kam Leung.Created: May 5, 2006; Last Update: August 12, 2008.
- Pamidronate-IRDye78 [PDF Version]PAM78Kam Leung.Created: January 4, 2005; Last Update: January 5, 2012.
- GPI-78 [PDF Version]
- IRDye 800CW
- Biotinylated vascular endothelial growth factor121-Avi-streptavidin-IRDye800 [PDF Version]VEGF121-Avib-SA800Kam Leung.Created: May 17, 2009; Last Update: July 7, 2009.
- Humanized anti-CD44v6 monoclonal antibody labeled with IRDye800CW [PDF Version]Anti-CD44v6-IRDye800CWArvind Chopra.Created: May 20, 2013; Last Update: June 28, 2013.
- IRDye800-2-(3-{5-[7-(5-amino-1-carboxy-pentylcarbamoyl)-heptanoylamino]-1-carboxy-pentyl}-ureido)-pentanedioic acid [PDF Version]YC-27Kam Leung.Created: May 12, 2010; Last Update: July 7, 2010.
- IRDye800-2-Deoxy-D-glucose [PDF Version]IRDye800-2-DGKam Leung.Created: May 17, 2009; Last Update: July 24, 2009.
- IRDye 800-albumin-binding domain-fused-ZHER2:342 Affibody [PDF Version]IRDye 800-ABD-ZHER2:342Kam Leung.Created: March 16, 2011; Last Update: March 6, 2013.
- IRDye 800-Anti–epidermal growth factor receptor Affibody [PDF Version]Eaff800Kam Leung.Created: June 17, 2010; Last Update: September 9, 2010.
- IRDye800-Anti-vascular endothelial growth factor receptor-2 monoclonal antibody Avas12a1 [PDF Version]IRDye800-Avas12a1Kam Leung.Created: February 17, 2010; Last Update: April 1, 2010.
- IRDye800CW-anti-CD105 TRC105 chimeric monoclonal antibody [PDF Version]IRDye800CW-TRC105Kam Leung.Created: December 1, 2011; Last Update: February 22, 2012.
- IRDye 800CW-Anti-epidermal growth factor receptor nanobody 7D12 [PDF Version]IRDye800CW-7D12Kam Leung.Created: April 6, 2012; Last Update: July 12, 2012.
- IRDye800CW-Cyclic albumin-binding domain (Ac-RLIEDICLPRWGCLWEDDK-NH2) [PDF Version]IRDye800-cABDKam Leung.Created: December 19, 2011; Last Update: March 1, 2012.
- IRDye 800CW-Epidermal growth factor [PDF Version]IRDye 800CW-EGFKam Leung.Created: January 19, 2007; Last Update: June 21, 2010.
- IRDye 800CW-Human serum albumin [PDF Version]HSA800Kam Leung.Created: January 19, 2007; Last Update: May 17, 2012.
- Near-infrared Dye®800CW–conjugated disulfide-based cyclic RGD peptide c(CRGDKGPDC) and its DOTA analog [PDF Version]Ac-Cys(IRDye800CW)-iRGD and DOTA-Cys(IRDye800CW)-iRGDArvind Chopra.Created: August 6, 2012; Last Update: August 30, 2012.
- Near-infrared dye IRDye 800CW-labeled butyrylcholinesterase [PDF Version]BChE-IRDye 800CWLiang Shan.Created: October 20, 2009; Last Update: December 14, 2009.
- Biotinylated vascular endothelial growth factor121-Avi-streptavidin-IRDye800 [PDF Version]
- IRIS Blue
- GKVLAK–(IRIS Blue-(1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid t-butyl ester)-10-acetic acid monoamide))–GGGGTVQQEL [PDF Version]DCCP16-IRIS BlueLiang Shan.Created: March 29, 2011; Last Update: April 26, 2011.
- GKVLAK–(IRIS Blue-(1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid t-butyl ester)-10-acetic acid monoamide))–GGGGTVQQEL [PDF Version]
- Luciferin
- Ad5-(PSE-BC)-(GAL4-(VP16)2)-(GAL4)5-Fluc [PDF Version]AdTSTA-FLHuiming Zhang.Created: December 5, 2008; Last Update: January 5, 2009.
- Gaussia princeps luciferase [PDF Version]hGLucArvind Chopra.Created: January 31, 2008; Last Update: February 28, 2008.
- Id protein-firefly luciferase N-fragment & firefly luciferase C-fragment-MyoD protein [PDF Version]Id-NFluc & CFluc-MyoDHuiming Zhang.Created: September 24, 2008; Last Update: October 23, 2008.
- Luciferase-expressing Escherichia coli [PDF Version]pLux-expressing E. coliArvind Chopra.Created: January 22, 2008; Last Update: February 5, 2008.
- NFluc-FHA2-Aktpep-CFluc [PDF Version]BARNCFlucHuiming Zhang.Created: November 14, 2008; Last Update: December 22, 2008.
- NRluc-hER281-549-CRluc [PDF Version]hERNCRlucHuiming Zhang.Created: December 29, 2008; Last Update: January 26, 2009.
- T84.66 Anti-CEA diabody-GSTSGSGKPGSGEGSTSG-Renilla luciferase [PDF Version]Db-18-Rluc8Huiming Zhang.Created: September 18, 2008; Last Update: October 23, 2008.
- Ad5-(PSE-BC)-(GAL4-(VP16)2)-(GAL4)5-Fluc [PDF Version]
- Malachite green
- Malachite green-isothiocyanate-polyethylene glycol-gold nanoparticles conjugated with scFv anti-EGFR B10 antibody [PDF Version]MGITC-AuNPs-scFvB10Kam Leung.Created: February 26, 2008; Last Update: May 14, 2008.
- Malachite green-isothiocyanate-polyethylene glycol-gold nanoparticles conjugated with scFv anti-EGFR B10 antibody [PDF Version]
- NIAD-4
- [[5'-(4-Hydroxyphenyl)[2,2’-bithiophen]-5-yl]methylene]-propanedinitrile NIAD-4 [PDF Version]Kenneth T. Cheng.Created: September 11, 2006; Last Update: November 8, 2007.
- [[5'-(4-Hydroxyphenyl)[2,2’-bithiophen]-5-yl]methylene]-propanedinitrile NIAD-4 [PDF Version]
- NIR2
- LTVSPWY peptide–modified PEGylated chitosan magnetic nanoparticles [PDF Version]LTVSPWY-PEG-CS NPsArvind Chopra.Created: September 7, 2012; Last Update: October 11, 2012.
- NIR2-Folate [PDF Version]Kam Leung.Created: May 19, 2006; Last Update: May 30, 2006.
- Pegylated bis(4-(N-(2-naphthyl)phenylamino)phenyl)-fumaronitrile (NPAPF) nanoparticles [PDF Version]NPAPF-PEG NPsArvind Chopra.Created: August 22, 2012; Last Update: September 27, 2012.
- LTVSPWY peptide–modified PEGylated chitosan magnetic nanoparticles [PDF Version]
- Oregon Green 488
- Cetuximab-Oregon Green 488 [PDF Version]Cetuximab-OGThe MICAD Research Team.Created: August 22, 2007; Last Update: September 24, 2007.
- Collagen-binding adhesion protein 35-Oregon Green 488 [PDF Version]CNA35-OG488Kenneth T. Cheng and Marc A.M.J. Van Zandvoort.Created: December 11, 2007; Last Update: January 28, 2008.
- OG488-Cyclo(Cys-Asn-Gly-Arg-Cys)-Gly-Lys [PDF Version]OG488-cNGRKam Leung.Created: January 15, 2009; Last Update: March 19, 2009.
- Cetuximab-Oregon Green 488 [PDF Version]
- Pyropheophorbide α (Pyro)
- Pyro-Gly-Asp-Glu-Val-Asp-Gly-Ser-Gly-Lys(BHQ3) [PDF Version]PPBHuiming Zhang.Created: May 22, 2008; Last Update: July 21, 2008.
- Pyro-Gly-Pro-Leu-Gly-Leu-Ala-Arg-Lys(BHQ3) [PDF Version]PPMMP7BHuiming Zhang.Created: May 22, 2008; Last Update: July 21, 2008.
- Pyro-Gly-Asp-Glu-Val-Asp-Gly-Ser-Gly-Lys(BHQ3) [PDF Version]
- Quantum dot (QD)
- Anti-α-Fetoprotein antibody-quantum dots [PDF Version]Anti-AFP-QDsKam Leung.Created: February 6, 2009; Last Update: February 24, 2009.
- Arginine-glycine-aspartic acid peptide-labeled quantum dot 705 [PDF Version]QD705-RGDKenneth T. Cheng.Created: May 1, 2006; Last Update: May 8, 2008.
- Epidermal growth factor conjugated to near-infrared fluorescent quantum dots [PDF Version]EGF-QDArvind Chopra.Created: February 2, 2009; Last Update: February 25, 2009.
- Humanized anti–type 1 insulin-like growth factor receptor monoclonal antibody conjugated to cadmium telluride quantum dots [PDF Version]AVE1642-QDArvind Chopra.Created: July 15, 2009; Last Update: August 12, 2009.
- Ligand-conjugated, gold-doped CdHgTe quantum dots for multispectral imaging [PDF Version]QD800-RGD, QD820-anti-CEACAM1, and QD840-anti-EGFRLiang Shan.Created: October 23, 2012; Last Update: November 7, 2012.
- QD800-Anti-epidermal growth factor receptor monoclonal antibody nanoparticles [PDF Version]QD800-EGFR AbKam Leung.Created: January 6, 2013; Last Update: April 4, 2013.
- QD800-Polyethylene glycol-Cys-ZHER2:342 Affibody [PDF Version]QD800-PEG-ZHER2:342Kam Leung.Created: July 20, 2012; Last Update: October 18, 2012.
- Quantum dot 800-conjugated anti-Tn IgM 2154F12A4 murine monoclonal antibody [PDF Version]Qdot 800-anti-Tn 2154F12A4 mAbLiang Shan.Created: August 21, 2009; Last Update: October 28, 2009.
- Quantum dot 800–mercaptopropionic acid [PDF Version]QD800-MPAKam Leung.Created: February 28, 2011; Last Update: May 28, 2011.
- Quantum dot800-poly(ethylene glycol)-c(Arg-Gly-Asp-d-Tyr-Lys) [PDF Version]QD800-PEG-c(RGDyK)Kam Leung.Created: March 21, 2011; Last Update: June 16, 2011.
- Quantum dot 800–prostate-specific membrane antigen antibody J591 [PDF Version]QD800-J591Kam Leung.Created: February 28, 2011; Last Update: May 18, 2011.
- Quantum dot-A10 RNA aptamer-doxorubicin conjugate [PDF Version]QD-Apt(Dox)Huiming Zhang.Created: August 25, 2008; Last Update: October 8, 2008.
- Quantum dot-prostate-specific membrane antigen antibody J591 [PDF Version]QD655-J591Kam Leung.Created: September 30, 2005; Last Update: February 14, 2011.
- Quantum dots-deoxycholic acid (DOCA)-conjugated low molecular weight heparin (LMWH) nanoparticles [PDF Version]Q-LHDKam Leung.Created: November 28, 2012; Last Update: February 28, 2013.
- Quantum dot-trastuzumab [PDF Version]QTKam Leung.Created: March 1, 2007; Last Update: February 24, 2011.
- Single-chain anti-epidermal growth factor receptor antibody fragment conjugated to functionalized quantum dots [PDF Version]ScFvEGFR-QDArvind Chopra.Created: January 22, 2009; Last Update: March 11, 2009.
- Anti-α-Fetoprotein antibody-quantum dots [PDF Version]
- Rhodamine green (RhodG)
- Galactosyl serum albumin-rhodamine green [PDF Version]GSA-RhodGKam Leung.Created: November 26, 2007; Last Update: January 15, 2008.
- Trastuzumab-rhodamine green [PDF Version]Trast-RhodGKam Leung.Created: January 19, 2008; Last Update: February 25, 2008.
- Galactosyl serum albumin-rhodamine green [PDF Version]
- RhodamineX
- Galactosamine-serum albumin-rhodamineX20 [PDF Version]GmSA-20ROXKam Leung.Created: December 10, 2007; Last Update: January 18, 2008.
- Galactosamine-serum albumin-rhodamineX20 [PDF Version]
- SIDAG
- 1,1’-bis-(4-sulfobutyl)indotricarbocyanine-5,5’-dicarboxylic acid diglucamide monosodium salt [PDF Version]SIDAGThe MICAD Research Team.Created: June 1, 2006; Last Update: June 18, 2006.
- 1,1’-bis-(4-sulfobutyl)indotricarbocyanine-5,5’-dicarboxylic acid diglucamide monosodium salt [PDF Version]
- Single-walled carbon nanotubes (SWNTs)
- Cyclic Arg-Gly-Asp-polyethyleneglycol-single-walled carbon nanotubes [PDF Version]RGD-PEG-SWNTsHuiming Zhang.Created: October 6, 2008; Last Update: November 17, 2008.
- Cyclic Arg-Gly-Asp-polyethyleneglycol-single-walled carbon nanotubes [PDF Version]
- Tetramethyl-6-carboxyrhodamine
- Avidin conjugated to tetramethyl-6-carboxyrhodamine-QSY®7 [PDF Version]Av-TM-Q7Arvind Chopra.Created: February 20, 2009; Last Update: April 6, 2009.
- Trastuzumab conjugated to tetramethyl-6-carboxyrhodamine-QSY®7 [PDF Version]Traz-TM-Q7Arvind Chopra.Created: March 2, 2009; Last Update: April 6, 2009.
- Avidin conjugated to tetramethyl-6-carboxyrhodamine-QSY®7 [PDF Version]
- Tetramethylrhodamine
- Polyethylene glycol-Cys-Arg-Ser-Gly-Pro-Leu-Gly-Val-Tyr-Lys-Lys-tetramethylrhodamine [PDF Version]PEG-peptide-TMRKam Leung.Created: February 6, 2012; Last Update: May 10, 2012.
- Polyethylene glycol-Cys-Arg-Ser-Gly-Pro-Leu-Gly-Val-Tyr-Lys-Lys-tetramethylrhodamine [PDF Version]
- THK-265
- 5-(2E,4E)-5-(6-hydroxy-4-oxo-2-thioxo-1,2,3,4-tetrahydroxy-5 pyrimidinyl)-2,4-pentadienylidene-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione [PDF Version]THK-265Kam Leung.Created: July 1, 2012; Last Update: October 25, 2012.
- 5-(2E,4E)-5-(6-hydroxy-4-oxo-2-thioxo-1,2,3,4-tetrahydroxy-5 pyrimidinyl)-2,4-pentadienylidene-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione [PDF Version]
- TOTO-3
- Quinolinium, 1,1'-[1,3-propanediylbis[(dimethyliminio)-3,1-propanediyl]]bis[4-[3-(3-methyl-2(3H)-benzothiazolylidene)-1-propen-1-yl]-,iodide (1:4) [PDF Version]TOTO-3Liang Shan.Created: April 2, 2012; Last Update: May 2, 2012.
- Quinolinium, 1,1'-[1,3-propanediylbis[(dimethyliminio)-3,1-propanediyl]]bis[4-[3-(3-methyl-2(3H)-benzothiazolylidene)-1-propen-1-yl]-,iodide (1:4) [PDF Version]
- VivoTag 750
- VivoTag-S 750-(S)-2-amino-4-pentynoic acid12-exendin-4 [PDF Version]E4X12-VT750Kam Leung.Created: November 1, 2011; Last Update: January 5, 2012.
- VivoTag-S 750-(S)-2-amino-4-pentynoic acid12-exendin-4 [PDF Version]
- VivoTag-S680
- VivoTag-S 680-anti-human mammaglobin-A monoclonal antibody [PDF Version]MamAb-680Kam Leung.Created: May 19, 2011; Last Update: July 21, 2011.
- VivoTag-S680–conjugated 3-aminomethyl αvβ3 antagonist derivative for fluorescence molecular tomography of tumors [PDF Version]IntegriSenseLiang Shan.Created: January 6, 2010; Last Update: May 19, 2010.
- VivoTag-S 680-anti-human mammaglobin-A monoclonal antibody [PDF Version]
- VM315
- 3,3-Diphenylpropylamido-indocyanine sulfonamide [PDF Version]VM315Milind Rajopadhye.Created: December 13, 2006; Last Update: January 26, 2007.
- 3,3-Diphenylpropylamido-indocyanine sulfonamide [PDF Version]
- ZW800-1
- ZW800-1, a zwitterionic near-infrared fluorophore, and its cyclic RGD peptide derivative cyclo-(RGDyK)-ZW800-1 [PDF Version]ZW800-1 and cRGD-ZW800-1Arvind Chopra.Created: February 12, 2013; Last Update: February 28, 2013.
- ZW800-1, a zwitterionic near-infrared fluorophore, and its cyclic RGD peptide derivative cyclo-(RGDyK)-ZW800-1 [PDF Version]
- 5-Carboxy-fluorescein
- PET
- 11C
- (-)-3-(4-Chlorophenyl)-N'-[(4-[11C]cyanophenyl)sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine [PDF Version][11C]CB1-(-)-12aKam Leung.Created: December 16, 2008; Last Update: January 2, 2009.
- (-)-4-[11C]Methoxycarbonyl-2-[(1-pyrrolidinylmethyl]-1-[(3,4-dichlorophenyl)acetyl]-piperidine [PDF Version][11C]GR103545Kam Leung.Created: May 21, 2006; Last Update: March 21, 2012.
- (-)-N-[11C]Propyl-norapomorphine [PDF Version][11C]NPAKam Leung.Created: April 6, 2006; Last Update: June 30, 2011.
- (+/-)-2-(N-Cyclohexylethyl-N-[11C]propyl)amino-5-hydroxytetralin [PDF Version][11C]ZYY-339Kam Leung.Created: August 16, 2006; Last Update: February 4, 2008.
- (+/-)-2-(N-Phenethyl-N-1'-[11C]propyl)amino-5-hydroxytetralin [PDF Version][11C]PPHTKam Leung.Created: August 16, 2006; Last Update: February 4, 2008.
- (+)-(2S,3S)-3-(2-[11C]Methoxybenzylamino)-2-phenylpiperidine [PDF Version][11C]CP-99,994Kenneth T. Cheng.Created: November 14, 2006; Last Update: January 23, 2008.
- (+)-8-Chloro-5-(7-benzofuranyl)-7-hydroxy-3-[11C]methyl-2,3,4,5-tetrahydro-1H-3-benzazepine [PDF Version][11C]NNC 112Kam Leung.Created: March 17, 2006; Last Update: January 12, 2008.
- (+)-p-[11C]Methylvesamicolphenoxy) [PDF Version](+)-[11C]PMVKenneth T. Cheng.Created: July 12, 2006; Last Update: January 23, 2008.
- (1R,2R)-N-(3-(4-[11C]Methoxyphenyl)-4-methylisothiazol-5-yl)-2-methylcyclopropane-carboxamide [PDF Version][11C]LY2428703Kam Leung.Created: January 18, 2013; Last Update: April 11, 2013.
- (20R)-4,5-α-Epoxy-17-methyl-3-hydroxy-6-[11C]methoxy-α,17-dimethyl-α-(2-phenylethyl)-6,14-ethenomorphinan-7-methanol [PDF Version][11C]PEOKam Leung.Created: October 24, 2009; Last Update: March 4, 2010.
- (2-methoxy-11C)-N-(4-(3,4-Dihydro-6,7-dimethoxy-isoquinolin-2(1H)-yl)butyl)-5-methylbenzamide [PDF Version][11C]RHM-1Kam Leung.Created: July 31, 2006; Last Update: May 18, 2008.
- (2S,3S)-(2-[11C]Methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine [PDF Version][11C]GR203040Kenneth T. Cheng.Created: August 30, 2006; Last Update: February 4, 2008.
- (2S,3S)-2-[α-(2-[11C]Methylphenoxy)phenylmethyl]morpholine [PDF Version][11C]MENET-1Kam Leung.Created: February 9, 2009; Last Update: May 15, 2009.
- (2S,3S)-N-[[2-[11C]Methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenyl-piperidin-3-amine [PDF Version][11C]GR205171Kenneth T. Cheng.Created: July 19, 2006; Last Update: April 3, 2008.
- (3-Ethyl-2-[11C]methyl-6-quinolinyl)(cis-4-methoxycyclohexyl)methanone [PDF Version][11C]JNJ-16567083Kam Leung.Created: November 15, 2012; Last Update: March 14, 2013.
- (3R,5R)-3-((R)-1-(4-Fluorophenyl)ethylamino)-5-(3-[11C]methoxyphenyl)-1-(4-trifluoromethylphenyl)pyrrolidin-2-one [PDF Version][11C]FMePPEPKam Leung and Sean Donohue.Created: August 6, 2010; Last Update: October 7, 2010.
- (3R,5R)-5-(3-[11C]Methoxy-phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one [PDF Version][11C]MePPEPKam Leung and Sean Donohue.Created: August 6, 2010; Last Update: October 7, 2010.
- (R,S)-1,2,3,4,10,14b-Hexahydro-2-[11C]methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine [PDF Version][11C]MirtazapineKam Leung.Created: March 9, 2006; Last Update: March 27, 2006.
- (R,S)-2-(N-Propyl-N-1'-[11C]-propyl)amino-5-hydroxytetralin [PDF Version][11C]-5-OH-DPATKam Leung.Created: August 26, 2006; Last Update: February 1, 2008.
- (R)-(-)-2-Chloro-N-[1-11C-propyl]n-propylnorapomorphine [PDF Version]2-Cl-[11C]-(-)-NPAKam Leung.Created: October 24, 2010; Last Update: December 11, 2010.
- (R)-(+)-8-Chloro-2,3,4,5-tetrahydro-3-[11C]methyl-5-phenyl-1H-3-benzazepin-7-ol ([11C]SCH 23390) [PDF Version][11C]SCH 23390Kam Leung.Created: November 22, 2005; Last Update: January 16, 2012.
- (R)-2,3,4,5,6,7-Hexahydro-1-[4-[1-[4-(2-[11C]methoxyphenyl)piperazinyl]]-2-phenylbutyryl]-1H-azepine [PDF Version](R)-[11C]RWAYKam Leung.Created: September 2, 2007; Last Update: October 22, 2007.
- (R)-2-[11C]Methoxy-N-n-propylnorapomorphine [PDF Version][11C]MNPAKam Leung.Created: April 11, 2006; Last Update: February 1, 2012.
- (S,S)-[11C]Methylreboxetine [PDF Version](S,S)-[11C]MRBThe MICAD Research Team.Created: April 19, 2006; Last Update: May 8, 2006.
- (S)-1-(4–2-[11C]Methoxybenzyl)-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione [PDF Version][11C]WC-98Kam Leung.Created: September 1, 2009; Last Update: September 30, 2009.
- (S)-5-Methoxymethyl-3-[6-(4,4,4-trifluorobutoxy)benzo[d]isoxazol-3-yl]-oxazolidin-2-[11C]one [PDF Version][11C]SL25.1188Kam Leung.Created: May 22, 2010; Last Update: July 7, 2010.
- (S)-6-[(4-Chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1-[11C]methyl-1H-benzotriazole [PDF Version][11C]VorozoleKam Leung.Created: May 8, 2009; Last Update: July 1, 2009.
- (S)-N-(1-Ethyl-2-pyrrolidinyl)methyl)-5-bromo-2-[11C]methoxy-3-methoxybenzamide [PDF Version][11C]FLB 457Kam Leung.Created: April 11, 2006; Last Update: October 6, 2011.
- [11C](+)-4-N-Propyl-,3,4a,5,6,10b-hexahydro-2H-naphth[1,2-b][1,4]-oxazin-9-ol [PDF Version][11C](+)-PHNOKam Leung.Created: May 2, 2006; Last Update: October 6, 2011.
- [11C](5R)-5-(Methoxymethyl)-3-[4-[(3R)-4,4,4-trifluoro-3-hydroxybutoxy]phenyl]-2-oxazolidinone [PDF Version][11C]BefloxatoneKam Leung.Created: July 15, 2006; Last Update: May 27, 2008.
- [11C]-[N-Methyl]3-[(3-fluorophenyl)sulfonyl]-8-(4-methyl-1-piperazinyl)quinoline [PDF Version][11C]-GSK215083Arvind Chopra.Created: February 6, 2012; Last Update: April 27, 2012.
- [11C]10-Methoxy-5-(2-propenyl)-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinoline [PDF Version][11C]AL-348Arvind Chopra.Created: January 13, 2009; Last Update: April 6, 2009.
- [11C]2-(2-((Dimethylamino)methyl)phenylthio)-5-(2-fluoroethyl)phenylamine [PDF Version][11C]AFEThe MICAD Research Team.Created: February 15, 2006; Last Update: March 7, 2006.
- [11C]2-(2-(Dimethylaminomethyl)phenylthio)-5-fluoromethylphenylamine [PDF Version][11C]AFMThe MICAD Research Team.Created: February 7, 2006; Last Update: February 14, 2006.
- [11C]2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole [PDF Version][11C]BF-227Kam Leung.Created: May 18, 2007; Last Update: August 26, 2008.
- [11C]2-(Dimethylamino)-N-(5,6-dihydro-6-oxophenanthridin-2-yl)acetamide [PDF Version][11C]PJ34The MICAD Research Team.Created: March 31, 2006; Last Update: March 31, 2006.
- [11C]2-2-(Dimethylaminomethyl)phenylthio)-5-fluorophenylamine [PDF Version][11C]AFAThe MICAD Research Team.Created: January 25, 2006; Last Update: February 14, 2006.
- [11C]4-N-Methylamino-4´-hydroxystilbene [PDF Version][11C]SB-13The MICAD Research Team.Created: February 27, 2005; Last Update: March 3, 2005.
- [11C]5-Hydroxy-2-(4-methyaminophenyl)benzofuran [PDF Version]The MICAD Research Team.Created: October 7, 2006; Last Update: October 16, 2006.
- [11C]Acetate [PDF Version]Kam Leung.Created: December 8, 2005; Last Update: May 19, 2008.
- [11C]Acetoacetate [PDF Version][11C]ACACKam Leung.Created: October 18, 2008; Last Update: November 12, 2008.
- [11C]Carfentanil [PDF Version][11C]CFNKam Leung.Created: March 24, 2007; Last Update: February 14, 2013.
- [11C]Choline [PDF Version][11C]CHKam Leung.Created: October 1, 2004; Last Update: February 7, 2011.
- [11C]Glycylsarcosine [PDF Version][11C]Gly-SarKam Leung.Created: September 21, 2008; Last Update: November 17, 2008.
- [11C]meta-Hydroxyephedrine [PDF Version][11C]mHEDKenneth T. Cheng.Created: January 19, 2006; Last Update: June 30, 2008.
- [11C]Methylated LY2181308 [PDF Version][11C]LY2181308Kam Leung.Created: January 27, 2011; Last Update: April 27, 2011.
- [11C]N,N-Dimethyl-2-(2´-amino-4´-hydroxymethylphenylthio)benzylamine [PDF Version][11C]HOMADAMThe MICAD Research Team.Created: January 10, 2005; Last Update: February 27, 2005.
- [11C]N,N-Dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine [PDF Version][11C]DASBKam Leung.Created: May 18, 2005; Last Update: June 24, 2008.
- [11C]N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine [PDF Version][11C]ErlotinibLiang Shan.Created: May 18, 2009; Last Update: June 18, 2009.
- [11C]N-Methyl-N-phenyl-[2-(4-chlorophenyl)-6,8-dichloroimidazo[1,2-a]pyridin-3-yl]acetamide [PDF Version][11C]PBR7Kam Leung.Created: October 8, 2008; Last Update: December 2, 2008.
- [11C]Norepinephrine [PDF Version][11C]NEKenneth T. Cheng.Created: February 14, 2006; Last Update: May 12, 2008.
- [11C]-p-Hydroxyphenethylguanidine [PDF Version][11C]-p-hydroxy-PGKenneth T. Cheng, David M. Raffel, and Yong-Woon Jung.Created: January 18, 2007; Last Update: February 11, 2008.
- [11C]Triphenylmethylphosphonium [PDF Version][11C]TPMPKam Leung.Created: September 21, 2006; Last Update: April 10, 2012.
- [18F]-3-Fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol [PDF Version][18F]-HX4Arvind Chopra.Created: August 16, 2010; Last Update: September 23, 2010.
- [1-methyl-11C]8-Dicyclopropylmethyl-1-methyl-3-propylxanthine [PDF Version][11C]MPDXKam Leung.Created: February 10, 2006; Last Update: July 6, 2008.
- [4-O-methyl-11C]-8-[(E)-2-(3,4-Dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methylpurine-2,6-dione [PDF Version][11C]KW-6002Kam Leung.Created: September 9, 2008; Last Update: October 15, 2008.
- [6-O-methyl-11C]Diprenorphine [PDF Version][11C]DPNKam Leung.Created: May 24, 2006; Last Update: May 12, 2007.
- [7-methyl-11C]-(E)-8-(3,4,5-Trimethoxystyryl)-1,3,7-trimethylxanthine [PDF Version][11C]TMSXKam Leung.Created: February 17, 2006; Last Update: July 8, 2008.
- [carbonyl-11C](R,S)-(N-(2-(1-(4-(2-Methoxyphenyl)piperazinyl)(2-methylethyl)))-N-pyridinyl)cyclohexanecarboxamide [PDF Version][carbonyl-11C](R,S)-JWAYKenneth T. Cheng.Created: October 16, 2006; Last Update: February 5, 2008.
- [Carbonyl-11C](S)-3-chloro-4-(4-((2-(pyridine-3-yl)pyrrolidin-1-yl)methyl)phenoxy)benzamide [PDF Version][11C]LY2795050Kam Leung.Created: March 21, 2013; Last Update: May 23, 2013.
- [Carbonyl-11C]N-(2-(1-(4-(2-Methoxyphenyl)-piperazinyl)ethyl)-N-pyridinyl)cyclohexanecarboxamide [PDF Version][Carbonyl-11C]WAY 100635The MICAD Research Team.Created: November 11, 2005; Last Update: February 21, 2007.
- [Carbonyl-11C]-N-(4-Fluorobenzyl)-4-(3-(piperidin-1-yl)indole-1-sulfonyl)benzamide [PDF Version][11C]PipISBKam Leung and Sean Donohue.Created: August 18, 2010; Last Update: October 28, 2010.
- [N-11C-methyl]-[4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]phenyl]benzamide [PDF Version][N-11C-methyl]ImatinibArvind Chopra.Created: May 30, 2007; Last Update: June 18, 2009.
- [N-Methyl-11C]-(11β17α)-11-[4-(dimethylamino)phenyl]-17-hydroxy-21-[4-(methylsulfonyl)phenyl]-19-norpregna-4,9-dien-20-yn-3-one [PDF Version][N-Methyl-11C]Org 34850Arvind Chopra.Created: January 7, 2009; Last Update: April 6, 2009.
- [N-methyl-11C]4-(4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl)-2,2-diphenyl-N-dimethyl-butanamide [PDF Version][11C]LopKam Leung.Created: December 23, 2008; Last Update: February 24, 2009.
- [N-methyl-11C]4-(4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl)-2,2-diphenyl-N-methyl-butanamide [PDF Version][11C]dLopKam Leung.Created: May 2, 2009; Last Update: December 3, 2009.
- [O-11C-methyl]4-N-(3-Bromoanilino)-6,7-dimethoxyquinazoline [PDF Version][11C]PD153035Kam Leung.Created: May 6, 2009; Last Update: July 7, 2009.
- [O-methyl-11C]2-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione [PDF Version][11C]MMP (CUMI-101)Kam Leung.Created: September 4, 2007; Last Update: June 20, 2012.
- [O-methyl-11C]2-{4-[4-(7-Methoxynaphthalen-1-yl)piperazin-1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione [PDF Version][11C]MPTKenneth T. Cheng.Created: January 30, 2007; Last Update: February 26, 2008.
- [S-methyl-11C]N,N-Dimethyl-4-(6-(methylthio)imidazo[1,2-a]pyridine-2-yl)aniline [PDF Version][11C]MeS-IMPYKam Leung.Created: October 6, 2007; Last Update: November 19, 2007.
- 1-([4-methoxy-11C]-3,4-Dimethoxyphenethyl)-4-(3-phenylpropyl)piperazinephenoxy) [PDF Version][11C]SA4503Kenneth T. Cheng.Created: June 30, 2006; Last Update: February 6, 2008.
- 1-([4-methoxy-11C]3,4-Dimethoxyphenethyl)-4-[3-(4-fluorophenyl)propyl]piperazine [PDF Version][11C]SA5845Kenneth T. Cheng.Created: October 21, 2006; Last Update: May 21, 2008.
- 1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid [11C]methyl ester [PDF Version][11C]MTOKam Leung.Created: June 10, 2005; Last Update: July 18, 2005.
- 1-(2,4-Dichlorophenyl)-4-cyano-5-(4-[11C]methoxyphenyl)-N-(pyrrolidin-1-yl)-1H-pyrazole-3-carboxamide [PDF Version][11C]JHU76609Kam Leung.Created: June 25, 2010; Last Update: August 26, 2010.
- 1-(2-Chlorophenyl)-N-[11C]methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide [PDF Version][11C]PK11195Kam Leung.Created: January 6, 2006; Last Update: February 22, 2012.
- 1-(3,4-[11C]Dimethoxyphenethyl)-4-[3-(3,4-dichlorophenyl)propyl]piperazinephenoxy) [PDF Version][11C]SA6298Kenneth T. Cheng.Created: December 28, 2006; Last Update: May 21, 2008.
- 1-(3-[11C]Methoxy-4-methoxybenzyl)-6,7-dimethoxyisoquinoline [PDF Version][11C]PapaverineKam Leung.Created: December 12, 2010; Last Update: March 2, 2011.
- 1-(9H-Carbazol-4-yloxy)-3-(2-(2-[11C]methoxyphenoxy)ethylamino)-propan-2-ol [PDF Version][11C]CarvedilolKam Leung.Created: December 30, 2005; Last Update: February 14, 2012.
- 1-(Benzofuran-2-ylmethyl)-4-(4-[11C]methoxybenzyl)piperazine [PDF Version][11C]13Liang Shan.Created: May 10, 2012; Last Update: June 27, 2012.
- 1-[11C]Arachidonic acid [PDF Version]1-[11C]AAArvind Chopra.Created: December 29, 2008; Last Update: January 14, 2009.
- 1-[11C]Methylpiperidin-4-yl propionate [PDF Version][11C]PMPKam Leung.Created: May 1, 2006; Last Update: February 28, 2012.
- 1-11C-Methyl-4-piperidinyl n-butyrate [PDF Version]11C-MP4BLiang Shan.Created: October 20, 2009; Last Update: December 14, 2009.
- 11C/68Ga-Labeled sel-tagged anti-epidermal growth factor receptor 2 affibody ZHER2:342 [PDF Version][11C/68Ga]ZHER2:342-STArvind Chopra.Created: October 2, 2012; Last Update: October 25, 2012.
- 11C-Labeled 1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate} [PDF Version][11C]-DocetaxelArvind Chopra.Created: July 22, 2011; Last Update: August 25, 2011.
- 11C-Labeled 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride [PDF Version][11C]GSK189254Arvind Chopra.Created: December 11, 2009; Last Revision: July 14, 2010.
- 11C-Labeled GSK931145 [PDF Version][11C]GSK931145Arvind Chopra.Created: March 2, 2012; Last Update: April 19, 2012.
- 11C-Labeled isoniazid [PDF Version][11C]INHLiang Shan.Created: August 2, 2010; Last Update: October 1, 2010.
- 11C-Labeled pyrazinamide [PDF Version][11C]PZALiang Shan.Created: August 2, 2010; Last Update: October 1, 2010.
- 11C-Labeled rhodamine-123 [PDF Version][11C]Rhodamine-123Arvind Chopra.Created: November 19, 2012; Last Update: December 27, 2012.
- 11C-Labeled rifampicin [PDF Version][11C]RIFLiang Shan.Created: August 2, 2010; Last Update: September 1, 2010.
- 11C-Labeled Telmisartan, an angiotensin II type 1 receptor antagonist [PDF Version][11C]TelmisartanArvind Chopra.Created: July 30, 2012; Last Update: August 30, 2012.
- 1R-[11C]Phenylephrine [PDF Version][11C]PHENKenneth T. Cheng.Created: January 25, 2006; Last Update: March 17, 2008.
- 2,2,3,3-Tetramethylcyclopropanecarboxylic acid [3-(2-[11C]methoxyethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]amide [PDF Version][11C]A-836339Kam Leung.Created: December 6, 2010; Last Update: January 27, 2011.
- 2-(2-(3-[11C]Methoxyphenyl)ethynyl)pyridine [PDF Version][11C]M-MPEPKenneth T. Cheng.Created: January 16, 2008; Last Update: February 25, 2008.
- 2-(2-(5-[11C]Methoxypyridin-3-yl)ethynyl)pyridine [PDF Version][11C]M-PEPyKenneth T. Cheng.Created: February 7, 2008; Last Update: March 18, 2008.
- 2-(2-[[O-11C]Tolyl)vinyl]-4,5-dihydro-1H-imidazole [PDF Version][11C]MetrazolineKam Leung.Created: February 24, 2012; Last Update: June 21, 2012.
- 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-[11C]methyl-amino]-2-propan-2-yl-pentanenitrile [PDF Version][11C]VerapamilKam Leung.Created: December 20, 2005; Last Update: February 7, 2012.
- 2-(3-Fluoro-[4-11C]tolyl)-4,5-dihydro-1H-imidazole [PDF Version][11C]FTIMDKam Leung.Created: February 19, 2012; Last Update: May 30, 2012.
- 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-[11C]methoxybenzyl)ethanamine [PDF Version][11C]CIMBI-36Kam Leung.Created: February 18, 2011; Last Update: March 30, 2011.
- 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-[11C]methoxybenzyl)ethanamine [PDF Version][11C]CIMBI-5Kam Leung.Created: January 18, 2011; Last Update: March 23, 2011.
- 2-(5-[11C]Methyl-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl)-xanthene-9-one [PDF Version][11C]A-844606Kam Leung.Created: October 12, 2010; Last Update: January 19, 2011.
- 2-(6-[11C]Methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)-7-(6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)-9H-fluoren-9-one [PDF Version][11C]A-752274Arvind Chopra.Created: April 9, 2013.
- 2-[11C]Methyl-5-[6-phenylpyridazine-3-yl]octahydropyrrolo[3,4-c]pyrrole [PDF Version][11C]A-582941Kam Leung.Created: October 12, 2010; Last Update: January 14, 2011.
- 2-[11C]Methyl-6-(2-phenylethynyl)pyridine [PDF Version][11C]MPEPKenneth T. Cheng.Created: November 15, 2007; Last Update: February 4, 2008.
- 2-[2-([O-11C]Tolyl)ethyl]-4,5-dihydro-1H-imidazole [PDF Version][11C]TEIMDKam Leung.Created: February 22, 2012; Last Update: June 21, 2012.
- 2-[methyl-11C]Methoxyestradiol [PDF Version][11C]2-MEKam Leung.Created: September 28, 2007; Last Update: December 4, 2007.
- 2-Butyl-5-[11C]methoxymethyl-6-(1-oxopyridin-2-yl)-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-3H-imidazo[4,5-b]pyridine [PDF Version][11C]KR31173Kam Leung.Created: May 12, 2006; Last Update: March 21, 2012.
- 2-chloro-N-((S)-((S)-1-[11C]methylpiperidine-2-yl)(thiophen-3-yl)methyl)-3-(trifluoromethyl)benzamide ([11C]SA1) and derivatives [PDF Version][11C]SA1, [11C]SA2, and [11C]SA3Arvind Chopra.Created: February 14, 2012; Last Update: May 10, 2012.
- 2-Hydroxy-3-isobutyl-9-[11C]methoxy-10-methoxy-1,2,3,4,6,7,-hexahydro-11bH-bezo[α]-quinolizine [PDF Version][11C]DTBZKam Leung.Created: March 17, 2006; Last Update: October 27, 2010.
- 2β-Carbo[11C]methoxy-3β-(3´-((Z)-2-iodoethenyl)phenyl)nortropane [PDF Version][11C]mZIENTJeffrey Stehouwer and Arvind Chopra.Created: January 31, 2011; Last Update: March 31, 2011.
- 2β-Carbo[11C]methoxy-3β-(4´-((Z)-2-iodoethenyl)phenyl)nortropane [PDF Version][11C]pZIENTJeffrey Stehouwer and Arvind Chopra.Created: January 31, 2011; Last Update: March 31, 2011.
- 2’-Fluoro-5-([11C]-methyl)-1-β-D-arabinofuranosyluracil [PDF Version][11C]FMAUArvind Chopra.Created: January 2, 2008; Last Update: January 24, 2008.
- 3-(6-Methyl-pyridin-2-ylethynyl)-cyclohex-2-enone-O-11C-methyl-oxime [PDF Version][11C]ABP688Kenneth T. Cheng.Created: April 27, 2006; Last Update: April 28, 2008.
- 3-[3,5-Dimethyl-4-(4-[11C]methylpiperazinecarbonyl)-1H-pyrrol-2-ylmethylene]-2-oxo-2,3-dihydro-1H-indole-5-sulfonic acid (3-chlorophenyl)methylamide [PDF Version][11C]SU11274Kam Leung.Created: April 17, 2010; Last Update: March 12, 2012.
- 3-Fluoromethyl-N-[11C]methyl-4-phenyl-N-(phenylmethyl)quinoline-2-carboxamide [PDF Version][11C]PBR6aKam Leung.Created: August 9, 2007; Last Update: September 17, 2007.
- 3-N-[11C]Methylspiperone [PDF Version][11C]NMSPKam Leung.Created: November 3, 2005; Last Update: October 6, 2011.
- 4-(3-Cyclopentoxy-4-[11C]methoxy-phenyl)pyrrolidin-2-one [PDF Version][11C]RolipramKam Leung.Created: January 12, 2006; Last Update: January 12, 2008.
- 4-[11C]Methylphenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate [PDF Version][11C]CHIBA-1001Kam Leung.Created: December 12, 2008; Last Update: October 7, 2010.
- 4-Acetoxy-7-chloro-3-(3-(-4-[11C]methoxybenzyl)phenyl)-2(1H)-quinolone [PDF Version][11C]AcL703,717Kam Leung.Created: May 8, 2009; Last Update: June 12, 2009.
- 4-Cyano-1-(2,4-dichlorophenyl)-5-(4-[11C]methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide [PDF Version][11C]JHU75528Kam Leung.Created: February 16, 2007; Last Update: March 5, 2007.
- 4-Hydroxy-, 5-hydroxy-, and 7-hydroxy- analogs of 6-hydroxy-2-(4’-[11C]methylaminophenyl)-1,3-benzothiazole [PDF Version][11C]6a, [11C]6b, and [11C]6cArvind Chopra.Created: December 8, 2009; Last Update: January 7, 2009.
- 5-(6-(5-[11C]methylhexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)pyridazin-3-yl)-1H-indole [PDF Version][11C]A-833834Arvind Chopra.Created: April 9, 2013; Last Update: June 27, 2013.
- 5-Amino-7-(3-(4-[11C]methoxy)phenylpropyl)-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine [PDF Version][11C]SCH442416Kam Leung.Created: July 7, 2007; Last Update: July 8, 2008.
- 5-Methyl-8-(4-[11C]methyl-piperazin-1-yl)-4-oxo-4H-chromene-2-carboxylic acid (4-morpholin-4-yl-phenyl)-amide [PDF Version][11C]AZ10419369Kam Leung.Created: May 4, 2009; Last Update: July 1, 2009.
- 6,7-Dimethoxy-2-[3-(5-[11C]methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-1,2,3,4-tetrahydro-isoquinoline [PDF Version][11C]MC-266Kam Leung.Created: June 24, 2010; Last Update: September 15, 2010.
- 6,7-Dimethoxy-2-{3-[4-[11C]methoxy-3,4-dihydro-2H-naphthalen-(1E)-ylidene]-propyl}-1,2,3,4-tetrahydro-isoquinoline [PDF Version][11C]6Kam Leung.Created: June 24, 2010; Last Update: September 15, 2010.
- 6-Hydroxy-[1,1'-biphenyl]-3-yl-cyclohexyl-[11C-carbonyl]carbamate [PDF Version][11C]CURBKam Leung.Created: October 24, 2012; Last Update: March 21, 2013.
- 7-[ 11C]Methoxy-1-methyl-9H-[3,4-b]indole [PDF Version][11C]HARKam Leung.Created: June 23, 2006; Last Update: March 14, 2012.
- 8-((E)-4-Fluoro-but-2-enyl)-3β-p-tolyl-8-aza-bicyclo[3.2.1]octane-2β-carboxylic acid [11C]methyl ester [PDF Version][11C]LBT-999Kam Leung.Created: December 11, 2008.
- Biphenyl-3-yl-4-[11C]methoxyphenylcarbamate [PDF Version][11C]URB597-1Kam Leung.Created: December 18, 2012; Last Update: February 21, 2013.
- Dimethylamino-3(4-[11C]methoxyphenyl)-3H-pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-one [PDF Version][11C]MMTPKam Leung.Created: December 5, 2012; Last Update: February 21, 2013.
- Ethyl 8-fluoro-5-[11C]methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate [PDF Version][11C]FMZArvind Chopra.Created: April 28, 2008; Last Update: June 10, 2008.
- L-[5-11C]-Glutamine [PDF Version]L-[5-11C]-GlnKam Leung.Created: January 7, 2012; Last Update: March 22, 2012.
- l-[methyl-11C]Methionine [PDF Version][11C]METKam Leung.Created: September 15, 2005; Last Update: December 21, 2011.
- Methyl-[11C]-4'-thiothymidine [PDF Version][11C]-4DSTArvind Chopra.Created: August 1, 2011; Last Update: September 8, 2011.
- N,N-Diethyl-2-2(2-(4-[11C]methoxyphenyl)-5,7-dimethyl-pyrazolo(1,5-a)pyrimidin-3-yl)-acetamide [PDF Version][11C]DPA-713Elisabeth Lutanie and Kam Leung.Created: April 19, 2006; Last Update: March 11, 2010.
- N-(2-[11C],5-Dimethoxybenzyl)-N-(5-fluoro-2-phenoxyphenyl)acetamide [PDF Version][11C]DAA1106Kam Leung.Created: January 30, 2006; Last Update: January 2, 2008.
- N-(4-(6-(Isopropylamino)pyrimidin-4-yl)-1,3-thiazol-2-yl)-4-[11C]methoxy-N-methylbenzamide [PDF Version][11C]ITMMKam Leung.Created: February 14, 2013; Last Update: May 2, 2013.
- N-(4-(6-(Isopropylamino)pyrimidin-4-yl)-1,3-thiazol-2-yl)-N-methyl-4-[11C]methylbenzamide [PDF Version][11C]ITDMKam Leung.Created: February 19, 2013; Last Update: May 2, 2013.
- N-[(1s)-1-[4-[[4-methoxy-2-[(4-[11C]methoxyphenyl)sulfonyl]-phenyl]sulfonyl]phenyl]ethyl]methanesulfonamide [PDF Version][11C]Methoxy-Sch225336Arvind Chopra.Created: May 12, 2010; Last Update: June 3, 2010.
- N-[[4'-[(2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridine-3-yl)methyl][1,1'-biphenyl]-2-yl]sul-fonyl]-4-[11C]methoxybenzamide [PDF Version][11C]L-159,884Kam Leung.Created: May 17, 2006; Last Update: March 14, 2012.
- N-[11C]Methyl-3-[[(dimethylamino)carbonyl]oxy]-2-(2’,2’-diphenylpropionoxymethyl)pyridinium [PDF Version][11C]MDDPThe MICAD Research Team.Created: June 24, 2006; Last Update: July 25, 2006.
- N-[11C]Methylpiperidin-4-yl acetate [PDF Version][11C]MP4AKam Leung.Created: April 19, 2006; Last Update: February 22, 2012.
- N-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-[11C]methoxybenzamide [PDF Version][11C]7Kam Leung.Created: May 5, 2013; Last Update: June 13, 2013.
- N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-S-[11C]methyl-L-cysteine [PDF Version][11C]DCMCArvind Chopra.Created: March 1, 2007; Last Update: December 6, 2007.
- N1’-([11C]Methyl)naltrindole [PDF Version][11C]MeNTIKam Leung.Created: April 12, 2007; Last Update: May 8, 2007.
- N2-{6-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]hexyl}-N2-[11C]methyl-2-furamide [PDF Version][11C]GB67Kam Leung.Created: February 2, 2006; Last Update: February 27, 2006.
- N-4-Fluorobut-2-yn-1-yl-2β-carbo-[11C]methoxy-3β-phenyltropane [PDF Version][11C]PR04.MZKam Leung.Created: August 8, 2011; Last Update: November 3, 2011.
- N-Acetyl-N-(2-[11C]methoxybenzyl)-2-phenoxy-5-pyridinamine [PDF Version][11C]PBR28Kam Leung.Created: June 12, 2007; Last Update: August 25, 2011.
- N-Benzyl-N-ethyl -2-(7-[11C]-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide [PDF Version][11C]AC-5216Kazuhiko Yanamoto and Ming-Rong Zhang.Created: December 4, 2007; Last Update: December 31, 2007.
- N-Methyl-[11C]-2-(4'-methylaminophenyl)-6-hydroxybenzothiasole [PDF Version][11C]6-OH-BTA-1 or [11C]PIBKam Leung.Created: July 11, 2005; Last Update: July 25, 2005.
- O-[11C]methyl derivative of 6,7-dimethoxy-2-(4-methoxy-biphenyl-4-yl-methyl)-1,2,3,4-tetrahydro-isoquinoline [PDF Version][11C]MC113Arvind Chopra.Created: November 5, 2012; Last Update: January 31, 2013.
- R-(−)-[11C]Epinephrine [PDF Version][11C]EPIKenneth T. Cheng.Created: March 28, 2006; Last Update: March 24, 2008.
- S-[11C]Methyl-L-cysteine [PDF Version][11C]MCYSKam Leung.Created: March 11, 2012; Last Update: June 28, 2012.
- S-4-(3-([11C]Isopropylamino)-2-hydroxypropoxy)-2H-benzimidazol-2-one [PDF Version]S-[11C]CGP 12388Kam Leung.Created: January 20, 2006; Last Update: February 12, 2011.
- trans-(+)-1,2,3,5,6,10b-Hexahydro-6-(4-([11C]methylthio)-phenyl)pyrrolo-(2,1-a)-isoquinoline [PDF Version][11C](+)McN5652The MICAD Research Team.Created: March 7, 2006; Last Update: April 12, 2006.
- (-)-3-(4-Chlorophenyl)-N'-[(4-[11C]cyanophenyl)sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine [PDF Version]
- 124I
- [124I]Iodo-azomycin-galactoside [PDF Version][124I]IAZGKam Leung.Created: November 22, 2007; Last Update: January 30, 2008.
- 124/131I-Labeled apoptosis-targeting peptide-1 (ApoPep-1) [PDF Version][124/131I]-ApoPep-1Arvind Chopra.Created: November 8, 2011; Last Update: December 1, 2011.
- 124I/64Cu-Labeled anti-CD20 minibody [PDF Version][124I/64Cu]Anti-CD20 ScFv-CH3 dimerArvind Chopra.Created: October 13, 2009; Last Update: November 24, 2009.
- 124I-Annexin V [PDF Version]Kenneth T. Cheng.Created: July 20, 2006; Last Update: January 2, 2008.
- 124I-Anti-CD44v6 chimeric monoclonal antibody U36 [PDF Version]124I-cMAb U36Kam Leung.Created: October 5, 2007; Last Update: November 19, 2007.
- 124I-Anti–prostate stem-cell antigen back-mutated 2B3 diabody [PDF Version]124I-bm2B3-Db8Kam Leung.Created: May 25, 2010; Last Update: August 1, 2010.
- 124I-Anti-PSCA 2B3 minibody [PDF Version]124I-2B3Kam Leung.Created: March 25, 2009; Last Update: May 13, 2009.
- 124I-Chimeric monoclonal antibody G250 [PDF Version]124I-cG250Kam Leung.Created: April 22, 2010; Last Update: May 20, 2010.
- 124I-Labeled antibody against lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) [PDF Version]124I-Anti-LYVE-1Kam Leung.Created: March 22, 2011; Last Update: July 6, 2011.
- 124I-Labeled anti-CD20 scFv-sc fragment [PDF Version][124I]Anti-CD20 scFv-sc DMArvind Chopra.Created: October 13, 2009; Last Update: November 24, 2009.
- 124I-Labeled anti-HER2-specific C6.5 diabody [PDF Version]124I-C6.5dbKam Leung.Created: May 22, 2011; Last Update: August 4, 2011.
- 124I-Labeled anti-prostate stem cell antigen affinity-matured A11 minibody [PDF Version]124I-A11Liang Shan.Created: June 23, 2010; Last Update: July 19, 2010.
- 124I-Labeled humanized CH2-domain-deleted anti-tumor-associated glycoprotein-72 (TAG-72) monoclonal antibody [PDF Version][124I]-HuCC49deltaCH2Arvind Chopra.Created: September 22, 2011; Last Update: October 27, 2011.
- 124I-Labeled residulizing ligand IMP-R4 conjugated chimeric monoclonal antibody ch806 targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII) [PDF Version][124I]-IMP-R4-ch806Arvind Chopra.Created: June 26, 2010; Last Update: August 5, 2010.
- 2'-Fluoro-2'-deoxy-5'-[123/124/125/131I]iodo-1β-d-arabinofuranosyluracil [PDF Version][123/124/125/131I]FIAUKam Leung.Created: February 1, 2005; Last Update: February 9, 2005.
- [124I]Iodo-azomycin-galactoside [PDF Version]
- 13N
- [13N]Ammonia [PDF Version][13N]NH3Kenneth T. Cheng.Created: December 5, 2005; Last Update: December 4, 2007.
- [13N]Ammonia [PDF Version]
- 149Tb, 152Tb, 155Tb, 161Tb
- [149/152/155/161Tb]-Labeled DOTA-folate conjugated to an albumin-binding entity [PDF Version][149/152/155/161Tb]cm09Arvind Chopra.Created: December 3, 2012; Last Update: December 27, 2012.
- [149/152/155/161Tb]-Labeled DOTA-folate conjugated to an albumin-binding entity [PDF Version]
- 18F
- (-)-7-Methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane [PDF Version][18F](-)-6cKam Leung.Created: April 12, 2009; Last Update: April 3, 2009.
- (+)-2-Hydroxy-3-isobutyl-9-(3-[18F]fluoropropoxy)-10-methoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine [PDF Version][18F]FP-(+)-DTBZKam Leung.Created: February 12, 2007; Last Update: October 14, 2010.
- (1R,2S,3S,5S)-Methyl-8-{[(1S,2S)-2-([18F]fluoromethyl)cyclopropyl]methyl}-3-phenyl-8-azabicyclo[3.2.1]octane-2-carboxylate [PDF Version][18F]PR17.MZKam Leung.Created: July 12, 2011; Last Update: December 8, 2011.
- (20R)-4,5-α-Epoxy-6-(2-[18F])fluoroethoxy)-3-hydroxy-α,17-dimethyl-α-(2-phenyleth-1-yl)-6,14-ethenomorphinan-7-methanol [PDF Version][18F]FE-PEOKam Leung.Created: February 24, 2013; Last Update: April 25, 2013.
- (3R,5R)-5-(3-(2-[18F]Fluoroethoxy)phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one [PDF Version][18F]FEPEPKam Leung and Sean Donohue.Created: August 6, 2010; Last Update: October 7, 2010.
- (3R,5R)-5-(3-[18F]Fluoromethoxy-d2)phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one [PDF Version][18F]FMPEP-d2Kam Leung and Sean Donohue.Created: August 6, 2010; Last Update: October 7, 2010.
- (3R,5R)-5-(3-[18F]Fluoromethoxy-phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one [PDF Version][18F]FMPEPKam Leung and Sean Donohue.Created: August 6, 2010; Last Update: October 7, 2010.
- (4S)-4-(3-[18F]Fluoropropyl)-l-glutamate [PDF Version][18F]FSPGArvind Chopra.Created: March 20, 2013; Last Update: May 23, 2013.
- (E)-2-(2-(2-(2-[18F]Fluoroethoxy)ethoxy)ethoxy)-5-(4-dimethylaminostyryl)-pyridine [PDF Version][18F]FPEGN3-StyrylpyridineKam Leung.Created: February 2, 2007; Last Update: March 5, 2007.
- (E)-3-(4-(Dimethylamino)phenyl)-1-(4-(2-(([18F]fluoroethoxy)ethoxy)ethoxy)phenyl)-2-propen-1-one [PDF Version][18F]7cKam Leung.Created: July 11, 2010; Last Update: October 20, 2010.
- (E)-3-(Pyridin-2-ylethynyl)-cyclohex-2-enone-O-2-(2-[18F]fluoroethoxy)ethyl oxime [PDF Version][18F]FDEGPECOKam Leung.Created: June 5, 2011; Last Update: September 29, 2011.
- (E)-4-(2-(6-(2-(2-(2-([18F]-fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)-N-methylbenzenamine [PDF Version][18F]AV-45Kam Leung.Created: February 11, 2010; Last Update: December 9, 2010.
- (R,S)-2-(N-Propyl-N-5'-[18F]fluoropentyl)amino-5-hydroxytetralin [PDF Version][18F]-5-OH-FPPATKam Leung.Created: August 27, 2006; Last Update: February 1, 2008.
- (R,S)-anti-1-Amino-2-[18F]fluorocyclopentyl-1-carboxylic acid [PDF Version]anti-2-[18F]FACPCKam Leung.Created: November 18, 2010; Last Update: February 10, 2011.
- (R)-2-(N-Benzyl-4-(2-[18F]fluoroethoxy)phenylsulfonamido)-N-hydroxy-3-methylbutanamide [PDF Version][18F]1fKam Leung.Created: March 10, 2008; Last Update: May 12, 2008.
- (R)-2-Amino-3-[18F]fluoro-2-methylpropanoic acid [PDF Version](R)-[18F]FAMPKam Leung.Created: May 18, 2010; Last Update: July 29, 2010.
- (R)-3-[18F]Fluoro-2-methyl-2-N-(methylamino)propanoic acid [PDF Version](R)-[18F]NMeFAMPKam Leung.Created: May 18, 2010; Last Update: July 29, 2010.
- (S,S)-2-(α-(2-[18F]Fluoro[2H2]methoxyphenoxy)phenoxy)benzyl)morpholine [PDF Version](S,S)-[18F]FMeNER-D2Kenneth T. Cheng.Created: May 5, 2006; Last Update: March 24, 2008.
- (S,S)-2-[α-(2-(2-[18F]Fluoro[2H4]ethoxy)phenoxy)benzyl]morpholine [PDF Version](S,S)-[18F]FRB-D4Kenneth T. Cheng.Created: September 14, 2006; Last Update: January 23, 2008.
- (S,S)-2-[α-(2-(2-[18F]Fluoroethoxy)phenoxy)benzyl]morpholine [PDF Version](S,S)-[18F]FRBKenneth T. Cheng.Created: August 9, 2006; Last Update: January 23, 2008.
- (S)-1-((1-(2-[18F]Fluoroethyl)-1H-[1,2,3]-triazol-4-yl)methyl)-5-(2-4-difluorophenoxymethyl-pyrrolidine-1-sulfonyl)isatin [PDF Version][18F]Isatin-15Kam Leung.Created: August 28, 2009; Last Update: September 30, 2009.
- (S)-1-(4-(2-[18F]Fluoroethoxy)benzyl)-5-[1-(2-methoxymethyl-pyrrolidinyl)sulfonyl]-1H-indole-2,3-dione [PDF Version][18F]CbR2Kam Leung.Created: June 29, 2007; Last Update: February 16, 2008.
- (S)-2-Amino-3-[1-(2-[18F]fluoroethyl)-1H-[1,2,3]triazol-4-yl]propanoic acid [PDF Version](S)-[18F]4Kam Leung.Created: July 7, 2011; Last Update: October 27, 2011.
- (S)-N-((1-Allyl-2-pyrrolidinyl)methyl)-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide [PDF Version][18F]FallyprideKam Leung.Created: November 29, 2005; Last Update: January 12, 2008.
- (S)-N-((1-Allyl-2-pyrrolidinyl)methyl)-5-(3-[18F]fluoropropyl)-2-methoxybenzamide [PDF Version][18F]DMFPKam Leung.Created: August 3, 2006; Last Update: May 17, 2008.
- [18F]1-(2-Fluoroethyl)-4-[(4-cyanophenoxy)methyl]piperidine [PDF Version][18F]SFEKenneth T. Cheng.Created: November 1, 2006; Last Update: February 5, 2008.
- [18F]1-(3-Fluoropropyl)-4-[(4-cyanophenoxy)methyl]piperidine [PDF Version][18F]FPSKenneth T. Cheng.Created: November 18, 2006; Last Update: December 20, 2007.
- [18F]-2-(2-Nitroimidazol-1H-yl)-(3,3,3-trifluoropropyl)acetamide [PDF Version][18F]EF3Kam Leung.Created: September 10, 2007; Last Update: October 22, 2007.
- [18F]3-(1H-Imidazol-4-yl)propyl-4-fluorobenzyl ether [PDF Version][18F]FluoroproxyfanKam Leung.Created: December 3, 2007; Last Update: January 28, 2008.
- [18F]3-Fluoro-5-[(2-methyl-1,3-thiazol-4-yl)ethynyl]benzonitrile [PDF Version][18F]F-MTEBThe MICAD Research Team.Created: July 12, 2006; Last Update: July 24, 2006.
- [18F]3-Fluoro-5-[(pyridin-3-yl)ethynyl]benzonitrile [PDF Version][18F]F-PEBKenneth T. Cheng.Created: May 22, 2006.
- [18F]-5-(2-fluoroethyl)2,4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate [PDF Version][18F]FE@SUPPYArvind Chopra.Created: December 26, 2007; Last Update: December 7, 2010.
- [18F]5-(6-Fluorohexyn-1-yl)-3-[2(S)-2-azetidinylmethoxy]pyridine [PDF Version][18F]ZW-104Kam Leung.Created: November 12, 2009; Last Update: January 14, 2010.
- [18F]6-(2-Fluoropropyl)-4-methyl-pyridin-2-amine [PDF Version][18F]iNOS-9Kam Leung.Created: August 11, 2009; Last Update: September 9, 2009.
- [18F]6-fluoro-3-O-methyl-L-3,4-dihydroxyphenylalanine [PDF Version][18F]OMFDArvind Chopra.Created: December 13, 2007; Last Update: January 8, 2008.
- [18F]FB-(Ac-NIe-Asp-His-d-Phe-Arg-Trp-Gly-Lys-NH2) [PDF Version][18F]FB-NAPamideKenneth T. Cheng, Sam Gambhir, and Zhen Cheng.Created: August 2, 2007; Last Update: August 10, 2007.
- [18F]FB-NH-mini-PEG-E{E[c(RGDyK)]2}2 [PDF Version][18F]FPRGD4Kenneth T. Cheng.Created: February 20, 2008; Last Update: March 12, 2008.
- [18F]Fluoro-[1,2-2H4]choline [PDF Version][18F]12cKam Leung.Created: March 1, 2011; Last Update: June 23, 2011.
- [18F]Fluoro-2-deoxy-2-D-glucose [PDF Version][18F]FDGKam Leung.Created: October 1, 2004; Last Update: January 12, 2005.
- [18F]-Fluoro-2-deoxy-d-glucose-folate [PDF Version][18F]-5Liang Shan.Created: October 1, 2012; Last Update: October 31, 2012.
- [18F]Fluorobenzaldehyde-leptin [PDF Version][18F]FBA-LeptinKam Leung.Created: November 6, 2008; Last Update: December 12, 2008.
- [18F]Fluorobenzoyl-((VHPKQHRGGSY)2K)2KK [PDF Version][18F]4VKam Leung.Created: June 29, 2010; Last Update: September 30, 2010.
- [18F]Fluorobenzoyl anti-HER2 Cys-diabody [PDF Version][18F]FB-Cys-DbLiang Shan.Created: October 31, 2012; Last Update: November 28, 2012.
- [18F]Fluorobenzoyl-PEGylated cyclic arginine-glycine-aspartic acid peptide [PDF Version][18F]FB-PEG-c(RGDyK)Kenneth T. Cheng and Peter S. Conti.Created: June 11, 2008; Last Update: July 4, 2008.
- [18F]Fluorobenzyl-bombesin[7-14]-c(RGDyK) [PDF Version][18F]FB-BBN-c(RGDyK)Kam Leung.Created: October 26, 2008; Last Update: December 2, 2008.
- [18F]Fluorobenzyl-PEG3-Glu-c(RGDyK)-bombesin[7-14] [PDF Version][18F]FB-PEG3-Glu-RGD-BBNKam Leung.Created: April 26, 2009; Last Update: July 1, 2009.
- [18F]Fluorocholine [PDF Version][18F]FCHKam Leung.Created: October 4, 2004; Last Update: February 1, 2011.
- [18F]Fluorodipalmitin-labeled liposomes [PDF Version][18F]FDP-liposomesKam Leung.Created: May 12, 2008; Last Update: May 29, 2008.
- [18F]Fluoroerythronitroimidazole [PDF Version][18F]FETNIMThe MICAD Research Team.Created: September 10, 2005; Last Update: February 6, 2006.
- [18F]Fluoroetanidazole [PDF Version][18F]FETAThe MICAD Research Team.Created: September 28, 2005; Last Update: October 19, 2005.
- [18F]Fluoroethylcholine [PDF Version][18F]FEChKam Leung.Created: March 1, 2011; Last Update: June 23, 2011.
- [18F]Fluoroethyl-recombinant human interlukin-1 receptor antagonist [PDF Version][18F]IL-1raKam Leung.Created: April 28, 2013; Last Update: June 6, 2013.
- [18F]Fluoromethyl-d-tyrosine [PDF Version]d-[18F]FMTArvind Chopra.Created: May 7, 2009; Last Update: June 18, 2009.
- [18F]Fluoromisonidazole [PDF Version][18F]FMISOThe MICAD Research Team.Created: July 18, 2005; Last Update: August 15, 2005.
- [18F]Fluoropropyl-Tanaproget [PDF Version][18F]FPTPKam Leung.Created: October 6, 2010; Last Update: December 11, 2010.
- [18F]-Labeled (R)-(2-(2-(2-methylpyrrolidin-1-yl)ethyl)benzofuran-5-yl)(4-fluorophenyl)-methanone [PDF Version][18F]9Liang Shan.Created: August 24, 2012; Last Update: September 25, 2012.
- [18F]N-(2-benzofuranylmethyl)-N'-[4-(2-fluoroethoxy)benzyl]piperazine [PDF Version][18F]6Liang Shan.Created: May 10, 2012; Last Update: June 27, 2012.
- [18F]-N-(2-Chloro-6-methylphenyl)-2-(6-(4-(2-fluoroethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide [PDF Version][18F]SKI-249380Kam Leung.Created: August 30, 2008; Last Update: October 15, 2008.
- [18F]-N-{4-[(4,5-Dichloro-2-fluorophenyl)amino]quinazoline-6-yl}-dimethylamine-butylamide [PDF Version][18F]ML04Arvind Chopra.Created: June 26, 2009; Last Update: August 12, 2009.
- [18F]Norchloro-fluoro-homoepibatidine [PDF Version][18F]NCFHEBKam Leung.Created: August 12, 2008; Last Update: August 22, 2008.
- [18F]SB209670 [PDF Version]The MICAD Research Team.Created: March 17, 2007; Last Update: March 25, 2007.
- [18F]Y1-973 [PDF Version][18F]Y1-973Kam Leung.Created: October 30, 2012; Last Update: February 14, 2013.
- [18F]α/γ-Fluorobenzylamine-folate [PDF Version][18F]α/γ-FBA-folateKam Leung.Created: July 12, 2006; Last Update: August 7, 2006.
- [2-[18F]Fluoromethoxy-5-(5-trifluoromethyl-tetrazol-1-yl)-benzyl]([2S,3S]2-phenyl-piperidin-3-yl)-amine [PDF Version][18F]SPA-RQThe MICAD Research Team.Created: June 21, 2006; Last Update: July 10, 2006.
- 1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-4-((6-[18F]fluoropyridin-3-yl)methyl)piperazine [PDF Version][18F]3dKam Leung.Created: May 10, 2013; Last Update: June 13, 2013.
- 1-(2'-Deoxy-2'-[18F]fluoroarabinofuranosyl)cytosine [PDF Version][18F]FACKam Leung.Created: December 18, 2010; Last Update: March 9, 2011.
- 1-(2'-Deoxy-2'-[18F]fluoro-β-d-arabinofuranosyl)-5-iodocytosine [PDF Version]18F-FIACLiang Shan.Created: March 19, 2012; Last Update: April 11, 2012.
- 1-(2-[18F]Fluoro-3-pyridyl)-4-(2-isopropyl-1-oxo-isoindoline-5-yl)-5-methyl-1H-1,2,3-triazole [PDF Version][18F]FPITKam Leung.Created: November 15, 2012; Last Update: March 7, 2013.
- 1-(2-[18F]Fluoro-3-pyridyl)-4-(2-propyl-1-oxo-isoindoline-5-yl)-5-methyl-1H-1,2,3-triazole [PDF Version][18F]MK-1312Kam Leung.Created: November 8, 2012; Last Update: March 7, 2013.
- 1-(2-{(2R)-1-[(2-[18F]Fluorophenyl)sulfonyl]pyrrolidin-2-yl}ethyl)-4-methylpiperidine [PDF Version][18F]-2FP3Kam Leung.Created: July 20, 2012; Last Update: November 1, 2012.
- 1-(2’-Deoxy-2’-[18F]-fluoro-β-D-arabinofuranosyl)thymine [PDF Version][18F]FMAUArvind Chopra.Created: January 9, 2008; Last Update: February 14, 2008.
- 1-(4-[18F]Fluoroethoxy-3-methoxyphenethyl)-4-(3-phenylpropyl)piperazine [PDF Version][18F]FE-SA4503Kenneth T. Cheng.Created: May 5, 2006; Last Update: May 27, 2008.
- 1-(4-[18F]Fluoromethoxy-3-methoxyphenethyl)-4-(3-phenylpropyl)piperazine [PDF Version][18F]FM-SA4503Kenneth T. Cheng.Created: June 7, 2007; Last Update: February 6, 2008.
- 1-(5-[18F]Fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole [PDF Version][18F]FAZAKam Leung.Created: July 19, 2005; Last Update: December 27, 2009.
- 1-[18F]Fluoro-3,6-dioxatetracosane [PDF Version][18F]SteP2Arvind Chopra.Created: March 31, 2009; Last Update: May 20, 2009.
- 1-[4-(2-[18F]Fluoroethoxy)-benzyl]-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione [PDF Version][18F]WC-II-89Kam Leung.Created: June 28, 2007; Last Update: February 16, 2008.
- 1-[4-(3-[18F]Fluoropropoxy)-3-methoxyphenyl]-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one [PDF Version][18F]Fluoropropyl-substituted curcuminThe MICAD Research Team.Created: October 17, 2006; Last Update: October 24, 2006.
- 11C-BMS-5p and 18F-FBzBMS: radiolabeled analogs of BMS-207940, a potent and selective antagonist of endothelin receptor subtype A [PDF Version][11C]-BMS-5p and [18F]FBzBMSArvind Chopra.Created: March 12, 2013; Last Update: June 27, 2013.
- 16α-[18F]Fluoro-17β-estradiol [PDF Version][18F]FESKam Leung.Created: December 6, 2004; Last Update: June 6, 2008.
- 18-[18F]Fluoro-4-thia-oleate [PDF Version][18F]FTOKam Leung.Created: September 15, 2010; Last Update: December 22, 2010.
- 18-[18F]Fluoro-4-thia-palmitate [PDF Version][18F]FTPKam Leung.Created: October 15, 2010; Last Update: December 22, 2010.
- 18F-(2S,4R)4-fluoroglutamine [PDF Version][18F]4-FGlnArvind Chopra.Created: December 15, 2011; Last Update: January 26, 2012.
- 18F-1,4,7-Triazacyclononane-1,4,7-triacetic acid-10-maleimidoethylacetamide-Affibody ZHER2:2395 [PDF Version]18F-NOTA-ZHER2:2395Kam Leung.Created: January 16, 2012; Last Update: March 29, 2012.
- 18F-6-Fluoro-N-[2-(diethylamino)ethyl]pyridine-3-carboxamide [PDF Version]18F-MEL050Liang Shan.Created: August 5, 2011; Last Update: September 28, 2011.
- 18F-Fluoroethyl triazole-βAG-[(d)-Phe1-c(Cys2-Tyr3-(d)-Trp4-Lys5-Thr6-Cys7)Thr8] [PDF Version]18F-FET-βAG-TOCALiang Shan.Created: March 7, 2012; Last Update: March 28, 2012.
- 18F-Labeled 4-(5-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N,N-dimethylbenzenamine [PDF Version][18F]FPHBF-1Liang Shan.Created: January 2, 2012; Last Update: March 7, 2012.
- 18F-Labeled 5-(5-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N,N-dimethylpyridin-2-amine [PDF Version][18F]FPYBF-1Liang Shan.Created: January 2, 2012; Last Update: March 7, 2012.
- 18F-Labeled 6-amino-2-(4’-fluorophenyl)-1,3-benzothiazole and other derivatives [PDF Version][18F]2Arvind Chopra.Created: November 23, 2009; Last Update: January 7, 2010.
- 18F-Labeled 6-methyl-2-(4’-fluorophenyl)-1,3-benzothiazole [PDF Version][18F]5Arvind Chopra.Created: December 4, 2009; Last Update: January 7, 2009.
- 18F-Labeled Cys-ZHER2:342, an anti-epidermal growth factor receptor-2 Affibody [PDF Version][18F]-Cys-ZHER2:342Arvind Chopra.Created: July 3, 2012; Last Update: August 9, 2012.
- 18F-Labeled exendin(9-39) [PDF Version][18F]Ex(9-39)Arvind Chopra.Created: February 9, 2012; Last Update: May 17, 2012.
- 18F-Labeled fluoropegylated 6-fluoroethoxy-4'-dimethylaminoflavone, 6-(2-(2-fluoro-ethoxy)-ethoxy)-4'-dimethylaminoflavone, and 6-(2-(2-(2-fluoro-ethoxy)-ethoxy)ethoxy)-4'-dimethylaminoflavone [PDF Version][18F]8(a–c)Liang Shan.Created: November 30, 2011; Last Update: December 28, 2011.
- 18F-Labeled N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-(2-[18F]-fluoroethoxy)-5-iodo-3-methoxybenzamide [PDF Version][18F]3fArvind Chopra.Created: November 18, 2009; Last Update: January 7, 2010.
- 18F-Labeled N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-(2-fluoroethoxy)-5-methylbenzamide [PDF Version][18F]3cArvind Chopra.Created: November 18, 2009; Last Update: January 7, 2010.
- 18F-Labeled N-(4-fluorobenzylidene)oxime-dimeric (ZHER2:477)2 [PDF Version]18F-FBO-(ZHER2:477)2Liang Shan.Created: November 2, 2011; Last Update: January 4, 2012.
- 18F-Labeled N-(4-fluorobenzylidene)oxime-monomeric ZHER2:477 [PDF Version]18F-FBO-ZHER2:477Liang Shan.Created: November 2, 2011; Last Update: January 4, 2012.
- 18F-Labeled N-(4-fluorobenzylidene)oxime-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH2 with a disulfide bridge between the two homoC [PDF Version]18F-FBO-MUT-DSLiang Shan.Created: November 15, 2011; Last Update: January 4, 2012.
- 18F-Labeled neogalactosylalbumin [PDF Version][18F]FNGAArvind Chopra.Created: October 19, 2009; Last Update: November 12, 2009.
- 18F-Labeled N-succinimidyl-4-fluorobenzoate–conjugated rat anti-mouse vascular endothelial growth factor receptor 2 monoclonal antibody linked to microbubbles [PDF Version][18F]-4SFB-Avas12a1 MBArvind Chopra.Created: November 14, 2011; Last Update: March 15, 2012.
- 18F-Labeled poly(L-lactic acid)-block-poly(sarcosine) lactosome, a polymer micelle [PDF Version][18F]-LactosomeArvind Chopra.Created: April 5, 2013; Last Update: May 2, 2013.
- 18F-Tetrazine-trans-cyclooctene-Cys40-exendin-4 [PDF Version]18F-TTCO-Cys40-exendin-4Kam Leung.Created: February 18, 2013; Last Update: April 25, 2013.
- 1-Deoxy-1-[18F]fluoro-scyllo-inositol [PDF Version][18F]-scyllo-InositolKam Leung.Created: December 7, 2011; Last Update: March 22, 2012.
- 1-O-(4-(2-[18F]Fluoroethyl-carbamoyloxymethyl)-2-nitrophenyl)-O-β-d-glucopyronuronate [PDF Version][18F]FEAnGAArvind Chopra.Created: March 28, 2012; Last Update: April 27, 2012.
- 2´-Deoxy-2´-[18F]fluoro-5-fluoro-1-β-D-arabinofuranosyluracil [PDF Version][18F]FFAUThe MICAD Research Team.Created: October 3, 2006; Last Update: October 16, 2006.
- 2'-Deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl-adenine [PDF Version][18F]FAAKam Leung.Created: September 11, 2007; Last Update: October 29, 2007.
- 2-((2-Amino-4-chloro-5-[18F]fluorophenyl)thio)-N,N-dimethylbenzenmethanamine [PDF Version][18F]ACFThe MICAD Research Team.Created: February 13, 2006; Last Update: February 27, 2006.
- 2-(+/-)-2-exo-(2'-[18F]Fluoro-3'-phenyl-pyridin-5'-yl)-7-azabicyclo[2.2.1]heptane [PDF Version][18F]FPhEPKam Leung.Created: October 6, 2006; Last Update: December 4, 2006.
- 2-(1-{6-[(2-[18F]Fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile [PDF Version][18F]FDDNPKam Leung.Created: July 25, 2005; Last Update: June 26, 2011.
- 2-(2'-((Dimethylamino)methyl)-4'-(3-[18F]fluoropropoxy)-phenylthio)benzenamine [PDF Version][18F]SERT-1Kam Leung.Created: September 24, 2008; Last Update: December 2, 2008.
- 2-(2-(2-(4-((4-(Methylamino)phenyl)ethynyl)phenoxy)ethoxy)[18F]fluoroethoxy)ethyl-4-methylbenzenamine [PDF Version][18F]AV-138Kam Leung.Created: May 11, 2011; Last Update: July 28, 2011.
- 2-(2-Nitro-1H-imidazol-1-yl)ethyl 2-[18F]fluoroacetate [PDF Version][18F]NEFTKam Leung.Created: July 19, 2011; Last Update: October 13, 2011.
- 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[18F]pentafluoropropyl)-acetamide [PDF Version][18F]EF5The MICAD Research Team.Created: November 8, 2005; Last Update: December 31, 2005.
- 2-(2-Nitroimidazol-1H-yl)-(3-[18F]fluoropropyl)acetamide [PDF Version][18F]EF1The MICAD Research Team.Created: November 5, 2005; Last Update: November 17, 2005.
- 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid [PDF Version][18F]DCFPyLLiang Shan.Created: November 10, 2012; Last Update: December 19, 2012.
- 2-(4-(2-[18F]Fluoroethyl)piperidin-1-yl)benzo[4,5]imidazo[1,2-a]pyrimidine [PDF Version][18F]T808Kam Leung.Created: September 27, 2012; Last Update: December 12, 2012.
- 2-(4-(4-[18F]Fluoro-butyl)-benzylsulfanyl)-3-methyl-chromen-4-one [PDF Version][18F]RP1005Kam Leung.Created: June 15, 2011; Last Update: January 26, 2012.
- 2-(4-Aminophenyl)-6-(2-([18F]fluoroethoxy))quinoline [PDF Version][18F]THK523Kam Leung.Created: June 27, 2011; Last Update: September 29, 2011.
- 2-(5-[18F]Fluoro-pentyl)-2-methyl-malonic acid (ML-10) [PDF Version][18F]ML-10Arvind Chopra.Created: August 15, 2012; Last Update: September 27, 2012.
- 2-(6-Chloro-2-(4-(3-[18F]fluoropropoxy)phenyl)imidazo[1,2-a]pyridin-3-yl)-N,N-diethylacetamide [PDF Version][18F]PBR111Kam Leung.Created: December 6, 2008; Last Update: March 11, 2009.
- 2-[(2-chloro-2’-18F-fluorodiethyl)amino]-2H-1,3,2-oxazaphosphorinane-2-oxide [PDF Version]18F-F-CPArvind Chopra.Created: December 21, 2007; Last Update: January 24, 2008.
- 2-[(4-{[(2-amino-4-oxohydropteridin-7yl)methyl]amino}phenyl) carbonylamino]-4-{N-[(2-[18F]-fluoro(4-pyridyl))carbonylamino] carbamoyl}butanoic acid [PDF Version][18F]-Folate-2Arvind Chopra.Created: November 16, 2011; Last Update: December 26, 2011.
- 2-[(4-{[(2-amino-4-oxohydropteridin-7yl)methyl]amino}phenyl) carbonylamino]-4-{N-[(4-[18F]-fluorophenyl)carbonylamino] carbamoyl}butanoic acid [PDF Version][18F]-Folate-1Arvind Chopra.Created: November 16, 2011; Last Update: December 26, 2011.
- 2-[18F]Fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine [PDF Version][18F]NifeneKam Leung.Created: September 6, 2006; Last Update: October 2, 2006.
- 2-[18F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine [PDF Version]2-[18F]FAKam Leung.Created: June 23, 2006; Last Update: April 8, 2008.
- 2-[18F]Fluoroacetate [PDF Version][18F]FACKam Leung.Created: March 22, 2007; Last Update: June 24, 2008.
- 2-[18F]Fluoro-N-(2-(2-nitro-1H-imidazol-1-yl)ethyl)acetamide [PDF Version][18F]NEFAKam Leung.Created: July 19, 2011; Last Update: October 13, 2011.
- 2-[18F]Fluoropropionyl-osteosarcoma–specific peptide-1 (ASGALSPSRLDT) [PDF Version][18F]FP-OSP-1Kam Leung.Created: September 23, 2010; Last Update: January 7, 2011.
- 2-[18F]Fluoropyridine-4-carbohydrazide-methotrexate [PDF Version][18F]-Folate-MTX-9Arvind Chopra.Created: November 16, 2011; Last Update: December 26, 2011.
- 2-[4-(4-[18F]Fluorobutyl)benzylsulfanyl]-3-methylchromene-4-one [PDF Version][18F]10Kam Leung.Created: December 15, 2007; Last Update: January 24, 2012.
- 2-{3-[18F]Fluoro-4-(methylamino)phenyl}-1,3-benzothiazol-6-ol [PDF Version][18F]FlutemetamolArvind Chopra.Created: November 14, 2012; Last Update: December 27, 2012.
- 2-{4-[-Pyridin-4-yl-1-(2-[18F]fluoro-ethyl)-1H-pyrazol-3-yl]-phenoxymethyl}-quinoline [PDF Version][18F]JNJ41510417Kam Leung.Created: December 20, 2010; Last Update: March 2, 2011.
- 2-Deoxy-2-[18F]fluorosorbitol [PDF Version][18F]FDSArvind Chopra.Created: January 14, 2008; Last Update: February 6, 2008.
- 2-tert-Butyl-4-chloro-5-[4-(2-[18F]fluoroethoxymethyl)-benzyloxy]-2H-pyridazin-3-one [PDF Version]BMS-747158-02Kam Leung.Created: December 15, 2007; Last Update: January 24, 2012.
- 2-tert-Butyl-4-chloro-5-[4-(2-[18F]fluoro-ethoxymethyl)-benzyloxy]-3-(2H)-pyridazinone [PDF Version][18F]MC1-27Kam Leung.Created: May 15, 2010; Last Update: July 29, 2010.
- 2-tert-Butyl-4-chloro-5-[4-(4-[18F]fluoro-butyl)-benzyloxy]-2H-pyridazin-3-one [PDF Version][18F]RP1004Kam Leung.Created: June 15, 2010; Last Update: August 26, 2010.
- 2β-Carbo(2-[18F]fluoroethoxy)-3β-(3´-((Z)-2-iodoethenyl)phenyl)nortropane [PDF Version][18F]FEmZIENTJeffrey Stehouwer and Arvind Chopra.Created: January 31, 2011; Last Update: March 31, 2011.
- 2β-Carbo(2-[18F]fluoroethoxy)-3β-(4´-((Z)-2-iodoethenyl)phenyl)nortropane [PDF Version][18F]FEpZIENTJeffrey Stehouwer and Arvind Chopra.Created: January 31, 2011; Last Update: March 31, 2011.
- 2β-Carbomethoxy-3β-(4-chlorophenyl)-8-(2-[18F]fluoroethyl)nortropane [PDF Version][18F]FECNTKam Leung.Created: October 27, 2005; Last Update: January 15, 2008.
- 2’-[18F]Fluoroflumazenil [PDF Version][18F]FFMZThe MICAD Research Team.Created: December 19, 2005; Last Update: December 17, 2005.
- 2’-[18F]Fluorofolic acid [PDF Version]2’-[18F]FFAKam Leung.Created: December 6, 2010; Last Update: March 9, 2011.
- 3'-Aza-2'-[18F]fluorofolic acid [PDF Version]3'-Aza-2'-[18F]FFAKam Leung.Created: April 6, 2013; Last Update: June 6, 2013.
- 3'-Deoxy-3'-[18F]fluoro-1-β-D-xylofuranosyl-adenine [PDF Version][18F]FXAKam Leung.Created: September 11, 2007; Last Update: October 29, 2007.
- 3'-Deoxy-3'-[18F]fluorothymidine [PDF Version][18F]FLTKam Leung.Created: October 1, 2004; Last Update: January 15, 2005.
- 3-(2-(S)-3,4-Dehydropyrrolinyl methoxy)-5-(3'-[18F]fluoropropyl)pyridine [PDF Version][18F]NifroleneKam Leung.Created: March 18, 2013; Last Update: May 23, 2013.
- 3-(3-(3-[18F]Flouropropyl)thio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine [PDF Version][18F]FP-TZTPKam Leung.Created: May 25, 2005; Last Update: June 6, 2005.
- 3-(4-[18F]Fluorobenzyl)-8-methoxy-1,2,3,4 tetrahydrochromeno[3,4-c]pyridin-5-one [PDF Version][18F]FMTPKam Leung.Created: December 5, 2005; Last Update: February 7, 2012.
- 3-(Pyridin-2-ylethynyl)-cyclohex-2-enone-O-[18F]fluoroethyl-oxime [PDF Version][18F]FE-DABP688Kam Leung.Created: December 3, 2007; Last Update: January 28, 2008.
- 3-[2-[4-(4-[18F]Fluorobenzoyl)-1-piperidyl]ethyl]-2-sulfanyl-3H-quinazolin-4-one [PDF Version][18F]AltanserinKam Leung.Created: December 8, 2005; Last Update: May 29, 2008.
- 3-{4-[2-[Benzoxazol-2-yl-methylamino]ethoxy]phenyl}-2-(2-[18F]fluoroethoxy)propionic acid [PDF Version]Compound [18F]22The MICAD Research Team.Created: April 2, 2007; Last Update: May 15, 2007.
- 3-Chloro-4-[18F]fluorophenyl-(4-fluoro-4-[[((5-methyl-4-methylamino-pyridin-2-ylmethyl)-amino]-methyl]-piperidin-1-yl)methanone (F13714) [PDF Version][18F]F13714Kam Leung.Created: June 24, 2012; Last Update: October 11, 2012.
- 3-Chloro-4-[18F]fluorophenyl-(4-fluoro-4-[[(5-methyl-pyrimidin-2-ylmethyl)-amino]-methyl]-piperidin-1-yl)methanone (F15599) [PDF Version][18F]F15599Kam Leung.Created: June 20, 2012; Last Update: October 11, 2012.
- 3-Cyano-4-[18F]fluoro-benzoyl-Ala(SO3H)-Ala(SO3H)-Ava-Gln-Trp-Ala-Val-NMeGly-His-Sta-Leu-NH2 [PDF Version][18F]BAY 86-4367Kam Leung.Created: June 5, 2011; Last Update: August 25, 2011.
- 3-Cyano-4-[18F]fluoro-benzoyl-Ala(SO3H)-Ava-Gln-Trp-Ala-Val-NMeGly-His-Sta-Leu-NH2 [PDF Version][18F]7bLiang Shan.Created: December 20, 2010; Last Update: January 24, 2011.
- 3-Cyano-4-[18F]fluoro-benzoyl-Arg-Ava-Gln-Trp-Ala-Val-NMeGly-His-Sta-Leu-NH2 [PDF Version][18F]6bLiang Shan.Created: December 20, 2010; Last Update: January 24, 2011.
- 3-N-(2-[18F]Fluoroethyl)spiperone [PDF Version][18F]FESPKam Leung.Created: October 7, 2005; Last Update: January 18, 2012.
- 3-β-(4-Iodophenyl)tropane-2-β-carboxylic acid 2-[18F]fluoroethyl ester [PDF Version][18F]FE@CITKam Leung.Created: August 11, 2008; Last Update: September 17, 2008.
- 4,16α-[16α-18F]Difluoro-11β-methoxyestradiol [PDF Version]4F-M[18F]FESKam Leung.Created: August 6, 2009; Last Update: September 12, 2009.
- 4-(2´-Methoxyphenyl)-1-[2´-(N-2´´-1,3 pyrimidino)-p-[18F]fluorobenzamido]ethylpiperazine [PDF Version][18F]FPWAYKenneth T. Cheng.Created: February 1, 2005; Last Update: June 30, 2008.
- 4-(2´-Methoxyphenyl)-1-[2´-(N-2´´-pyridinyl)-p-[18F]fluorobenzamido]ethylpiperazine [PDF Version]p-[18F]MPPFKenneth T. Cheng.Created: December 20, 2005; Last Update: March 10, 2008.
- 4-(2-(4-(4-[18F]Fluoro-butyl)-phenyl)ethoxy) quinazoline [PDF Version][18F]RP1003Kam Leung.Created: June 15, 2011; Last Update: January 26, 2012.
- 4-(3-((5-(2-[18F]Fluoroethoxy)pyridine-2-yl)oxy)benzylidene)-N-(pyridazin-3-yl)piperidine-1-carboxamide [PDF Version][18F]PF-9811Kam Leung.Created: October 20, 2012; Last Update: February 7, 2013.
- 4-[18F]Fluoro-2-D-methyl-3-mercaptopropanoyl-L-proline [PDF Version][18F]FCAPArvind Chopra.Created: March 8, 2007; Last Update: January 2, 2008.
- 4-[18F]Fluorobenzenecarbohydrazide-methotrexate [PDF Version][18F]-Folate-MTX-8Arvind Chopra.Created: November 16, 2011; Last Update: December 26, 2011.
- 4-[18F]Fluorobenzoyl-annexin V [PDF Version]4-[18F]FBAKam Leung.Created: February 7, 2006; Last Update: March 27, 2008.
- 4-[18F]Fluorobenzoyl-Arg-Arg-Natl-Cys-Tyr-Cit-Lys-d-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2 [PDF Version]4-[18F]F-T140Kam Leung.Created: January 15, 2011; Last Update: March 23, 2011.
- 4-[18F]Fluorobenzoyl-C2A domain of synaptotagmin I-glutathione-S-transferase [PDF Version]4-[18F]FB-C2A-GSTKam Leung.Created: May 27, 2011; Last Update: August 4, 2011.
- 4-[18F]Fluorobenzoyl-endothelin-1 [PDF Version][18F]ET-1The MICAD Research Team.Created: March 12, 2007; Last Update: April 12, 2007.
- 4-[18F]Fluorobenzoyl-knottin 2.5D [PDF Version][18F]FB-2.5DKam Leung.Created: March 23, 2010; Last Update: September 23, 2010.
- 4-[18F]Fluorobenzoyl-NAVPNLRGDLQVLAQKVART [PDF Version][18F]FB-A20FMDV2Kam Leung.Created: March 16, 2008; Last Update: May 12, 2008.
- 4-[18F]Fluorobenzoyl-Phe-Ala-Leu-Gly-Glu-Ala-NH2 [PDF Version][18F]FBA-FALGEA-NH2Kam Leung.Created: August 26, 2011; Last Update: December 8, 2011.
- 4-[18F]Fluorobenzoyl-rhenium-cyclized-Ac-D-Lys-[Cys3,4,10, D-Phe7, Arg11]α-MSH3-13 [PDF Version][18F]FB-RMSHKam Leung.Created: February 20, 2010; Last Update: April 8, 2010.
- 4-[18F]Fluorobenzoyl-T84.66 diabody [PDF Version][18F]FB-T84.66 diabodyKam Leung.Created: April 15, 2007; Last Update: February 1, 2008.
- 4-[18F]Fluorobenzoyl-ε-Lys1-c(KRGDe)MDDPGRNPHhCitGPAT [PDF Version][18F]FB-RGDechi-hCitKam Leung.Created: November 26, 2009; Last Update: December 17, 2009.
- 4-[18F]Fluorobenzyl-triphenylphosphonium [PDF Version][18F]FBnTPKam Leung.Created: September 26, 2006; Last Update: January 2, 2008.
- 4-[18F]Fluoro-l-m-tyrosine [PDF Version]4-[18F]FMTThe MICAD Research Team.Created: October 11, 2006; Last Update: November 9, 2006.
- 4-[18F]Fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide [PDF Version][18F]FITMKam Leung.Created: November 5, 2012; Last Update: February 14, 2013.
- 4-[18F]Fluoropaclitaxel [PDF Version][18F]FPACKam Leung.Created: January 2, 2006; Last Update: February 14, 2012.
- 4-[5-(4-[18F]Fluoro-phenyl)-[1,3,4]oxadiazol-2-yl]-1,4-diaza-bicyclo[3.2.2]nonane [PDF Version][18F]NS10743Kam Leung.Created: December 12, 2010; Last Update: January 27, 2011.
- 4-Bromo-1-(3-[18F]fluoropropyl)-2-nitroimidazole [PDF Version]4-Br[18F]FPNThe MICAD Research Team.Created: October 27, 2005; Last Update: December 12, 2005.
- 5-(2-[18F]Fluoroethoxy)-L-tryphan [PDF Version][18F]-L-FEHTPKam Leung.Created: March 3, 2012; Last Update: June 28, 2012.
- 5-(5-(2-(2-(2-[18F]Fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N-methylbenzenamine [PDF Version][18F]FPHBF-2Kam Leung.Created: June 11, 2011; Last Update: September 1, 2011.
- 5-(5-(2-(2-(2-[18F]Fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N-methylpyridin-2-amine [PDF Version][18F]FPYBF-2Kam Leung.Created: June 11, 2011; Last Update: September 1, 2011.
- 5-[(E)-2-(4-[18F]Fluorophenyl)ethenyl]-1,3-benzenediol [PDF Version]3,5-Dihydroxy-4'-[18F]fluoro-trans-stilbeneThe MICAD Research Team.Created: August 22, 2006; Last Update: September 11, 2006.
- 5-[18F]Fluoro-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-oxazolo[5,4-b]pyridine [PDF Version][18F]MK-3328Arvind Chopra.Created: December 20, 2011; Last Update: February 16, 2012.
- 5-3’-[18F]Fluoropropyl-3-[2-((S)-pyrrolidinyl)methoxy]pyridine [PDF Version][18F]NifrolidineKam Leung.Created: September 18, 2006; Last Update: April 3, 2012.
- 6-(2-[18F]Fluoroethoxy)-2-[2-(4-methylaminophenyl)ethenyl]benzoxazole [PDF Version][18F]BF-168Kenneth T. Cheng.Created: October 3, 2006; Last Update: January 28, 2008.
- 6-(3'-[18F]Fluoropropyl)-2-(4'-dimethylamino)phenylimidazol[1,2-α]pyridine [PDF Version][18F]FPPIPKenneth T. Cheng.Created: October 3, 2006; Last Update: April 9, 2008.
- 6-[1-(2-[18F]Fluoro-3-pyridyl)-5-methyl-1H-1,2,3-triazol-4-yl]quinoline [PDF Version][18F]FPTQKam Leung.Created: November 11, 2012; Last Update: March 7, 2013.
- 6-[18F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine [PDF Version]6-[18F]FAKam Leung.Created: June 26, 2006; Last Update: April 11, 2008.
- 6-[18F]Fluorodopamine [PDF Version][18F]FDAKam Leung.Created: April 6, 2005; Last Update: December 29, 2011.
- 6-[18F]Fluoro-l-m-tyrosine [PDF Version]6-[18F]FMTThe MICAD Research Team.Created: May 22, 2006; Last Update: September 6, 2006.
- 6-Deoxy-6-[18F]fluoro-D-fructose [PDF Version]6-[18F]FDFKam Leung.Created: July 10, 2011; Last Update: October 27, 2011.
- 6-Iodo-2-[4'-N-(2-[18F]fluoroethyl)methylamino]phenylimidazo[1,2-a]pyridine [PDF Version][18F]FEM-IMPYThe MICAD Research Team.Created: December 13, 2006; Last Update: December 31, 2006.
- 6-O-(2-[18F]Fluoroethyl)-6-O-desmethyldiprenorphine [PDF Version][18F]FDPNKam Leung.Created: June 15, 2006; Last Update: May 27, 2008.
- 8-Cyclopentyl-3-(3-[18F]fluoropropyl)-1-propylxanthine [PDF Version][18F]CPFPXKam Leung.Created: February 13, 2006; Last Update: July 8, 2006.
- 9-(4-(2-[18F]Fluoroethyl)benzyl)-9-azabicyclo[3.3.1]nonan-3-yl-2-methoxy-5-methyl-phenylcarbamate [PDF Version][18F]WC-59Arvind Chopra.Created: November 10, 2009; Last Update: December 9, 2009.
- 9-(4-[18F]Fluoro-3-hydroxymethylbutyl)guanine [PDF Version][18F]FHBGKam Leung.Created: January 24, 2005; Last Update: February 23, 2005.
- Ad5-(PSE-BC)-(GAL4-(VP16)2)-(GAL4)5-sr39tk [PDF Version]AdTSTA-sr39tkHuiming Zhang.Created: December 15, 2008; Last Update: January 5, 2009.
- Al18F-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Glu-[cyclo(Arg-Gly-Asp-d-Phe-Lys)]2 [PDF Version]Al18F-NODAGA-E-[c(RGDfK)]2Kam Leung.Created: May 7, 2013; Last Update: June 13, 2013.
- Al18F-1,4,7-Triazacyclononane-1,4,7-diacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 [PDF Version]Al18F-NOTA-8-Aoc-BBN[7-14]NH2Kam Leung.Created: June 26, 2012; Last Update: October 4, 2012.
- anti-1-Amino-2-[18F]fluorocyclobutane-1-carboxylic acid [PDF Version]anti-2-[18F]FACBCKam Leung.Created: November 18, 2010; Last Update: February 10, 2011.
- anti-1-Amino-3-[18F]fluorocyclobutane-1-carboxylic acid [PDF Version]anti-[18F]FACBCKam Leung.Created: October 18, 2004; Last Update: October 21, 2010.
- CtPyPyIm-(R)H2Nγ-PyImPyPy-C3-18F [PDF Version][18F]PIPAM8Huiming Zhang.Created: November 4, 2008; Last Update: December 1, 2008.
- Cyclo(-Arg-Gly-Asp-d-Phe-Lys(([18F]Fluoropropionyl)galacto-amino acid)-) [PDF Version][18F]Galacto-RGDKam Leung.Created: November 18, 2004; Last Update: January 9, 2006.
- Cys-Arg-Pro-Pro-Arg-[18F]fluorodipalmitin-liposomes [PDF Version]CRPPR-[18F]FDP-liposomesKam Leung.Created: May 12, 2008; Last Update: May 29, 2008.
- Fluoro-pegylated (1E,4E)-1-(4-(dimethylamino)phenyl)-5-(4-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)phenyl)penta-1,4-dien-3-one and (1E,4E)-1-(4-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)phenyl)-5-(4-(methylamino)phenyl)penta-1,4-dien-3-one [PDF Version][18F]83, [18F]85Liang Shan.Created: November 30, 2011; Last Update: February 7, 2012.
- ImPyβImPyβImβ-C3-18F [PDF Version][18F]PIPAM5Huiming Zhang.Created: November 4, 2008; Last Update: December 1, 2008.
- L-3,4-Dihydroxy-6-[18F]fluorophenylalanine [PDF Version][18F]FDOPAKam Leung.Created: March 21, 2005; Last Update: December 21, 2011.
- L- and D-S-(3-[18F]fluoropropyl)homocysteine [PDF Version]l- and d-[18F]FPHCysArvind Chopra.Created: January 10, 2012; Last Update: February 16, 2012.
- m-Cyano-p-[18F]fluorohippurate [PDF Version][18F]-CNPFHArvind Chopra.Created: October 24, 2012; Last Update: November 21, 2012.
- Methyl 2-(2-[18F]fluoro-4-nitrobenzamido)-3-methylbutanoate [PDF Version][18F]MFNBMBArvind Chopra.Created: August 5, 2009; Last Update: September 17, 2009.
- Methyl 2-(2-[18F]fluoro-4-nitrobenzamido)-3- methylbutanoic acid [PDF Version][18F]FNBMBAArvind Chopra.Created: August 5, 2009; Last Update: September 17, 2009.
- Methyl ester of 1-O-(4-(2-[18F]fluoroethyl-carbamoyloxymethyl)-2-nitrophenyl)-O-β-d-glucopyronuronate [PDF Version][18F]FEAnGA-MeArvind Chopra.Created: April 4, 2012; Last Update: April 27, 2012.
- N-((E)-4-[18F]Fluorobut-2-en-1-yl)-2β-carbomethoxy-3β-(4'-fluorophenyl)nortropane [PDF Version][18F]FBFNTJeffrey S. Stehouwer and Arvind Chopra.Created: January 31, 2011; Last Update: March 31, 2011.
- N-(2-(1-(4-(2-Methoxyphenyl)piperazinyl)ethyl))-N-(2-(6-[18F]fluoro)-pyridinyl)cyclohexanecarboxamide [PDF Version][18F]6FPWAYKenneth T. Cheng.Created: December 29, 2005; Last Update: June 30, 2008.
- N-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)-4-[18F]-fluorobenzamide ([18F]FBEM) conjugated to EM3106B, an analog of glucagon-like peptide-1 [PDF Version][18F]FBEM-EM3106BArvind Chopra.Created: February 23, 2012; Last Update: March 22, 2012.
- N-(2-(Diethylamino)ethyl)-6-[18F]fluoronicotinamide [PDF Version][18F]2Kam Leung.Created: October 7, 2009; Last Update: February 24, 2010.
- N-(2-Diethylaminoethyl)-4-[18F]fluorobenzamide for imaging melanoma [PDF Version][18F]-DAFBALiang Shan.Created: November 19, 2009; Last Update: December 30, 2009.
- N-(3-[18F]Fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl)nortropane [PDF Version][18F]FP-CITKam Leung.Created: December 15, 2004; Last Update: February 1, 2011.
- N-(4-(4-(2-(2-[18F]Fluoroethoxy)phenyl)piperazine-1-yl)butyl)-4-(3-thienyl)benzamide [PDF Version][18F]5Kam Leung.Created: June 24, 2011; Last Update: October 6, 2011.
- N-(4-[18F]Fluoro-benzoyl)-N'-{2-[5-(4-fluoro-benzyl)-1-(4-methoxy-benzyl)-4,6-dioxo-1,4,5,6-tetrahydro-[1,3,5]triazin-2-ylamino]-ethyl}-guanidine [PDF Version][18F]PC-10Kam Leung.Created: June 29, 2011; Last Update: August 25, 2011.
- N-(4-[18F]Fluorobenzyl)-4-(3-(piperidin-1-yl)indole-1-sulfonyl)benzamide [PDF Version][18F]PipISBKam Leung and Sean Donohue.Created: August 18, 2010; Last Update: October 28, 2010.
- N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide [PDF Version][18F]FEDAA1106Kam Leung.Created: March 10, 2006; Last Update: March 27, 2008.
- N-(6-[18F]Fluoro-4-phenoxypyridin-3-yl)-N-(2-methoxybenzyl)acetamide [PDF Version]6-[18F]Fluoro-PBR28Arvind Chopra.Created: March 26, 2013; Last Update: April 25, 2013.
- N-[18F]Fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline [PDF Version][18F]PBR06Kam Leung.Created: June 6, 2007; Last Update: March 11, 2010.
- N-[18F]Fluoroethylpiperidin-4ylmethyl acetate [PDF Version][18F]FEP-4MAKam Leung.Created: March 17, 2010; Last Update: September 23, 2010.
- N-[2-(3-cyanophenyl)-3-(4-(2-[18F]fluorethoxy)phenyl)-1-methylpropyl]-2-(5-methyl-2-pyridyloxy)-2-methylproponamide [PDF Version][18F]MK-9470Arvind Chopra.Created: February 28, 2008; Last Update: March 25, 2008.
- N-[2-(4-[18F]Fluorobenzamido)ethyl]maleimide-Cys-ZEGFR:1907 [PDF Version][18F]FBEM-Cys-ZEGFR:1907Kam Leung.Created: July 31, 2012; Last Update: November 1, 2012.
- N-[2-(4-[18F]Fluorobenzamido)ethyl]maleimide-sulfhydryl-cyclic-arginine-glycine-aspartic acid dimeric peptide [PDF Version][18F]FBEM-SRGD2Kenneth T. Cheng.Created: July 6, 2007; Last Update: February 25, 2008.
- N-[2-(4-[18F]Fluorobenzamido)ethyl]maleimide-sulfhydryl-cyclic-arginine-glycine-aspartic acid peptide [PDF Version][18F]FBEM-SRGDKenneth T. Cheng.Created: July 6, 2007; Last Update: February 25, 2008.
- N-[2-[N-Ethyl-N-[2-(2-[18F]fluoropyridin-3-yloxy)ethyl]amino]ethyl]-6-iodoquinoxaline-2-carboxamide [PDF Version][18F]44Liang Shan.Created: August 5, 2011; Last Update: August 20, 2011.
- N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine [PDF Version]18F-DCFBCKam Leung.Created: November 1, 2008; Last Update: December 2, 2008.
- N-{2-[4-(2-Methoxyphenyl)piperazinyl]ethyl}-N-(2-pyridyl)-N-(4-[18F]-fluoromethylcyclohexane)carboxamide [PDF Version][18F]MeFWAYKam Leung.Created: November 9, 2006; Last Update: April 11, 2012.
- N-2-(4-[18F]-Fluorobenzamido)ethylmaleimide coupled to cysteine-tagged epidermal growth factor [PDF Version][18F]FBEM-cEGFArvind Chopra.Created: January 30, 2012; Last Update: March 29, 2012.
- N-2-(4-[18F]-Fluorobenzamido)ethylmaleimide coupled to cysteine-tagged on the C- or N-terminal of exendin-4 [PDF Version][18F]FBEM-[Cys0]-exendin-4 and [18F]FBEM-[Cys40]-exendin-4Arvind Chopra.Created: February 21, 2012; Last Update: March 22, 2012.
- N-4'-[18F]Fluorobenzylpiperidin-4yl-(2-fluorophenyl)acetamide [PDF Version][18F]FBFPAKam Leung.Created: October 6, 2006; Last Update: March 5, 2008.
- N-4-[18F]Fluorobenzoyl-c(RGDyK) [PDF Version][18F]FB-c(RGDyK)Kam Leung.Created: March 6, 2006; Last Update: March 11, 2008.
- N-4-[18F]Fluorobenzoyl-c[(RGDyK)]2 [PDF Version][18F]FB-c[(RGDyK)]2Kam Leung.Created: March 3, 2006; Last Update: March 6, 2008.
- N-4-[18F]Fluorobut-2-yn-1-yl-2β-carbomethoxy-3β-phenyltropane [PDF Version][18F]PR04.MZKam Leung.Created: August 10, 2011; Last Update: November 3, 2011.
- N-Acetyl-N-(2-[18F]fluoroethoxybenzyl)-2-phenoxy-5-pyridinamine [PDF Version][18F]FEPPAKam Leung.Created: August 12, 2008; Last Update: August 22, 2008.
- N-Benzyl-N-ethyl-2-[7,8-dihydro-7-(2-[18F]fluoroethyl)-8-oxo-2-phenyl-9H-purin-9-yl]acetamide [PDF Version][18F]FEACKam Leung.Created: May 6, 2010; Last Update: August 19, 2010.
- N-Benzyl-N-methyl-2-[7,8-dihydro-7-(2-[18F]fluoroethyl)-8-oxo-2-phenyl-9H-purin-9-yl]acetamide [PDF Version][18F]FEDACKam Leung.Created: May 6, 2010; Last Update: August 19, 2010.
- O-(2-[18F]Fluoroethyl)-L-tyrosine [PDF Version][18F]FETKam Leung.Created: September 15, 2005; Last Update: December 6, 2011.
- O-(3-[18F]Fluoropropyl)-L-tyrosine [PDF Version][18F]FPTKam Leung.Created: February 18, 2005; Last Update: December 5, 2011.
- p-(2-[18F]Fluoroethyl)-l-phenylalanine [PDF Version][18F]FEPKam Leung.Created: February 7, 2011; Last Update: June 16, 2011.
- P2,P3-[18F]Monofluoromethylene diadenosine-5’,5’’’-P1,P4-tetraphosphate [PDF Version][18F]AppCHFppAHuiming Zhang.Created: March 20, 2008; Last Update: April 21, 2008.
- Para-[18F]-fluorohippurate [PDF Version][18F]-PFHHariprasad Gali and Arvind Chopra.Created: January 4, 2011; Last Update: February 24, 2011.
- PEGylated 4-[18F]fluorobenzoyl-NAVPNLRGDLQVLAQKVART [PDF Version]PEGylated [18F]FBA-A20FMDV2Arvind Chopra.Created: July 17, 2009; Last Update: October 1, 2009.
- Polyethylene glycol-Cys-Arg-Ser-Gly-Pro-Leu-Gly-Val-Tyr-[18F]fluorobenzoyl-Lys-Lys-tetramethylrhodamine [PDF Version]PEG-peptide-[18F]-TMRKam Leung.Created: February 6, 2012; Last Update: May 10, 2012.
- syn-1-Amino-3-[18F]fluorocyclobutane-1-carboxylic acid [PDF Version]syn-3-[18F]FACBCKam Leung.Created: November 18, 2010; Last Update: February 10, 2011.
- Trans-1,2,3,5,6,10b-hexahydro-6-[4-([18F]fluoroethylthio)-phenyl]pyrrolo-[2,1-a]-isoquinoline [PDF Version][18F]FEMcNArvind Chopra.Created: May 29, 2007; Last Update: June 27, 2007.
- Trans-4-(N-Methylamino)-4´-{2-[2-(2-[18F]fluoro-ethoxy)-ethoxy]-ethoxy}-stilbene [PDF Version][18F]BAY94-9172Kam Leung.Created: May 11, 2009; Last Update: June 5, 2009.
- (-)-7-Methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane [PDF Version]
- 44Sc
- 44Sc-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid–conjugated puromycin [PDF Version][44Sc]-DOTA-PurArvind Chopra.Created: January 28, 2013; Last Update: February 28, 2013.
- 44Sc-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid–conjugated puromycin [PDF Version]
- 60,61,62,64, 67Cu
- Copper(II) diacetyl-di(N4-methylthiosemicarbazone) [PDF Version]Cu-ATSMThe MICAD Research Team.Created: November 10, 2004; Last Update: July 31, 2005.
- Copper pyruvaldehyde bis(N4-methylthiosemicarbazone) complex [PDF Version]Cu-PTSMThe MICAD Research Team.Created: December 3, 2004; Last Update: January 3, 2005.
- Copper(II) diacetyl-di(N4-methylthiosemicarbazone) [PDF Version]
- 64Cu
- [64Cu](1-N-(4-aminobenzyl)-3,6,10,13,16,19-hexaazabicyclo[6.6.6]-eicosane-1,8-diamine)-anti-GD2 monoclonal antibody [PDF Version]Arvind Chopra.
- [64Cu]-1,4,7,10-Tetra-azacyclododecane-N,N’,N’’,N’’’-tetraacetic acid conjugated knottin 2.5D [PDF Version][64Cu] Knottin 2.5DArvind Chopra.Created: March 23, 2009; Last Update: May 28, 2009.
- [64Cu]-1,4,7,10-Tetra-azacyclododecane-N,N’,N’’,N’’’-tetraacetic acid conjugated knottin 2.5F [PDF Version][64Cu] Knottin 2.5FArvind Chopra.Created: March 25, 2009; Last Update: May 28, 2009.
- 64Cu-[Ac-NIe-Asp-His-d-Phe-Arg-Trp-Gly-Lys(1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid)-NH2] [PDF Version]64Cu-DOTA-NAPamideKenneth T. Cheng, Sam Gambhir, and Zhen Cheng.Created: August 10, 2007; Last Update: December 3, 2007.
- 64Cu-[cinnamoyl-Phe-D-Leu-Phe-D-Leu-Phe-Lys(PEG-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid)-NH2] [PDF Version]cFLFLFK-PEG-64CuArvind Chopra and Dongfeng Pan.Created: November 1, 2007; Last Update: May 30, 2008.
- 64Cu-{N-[1,4,8,11-Tetraazacyclotetradecanyl-1,4-phenylenebis(methylene)]-2-(aminomethyl)pyridine} [PDF Version]64Cu-AMD3465Kam Leung.Created: September 15, 2011; Last Update: January 5, 2012.
- 64Cu-1,4,7,10-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13 [PDF Version]64Cu-CBTE2A-ReCCMSH(Arg11)Kam Leung.Created: December 30, 2008; Last Update: May 11, 2009.
- 64Cu-1,4,7,10-Tetraazacyclodecane-N,N',N'',N'''-tetraacetic acid-vascular endothelial growth factor [PDF Version]64Cu-DOTA-VEGFKenneth T. Cheng.Created: December 19, 2006; Last Update: January 28, 2008.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-anti-CD105 TRC105 chimeric monoclonal antibody [PDF Version]64Cu-DOTA-TRC105Kam Leung.Created: October 27, 2011; Last Update: January 12, 2012.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Arg-Arg-Natl-Cys-Tyr-Cit-Lys-d-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2 [PDF Version]64Cu-DOTA-NFBKam Leung.Created: November 15, 2011; Last Update: February 9, 2012.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Arg-rich Cys knot scaffold grafted with integrin αvβ6-binding peptide RSLARTDLDHLRGR [PDF Version]64Cu-DOTA-R01Kam Leung.Created: August 16, 2012; Last Update: November 29, 2012.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Arg-rich Cys knot scaffold grafted with integrin αvβ6-binding peptide RSLARTDLDHLRGR [PDF Version]64Cu-DOTA-R02Kam Leung.Created: August 16, 2012; Last Update: November 22, 2012.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Asp-Gly-Glu-Ala [PDF Version]64Cu-DOTA-DGEAKam Leung.Created: January 3, 2012; Last Update: March 15, 2012.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-cyclo(CGNSNPKSC) [PDF Version]64Cu-DOTA-GX1Kam Leung.Created: January 30, 2012; Last Update: May 3, 2012.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-epidermal growth factor receptor-binding fibronectin domain E13.4.3' [PDF Version]64Cu-DOTA-FnE13.4.3'Kam Leung.Created: May 3, 2012; Last Update: August 9, 2012.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Ser-rich Cys knot scaffold grafted with integrin αvβ6-binding peptide RSLARTDLDHLRGR [PDF Version]64Cu-DOTA-S02Kam Leung.Created: August 16, 2012; Last Update: November 22, 2012.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-(Gly-Ser-Gly)-Lys-Cys-Cys-Tyr-Ser-Leu [PDF Version]64Cu-DO3A-(GSG)-KCCYSLKam Leung.Created: April 26, 2012; Last Update: July 5, 2012.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-human serum albumin-Ac-Cys-ZEGFR:1907 [PDF Version]64Cu-DO3A-HSA-ZEGFR:1907Kam Leung.Created: June 25, 2012; Last Update: September 27, 2012.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-tris-acetic acid-10-maleimidethylacetamide-Ac-Cys-ZEGFR:1907 [PDF Version]64Cu-DOTA-ZEGFR:1907Kam Leung.Created: June 21, 2012; Last Update: September 27, 2012.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-Tris-acetic acid-10-maleimidoethylacetamide-ACEQNPIYWARYADWLFTTPLLLLDLALLVDADEGTG [PDF Version]64Cu-DOTA-pHLIPLiang Shan.Created: May 29, 2009; Last Update: July 27, 2009.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-β max tris(acetic acid)-10-acetate mono(N-ethylmaleimide amide)-dimeric (ZHER2:477)2 [PDF Version]64Cu-DOTA-(ZHER2:477)2Liang Shan.Created: November 2, 2011; Last Update: November 30, 2011.
- 64Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-β max tris(acetic acid)-10-acetate mono(N-ethylmaleimide amide)-monomeric ZHER2:477 [PDF Version]64Cu-DOTA-ZHER2:477Liang Shan.Created: November 2, 2011; Last Update: November 30, 2011.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-anti-prostate-specific membrane antigen 3/A12 monoclonal antibody [PDF Version]64Cu-DOTA-3/A12Kam Leung.Created: August 1, 2009; Last Update: September 16, 2009.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Asp-cyclohexylalanine-Phe-D-Ser-D-Arg-Tyr-Leu-Trp-Ser [PDF Version]64Cu-DOTA-AE105Kam Leung.Created: January 7, 2009; Last Update: March 3, 2009.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Asp-cyclohexylalanine-Phe-d-Ser-d-Arg-Tyr-Leu-Trp-Ser-NH2 (AE105-NH2) [PDF Version]64Cu-DOTA-AE105-NH2Kam Leung.Created: May 18, 2012; Last Update: August 23, 2012.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-cetuximab [PDF Version]64Cu-DOTA-cetuximabKam Leung.Created: February 6, 2007; Last Update: June 15, 2009.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-C-type atrial natriuretic factor [PDF Version]64Cu-DOTA-C-ANFLiang Shan.Created: July 14, 2010; Last Update: August 24, 2010.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid- cyclic arginine-glycine-aspartic acid peptide [PDF Version]64Cu-DOTA-c(RGDyK)Kenneth T. Cheng.Created: February 7, 2007; Last Update: May 20, 2008.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-E(E{E[c(RGDyK)]2}2)2 peptide [PDF Version]64Cu-DOTA-RGD OctamerKenneth T. Cheng.Created: August 16, 2007; Last Update: February 21, 2008.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-E{E[c(RGDfK)]2}2 [PDF Version]64Cu-DOTA-E{E[c(RGDfK)]2}2Kenneth T. Cheng.Created: February 27, 2007; Last Update: February 21, 2008.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-E{E[c(RGDyK)]2}2 [PDF Version]64Cu-DOTA-E{E[c(RGDyK)]2}2The MICAD Research Team.Created: August 10, 2007; Last Update: August 29, 2007.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-HB22.7 [PDF Version]64Cu-DOTA-HB22.7Kam Leung.Created: February 20, 2009; Last Update: May 15, 2009.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-interleukin-18-binding protein-Fc [PDF Version]64Cu-DOTA-IL-18bp-FcKam Leung.Created: February 23, 2009; Last Update: May 15, 2009.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-panitumumab [PDF Version]64Cu-DOTA-PanitumumabKam Leung.Created: June 25, 2010; Last Update: September 30, 2010.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-p-benzyl-NH-hu14.18K322A [PDF Version]64Cu-DOTA-Bn-NH-hu14.18K322AKam Leung.Created: December 16, 2012; Last Update: March 14, 2013.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-PEGylated cyclic arginine-glycine-aspartic acid peptide [PDF Version]64Cu-DOTA-PEG-c(RGDyK)The MICAD Research Team.Created: May 10, 2007; Last Update: July 17, 2007.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-PEGylated dimeric cyclic arginine-glycine-aspartic acid peptide [PDF Version]64Cu-DOTA-PEG-E[c(RGDyK)]2Kenneth T. Cheng.Created: June 1, 2007; Last Update: May 8, 2008.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-polyethylene glycol 12 anti–tumor-associated glycoprotein 72 diabody [PDF Version]64Cu-PEG12 AVP04-07Liang Shan.Created: June 23, 2010; Last Update: September 1, 2010.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-polyethylene glycol 27 anti–tumor-associated glycoprotein 72 diabody [PDF Version]64Cu-PEG27 AVP04-07Liang Shan.Created: June 23, 2010; Last Update: July 19, 2010.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121 [PDF Version]64Cu-DOTA-PEG-scVEGFKam Leung.Created: February 27, 2008; Last Update: March 22, 2008.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-polyethylene-glycol-single-walled nanotube-c(RGDyK) [PDF Version]64Cu-DOTA-SWNT-PEG-c(RGDyK)Kam Leung.Created: October 6, 2008; Last Update: October 21, 2008.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 scFv-human serum albumin [PDF Version]64Cu-DOTA-T84.66 scFv-HSAKam Leung.Created: July 2, 2008; Last Update: September 2, 2008.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-vascular endothelial growth factor-121(D63AE64AE67A) [PDF Version]64Cu-DOTA-VEGFDEEKam Leung.Created: September 17, 2007; Last Update: October 22, 2007.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-1,4,7,10-tetraacetic acid-rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13 [PDF Version]64Cu-DOTA-ReCCMSH(Arg11)Kam Leung.Created: December 30, 2008; Last Update: May 11, 2009.
- 64Cu-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid agouti-related protein-7C [PDF Version]64Cu-DOTA-AgRP-7CKam Leung.Created: May 23, 2010; Last Update: July 16, 2010.
- 64Cu-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-cyclo(Arg-Gly-Asp-d-Phe-Lys) [PDF Version]64Cu-NODAGA-c(RGDfK)Kam Leung.Created: November 28, 2011; Last Update: February 16, 2012.
- 64Cu-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-cyclo(Arg-Gly-Asp-d-Tyr-Lys) [PDF Version]64Cu-NODAGA-c(RGDyK)Kam Leung.Created: March 28, 2013; Last Update: June 6, 2013.
- 64Cu-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2 [PDF Version]64Cu-NODAGA-LM3Kam Leung.Created: May 5, 2012; Last Update: August 16, 2012.
- 64Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-Arg-Arg-Natl-Cys-Tyr-Cit-Lys-d-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH2 [PDF Version]64Cu-NOTA-NFBKam Leung.Created: November 15, 2011; Last Update: February 9, 2012.
- 64Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-ALT-836 [PDF Version]64Cu-NOTA-ALT-836Kam Leung.Created: December 6, 2012; Last Update: March 21, 2013.
- 64Cu-1,4,7-Triazacyclononane-1,4-7-triacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 [PDF Version]64Cu-NOTA-8-Aoc-BBN[7-14]NH2Kam Leung.Created: June 26, 2009; Last Update: July 24, 2009.
- 64Cu-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-c(RGDyK)-bombesin[7-14] [PDF Version]64Cu-NOTA-RGD-BBNKam Leung.Created: October 26, 2009; Last Update: January 28, 2010.
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetate-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 [PDF Version]64Cu-NO2A-8-Aoc-BBN[7-14]NH2Kam Leung.Created: June 26, 2009; Last Update: July 23, 2009.
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-(Gly-Ser-Gly)-Lys-Cys-Cys-Tyr-Ser-Leu [PDF Version]64Cu-NO2A-(GSG)-KCCYSLKam Leung.Created: April 26, 2012; Last Update: July 5, 2012.
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-6-aminohexanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 [PDF Version]64Cu-NO2A-(6-Ahx)-BBN(7–14)NH2Liang Shan.Created: January 2, 2011; Last Update: January 25, 2011.
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-9-aminonanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 [PDF Version]64Cu-NO2A-(9-Anc)-BBN(7–14)NH2Liang Shan.Created: January 2, 2011; Last Update: January 25, 2011.
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-c(RGDyK)-Glu-6-aminohexanoic acid-bombesin[7-14]NH2 [PDF Version]64Cu-NO2A-RGD-Glu-6-Ahx-BBNKam Leung.Created: August 6, 2012; Last Update: November 8, 2012.
- 64Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-para-aminobenzoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 [PDF Version]64Cu-NO2A-(AMBA)-BBN(7–14)NH2Liang Shan.Created: January 2, 2011; Last Update: January 25, 2011.
- 64Cu-1,4,8,11-Tetraazacyclotetradecane-N,N',N",N"'-tetraacetic acid-D-Phe-cyclo(Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr(OH) [PDF Version]64Cu-TETA-Y3-TATEKam Leung.Created: September 1, 2009; Last Update: October 8, 2009.
- 64Cu-1,4,8,11-Tetraazacyclotetradecane-regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-d-Phe-Lys)]4 [PDF Version]64Cu-Cyclam-RAFT-c(-RGDfK-)4Kam Leung.Created: August 9, 2011; Last Update: December 1, 2011.
- 64Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-cyclic-arginine-glycine-aspartic acid peptide [PDF Version]64Cu-CB-TE2A-c(RGDyK)Kenneth T. Cheng.Created: May 9, 2007; Last Update: May 20, 2008.
- 64Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-D-Phe-cyclo(Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr(OH) [PDF Version]64Cu-CB-TE2A-Y3-TATEKam Leung.Created: September 1, 2009; Last Update: October 8, 2009.
- 64Cu-4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-LLP2A [PDF Version]64Cu-CB-TE2A-LLP2AKam Leung.Created: June 10, 2009; Last Update: August 12, 2009.
- 64Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2 [PDF Version]64Cu-CB-TE2A-LM3Kam Leung.Created: May 5, 2012; Last Update: August 16, 2012.
- 64Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-Phe(4-NO2)-cyclo(D-Cys-Tyr-D-Trp-Lys-Thr-Cys)-D-Tyr-NH2 [PDF Version]64Cu-CB-TE2A-sst2-ANTKam Leung.Created: September 1, 2009; Last Update: October 15, 2009.
- 64Cu-Anti-human integrin αvβ3 monoclonal antibody [PDF Version]64Cu-DOTA-hLM609-IIKenneth T. Cheng.Created: January 31, 2007; Last Update: February 13, 2008.
- 64Cu-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-(Gly-Ser-Gly)-Lys-Cys-Cys-Tyr-Ser-Leu [PDF Version]64Cu-CB-TE2A-(GSG)-KCCYSLKam Leung.Created: April 26, 2012; Last Update: July 5, 2012.
- 64Cu-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-cyclo(Arg-Gly-Asp-d-Phe-Lys) [PDF Version]64Cu-CB-TE2A-c(RGDfK)Kam Leung.Created: November 28, 2011; Last Update: February 16, 2012.
- 64Cu-Diethylenetriamine pentaacetic acid-NH-CO-CH2-S-CH2-Phe-Pro-Arg-CH2-prothrombin [PDF Version]64Cu-DTPA-ProTLiang Shan.Created: March 15, 2012; Last Update: May 15, 2012.
- 64Cu-DOTA-[Pro1,Tyr4]-Bombesin[1-14] [PDF Version]64Cu-MP2346Kenneth T. Cheng, Jason S. Lewis, and Gráinne B. Biddlecombe.Created: August 16, 2007; Last Update: January 8, 2008.
- 64Cu-DOTA hu4D5v8 (scFv-CH2-CH3)2 [PDF Version]64Cu-DOTA hu4D5v8 scFv-Fc DMKenneth T. Cheng.Created: April 11, 2006; Last Update: April 3, 2008.
- 64Cu-Labeled, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-chelated, and cysteine-modified anti-activated leukocyte cell adhesion molecule diabody [PDF Version]64Cu-DOTA-CysDbLiang Shan.Created: November 7, 2012; Last Update: November 28, 2012.
- 64Cu-Labeled 1,1’-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane} [PDF Version][64Cu]-AMD3100Arvind Chopra.Created: June 8, 2009; Last Update: July 7, 2009.
- 64Cu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH2 with a disulfide bridge between the two homoC [PDF Version]64Cu-DOTA-MUT-DSLiang Shan.Created: November 15, 2011; Last Update: December 21, 2011.
- 64Cu-Labeled 1,4,7,10-Tetraazacyclododedane-N,N’,N’’,N’’’-tetraacetic acid–conjugated vascular endothelial growth factor A isoform 121-gelonin fusion protein [PDF Version]64Cu-DOTA-VEGF121/rGelLiang Shan.Created: July 6, 2011; Last Update: August 10, 2011.
- 64Cu-Labeled 1,4,7-tris(acetic acid)-10-vinylsulfone-1,4,7,10-tetraazacyclododecane conjugated to Cys40-Exendin-4 [PDF Version]64Cu-DO3A-VS-Cys40-Exendin-4Arvind Chopra.Created: August 24, 2011; Last Update: March 15, 2012.
- 64Cu-Labeled 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo [6.6.6] icosane-1-ylamino)methyl)benzoic acid (AmBaSar) [PDF Version][64Cu]-AmBaSarArvind Chopra.Created: September 23, 2010; Last Update: October 28, 2010.
- 64Cu-Labeled 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo [6.6.6]
icosane-1-ylamino)methyl)benzoic acid (AmBaSar) conjugated to cyclic
arginine-glycine-aspartic acid (RGD) peptide [PDF Version][64Cu]-AmBaSar-RGDArvind Chopra.Created: September 20, 2010; Last Update: October 28, 2010.
- 64Cu-Labeled anti-c-kit monoclonal antibody 12A8 Fab fragment [PDF Version][64Cu]12A8 FabArvind Chopra.Created: June 9, 2011; Last Update: June 30, 2011.
- 64Cu-Labeled bis-1,4,7,10-tetraazacyclododecane-N,N',N,N'-tetraacetic acid conjugated hypericin [PDF Version][64Cu]-bis DOTA-hypericinArvind Chopra.Created: May 3, 2011; Last Update: May 26, 2011.
- 64Cu-Labeled cysteine–tagged dimeric epidermal growth factor [PDF Version][64Cu]Cys-dEGFArvind Chopra.Created: May 18, 2009; Last Update: July 15, 2009.
- 64Cu-Labeled cysteine–tagged epidermal growth factor [PDF Version][64Cu]Cys-EGFArvind Chopra.Created: May 18, 2009; Last Update: July 15, 2009.
- 64Cu-Labeled DOTA conjugated anti-epithelial membrane protein 2 minibody KS83 [PDF Version][64Cu]-DOTA-KS83Arvind Chopra.Created: February 20, 2013; Last Update: February 28, 2013.
- 64Cu-Labeled DOTA-conjugated rituximab, a chimeric murine/human anti-CD20 monoclonal antibody [PDF Version][64Cu]-DOTA-RituximabArvind Chopra.Created: September 20, 2012; Last Update: October 25, 2012.
- 64Cu-Labeled human serum albumin–conjugated Affibody ZHER2:342 that targets the human epidermal growth factor receptor 2 (HER2) [PDF Version][64Cu]-DOTA-HSA-ZHER2:342Arvind Chopra.Created: May 19, 2011; Last Update: June 1, 2011.
- 64Cu-Labeled l-histidine [PDF Version][64Cu]-HisArvind Chopra.Created: June 14, 2012; Last Update: July 26, 2012.
- 64Cu-Labeled Lys40(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid)NH2–conjugated exendin-4 [PDF Version][64Cu](Lys40(DOTA)NH2)Exendin-4Arvind Chopra.Created: January 25, 2012; Last Update: February 23, 2012.
- 64Cu-Labeled Oxo-DO3A-conjugated trastuzumab and PCTA-conjugated trastuzumab [PDF Version][64Cu]-Oxo-DO3A-trastuzumab and [64Cu]-PCTA-trastuzumabArvind Chopra.Created: July 24, 2012; Last Update: August 23, 2012.
- 64Cu-Labeled PEGylated nano-graphene oxide (GO) covalently linked to NOTA-conjugated anti-CD105 (endoglin) chimeric monoclonal antibody TRC105 [PDF Version][64Cu]-NOTA-GO-TRC105Arvind Chopra.Created: May 17, 2012; Last Update: June 28, 2012.
- 64Cu-N,N'-Bis(S-benzoyl-thioglycoloyl)diaminopropanoate-KRAS-PNA-d(Cys-Ser-Lys-Cys) [PDF Version]64Cu-WT4351Kenneth T. Cheng, Atis Chakrabart, Mohan R. Aruva, Mathew L. Thakur, and Eric Wickstrom.Created: August 10, 2007; Last Update: January 3, 2008.
- 64Cu-Polyethylenimine [PDF Version]64Cu-PEIKam Leung.Created: April 16, 2010; Last Update: July 1, 2010.
- 64Cu-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-conatumumab [PDF Version]64Cu-DOTA-conatumumabKam Leung.Created: October 8, 2011; Last Update: December 29, 2011.
- 64Cu-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-MEDI-522 [PDF Version]64Cu-DOTA-MEDI-522Kam Leung.Created: June 8, 2011; Last Update: June 30, 2011.
- 64Cu-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-TNYLFSPNGPIARAW (TNYL-RAW) [PDF Version]64Cu-DOTA-TNYL-RAWKam Leung.Created: September 10, 2011; Last Update: December 15, 2011.
- 64Cu-Z-E-(1,8-Diamino-3,6,10,13,16,19-hexaazabicyclo(6,6,6)eicosane)-aminohexanoyl-Asp-Gly-Glu-Ala [PDF Version]64Cu-Z-E(diamsar)-Ahx-DGEAKam Leung.Created: January 3, 2012; Last Update: March 15, 2012.
- Copper 1,4,8,11-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid-octreotide [PDF Version]Cu-TETA-OCThe MICAD Research Team.Created: December 20, 2004; Last Update: March 14, 2005.
- HSDAVFTDNYTKLRKQ-NIe-AVKK-(3-OCH3,4-OH)-FLNSSV-GABA-L-(Dap-(BMA)2)-64Cu [PDF Version]64Cu-TP3939Kenneth T. Cheng and Mathew L. Thakur.Created: March 17, 2008; Last Update: June 11, 2008.
- NR-LU-10/streptavidin-copper 64-(1,4,7,10-tetraazacyclododecane-N,N′,N′′,N′′′-tetraacetic acid)-biotin [PDF Version]NR-LU-10/SA-64Cu-DOTA-biotinThe MICAD Research Team.Created: February 15, 2005; Last Update: May 25, 2005.
- [64Cu](1-N-(4-aminobenzyl)-3,6,10,13,16,19-hexaazabicyclo[6.6.6]-eicosane-1,8-diamine)-anti-GD2 monoclonal antibody [PDF Version]
- 66Ga
- 66Ga-Labeled NOTA-conjugated anti-CD105 (endoglin) chimeric monoclonal antibody [PDF Version][66Ga]-NOTA-TRC105Arvind Chopra.Created: May 10, 2012; Last Update: June 21, 2012.
- 66Ga-Labeled PEGylated nano-graphene oxide (GO) covalently linked to NOTA-conjugated anti-CD105 (endoglin) chimeric monoclonal antibody TRC105 [PDF Version][66Ga]-NOTA-GO-TRC105Arvind Chopra.Created: May 14, 2012; Last Update: June 28, 2012.
- 66Ga-Labeled NOTA-conjugated anti-CD105 (endoglin) chimeric monoclonal antibody [PDF Version]
- 68Ga
- 67/68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-1,2-diaminoethane-γ-folate [PDF Version]67/68Ga-P3026Kam Leung.Created: February 14, 2011; Last Update: May 26, 2011.
- 68Ga-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Cpa-cyclo(d-Cys-amino-Phe-hydroorotic acid-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)-D-Tyr-NH2 (JR11) [PDF Version]68Ga-DOTA-JR11Kam Leung.Created: October 7, 2012; Last Update: January 3, 2013.
- 68Ga-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2 [PDF Version]68Ga-DOTA-LM3Kam Leung.Created: May 5, 2012; Last Update: November 1, 2012.
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-aminohexanoic acid-Lys40-exendin-4 [PDF Version][Lys40(Ahx-DOTA-68Ga)NH2]-exendin-4Kam Leung.Created: January 30, 2012; Last Update: April 26, 2012.
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-cyclo(Arg-Gly-Asp-D-Phe-Lys) [PDF Version]68Ga-DOTA-c(RGDfK)Kam Leung.Created: October 9, 2007; Last Update: December 10, 2009.
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Epidermal growth factor [PDF Version]68Ga-DOTA-EGFKam Leung.Created: July 25, 2006; Last Update: April 10, 2012.
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Gly-Gly-Gly-Gly-Lys-Gly-Gly-Gly-Gly [PDF Version]68Ga-DOTA-VAP-P1Kam Leung.Created: March 1, 2008; Last Update: May 15, 2008.
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-HER2-specific Affibody ZHER2:2891 [PDF Version]68Ga-DOTA-ZHER2:2891Kam Leung.Created: August 26, 2012; Last Update: December 12, 2012.
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Lys40-exendin-3 [PDF Version]68Ga-DOTA-Lys40-exendin-3Kam Leung.Created: August 20, 2010; Last Update: November 3, 2010.
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-synthetic HER2 specific Affibody ZHER2:342-pep2 [PDF Version]68Ga-DOTA-ZHER2:342-pep2Kam Leung.Created: August 26, 2010; Last Update: November 10, 2010.
- 68Ga-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-1,4,7,10-tetraacetic acid-rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13 [PDF Version]68Ga-DOTA-ReCCMSH(Arg11)Kam Leung.Created: January 30, 2009; Last Update: May 11, 2009.
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-1,2-diaminoethane-γ-5,8-dideazfolic acid (P3238) [PDF Version]68Ga-P3238Kam Leung.Created: June 14, 2012; Last Update: September 20, 2012.
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-1,2-diaminoethane-γ-folate (P3246) [PDF Version]68Ga-P3246Kam Leung.Created: June 14, 2012; Last Update: September 20, 2012.
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Asp-cyclohexylalanine-Phe-d-Ser-d-Arg-Tyr-Leu-Trp-Ser-NH2 (AE105-NH2) [PDF Version]68Ga-NODAGA-AE105-NH2Kam Leung.Created: May 20, 2012; Last Update: August 23, 2012.
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Cpa-cyclo(d-Cys-amino-Phe-hydroorotic acid-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)-D-Tyr-NH2 (JR11) [PDF Version]68Ga-NODAGA-JR11Kam Leung.Created: October 5, 2012; Last Update: January 3, 2013.
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-cyclo(Arg-Gly-Asp-d-Phe-Lys) [PDF Version]68Ga-NODAGA-c(RGDfK)Kam Leung.Created: August 26, 2011; Last Update: November 10, 2011.
- 68Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2 [PDF Version]68Ga-NODAGA-LM3Kam Leung.Created: May 5, 2012; Last Update: November 1, 2012.
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-2-nitroimidazole-N-ethylamine [PDF Version]68Ga-NOTA-NIKam Leung.Created: January 19, 2011; Last Update: March 23, 2011.
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-c(RGDfK)-human serum albumin-tissue inhibitor of matrix metalloproteinase 2 fusion protein [PDF Version]68Ga-NOTA-RGD-HSA-TIMP2Kam Leung.Created: February 14, 2012; Last Update: May 24, 2012.
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-c(RGDyK)-S-S-CPLHSpT [PDF Version]68Ga-NOTA-cRGDyK-CPLHSpTKam Leung.Created: August 14, 2012; Last Update: October 25, 2012.
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-vascular endothelial growth factor-121 [PDF Version]68Ga-NOTA-VEGF121Kam Leung.Created: April 7, 2013; Last Update: June 6, 2013.
- 68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121 [PDF Version]68Ga-NOTA-PEG-scVEGFKam Leung.Created: November 17, 2010; Last Update: February 17, 2011.
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-[15-amino-4,7,10,13-tetraoxapentadecanoic acid-c(Arg-Gly-Asp-D-Phe-Lys)]2 [PDF Version]68Ga-NOTA-P4-RGD2Kam Leung.Created: October 26, 2009; Last Update: December 10, 2009.
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-[c(Arg-Gly-Asp-D-Tyr-Lys)]2 [PDF Version]68Ga-NOTA-RGD2Kam Leung.Created: October 26, 2009; Last Update: December 10, 2009.
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-[Gly-Gly-Gly-c(Arg-Gly-Asp-D-Phe-Lys)]2 [PDF Version]68Ga-NOTA-G3-RGD2Kam Leung.Created: October 26, 2009; Last Update: December 10, 2009.
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-c(RGDyK)-bombesin[7-14] [PDF Version]68Ga-NOTA-RGD-BBNKam Leung.Created: January 2, 2010; Last Update: January 28, 2010.
- 68Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-isothiocyanatobenzyl-c(Arg-Gly-Asp-d-Tyr-Lys) [PDF Version]68Ga-NOTA-RGDKam Leung.Created: January 26, 2011; Last Update: April 7, 2011.
- 68Ga-1,4,7-Triazacyclononane-1,4-diacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 [PDF Version]68Ga-NOTA-8-Aoc-BBN[7-14]NH2Kam Leung.Created: June 26, 2012; Last Update: October 4, 2012.
- 68Ga-CHX-A”-Rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13 [PDF Version]68Ga-CHX-A”-ReCCMSH(Arg11)Kam Leung.Created: August 20, 2009; Last Update: September 8, 2010.
- 68Ga-Desferrioxamine p-isothiocyanatobenzyl-anti-EGFR nanobody 7D12 [PDF Version]68Ga-Df-Bz-NCS-7D12Kam Leung.Created: March 21, 2012; Last Update: June 7, 2012.
- 68Ga-DOTA-4-amino-1-carboxymethyl-piperidine-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 [PDF Version]68Ga-RM2Kam Leung.Created: February 5, 2011; Last Update: May 4, 2011.
- 68Ga-Glutamate peptide-3 aminoethyl estradiol [PDF Version]68Ga-GAP-EDLArvind Chopra.Created: August 23, 2007; Last Update: June 18, 2009.
- 68Ga-Isothiocyanatobenzyl-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-2-(2-nitroimidazolyl)ethylamine [PDF Version]68Ga-SCN-Bz-DOTA-NIKam Leung.Created: May 19, 2011; Last Update: September 22, 2011.
- 68Ga-Labeled (1,4,7,10-tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid)-1-NaI3-octreotide [PDF Version][68Ga]-DOTA-NOCArvind Chopra.Created: May 12, 2009; Last Update: June 5, 2009.
- 68Ga-Labeled (4-{[(bis(phosphonomethyl))carbamoyl]methyl}-7,10-bis(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl)acetic acid (BPAMD) [PDF Version][68Ga]BPAMDArvind Chopra.Created: September 18, 2012; Last Update: November 21, 2012.
- 68Ga-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-d-Trp-Lys-Thr-Cys)) [PDF Version]68Ga-AM3Liang Shan.Created: December 10, 2010; Last Update: January 18, 2011.
- 68Ga-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH2 with a disulfide bridge between the two homoC [PDF Version]68Ga-DOTA-MUT-DSLiang Shan.Created: November 15, 2011; Last Update: January 4, 2012.
- 68Ga-Labeled 2-[3-(1-carboxy-5-{7-[5-carboxy-5-(3-phenyl-2-{3-phenyl-2-[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraazacyclododec-1-l)acetylamino]propionylamino}propionylamino)pentylcarbamoyl]heptanoylamino}pentyl)ureido]pentanedioic acid [PDF Version][68Ga]6Arvind Chopra.Created: September 27, 2010; Last Update: December 28, 2010.
- 68Ga-Labeled 2-[4,7-di(carboxymethyl)-1,4,7-triazonan-1-yl]-5-[(4-hydroxy-4,4-diphosphonobutyl)amino]-5-oxopentanoic acid (NOTA-bisphosphonate (BP)) [PDF Version][68Ga]-NOTA-BPArvind Chopra.Created: December 7, 2011; Last Update: December 27, 2011.
- 68Ga-Labeled 2-{3-[5-(7-{1-benzyloxycarbonyl-5-[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraazacyclododec-1-l)acetylamino]pentylcarbamoyl}-heptanoylamino)-1-carboxypentyl]ureido}pentanedioic acid [PDF Version][68Ga]3Arvind Chopra.Created: September 28, 2010; Last Update: December 28, 2010.
- 68Ga-Labeled alanine derivatives of 1,4,7,10-tetraazacyclododecane-1,7-diacetic acid and 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid [PDF Version]68Ga-21, 68Ga-22Liang Shan.Created: August 29, 2011; Last Update: October 12, 2011.
- 68Ga-Labeled anti-EpCAM diabody against epithelial cell adhesion molecule [PDF Version]68Ga-HBED-CC-anti-EpCAM diabodyKam Leung.Created: August 6, 2010; Last Update: November 19, 2010.
- 68Ga-Labeled DOTA-conjugated sCCK8[Phe2(p-CH2SO3H),Nle3,6], a sulfated cholecystokinin 8 (sCCK8) peptide derivative [PDF Version][68Ga]sCCK8[Phe2(p-CH2SO3H),Nle3,6Arvind Chopra.Created: January 10, 2013; Last Update: January 31, 2013.
- 68Ga-Labeled homoalanine derivatives of 1,4,7,10-tetraazacyclododecane-1,7-diacetic acid and 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid [PDF Version]68Ga-23, 68Ga-24Liang Shan.Created: August 29, 2011; Last Update: October 12, 2011.
- 68Ga-Labeled NODAGA-conjugated ghrelin receptor agonists and inverse agonists [PDF Version][68Ga]-NODAGA-ghrelin derivativesArvind Chopra.Created: June 10, 2012; Last Update: July 12, 2012.
- 68Ga-Labeled β-aminoalanine, γ-aminohomoalanine, and ε-aminolysine conjugates of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid [PDF Version]68Ga-2a-cLiang Shan.Created: August 29, 2011; Last Update: October 12, 2011.
- 68Ga-Labeled β-aminoalanine, γ-aminohomoalanine, and ε-aminolysine conjugates of 1,4,7-triazacyclononane-1,4,7-triacetic acid [PDF Version]68Ga-1a-cLiang Shan.Created: August 29, 2011; Last Update: October 12, 2011.
- 68Ga-N,N’-bis[2-Hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N’-diacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121 [PDF Version]68Ga-HBED-CC-PEG-scVEGFKam Leung.Created: December 18, 2010; Last Update: February 17, 2011.
- 68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-2-(2-nitroimidazolyl)ethylamine [PDF Version]68Ga-DOTA-NIKam Leung.Created: May 19, 2011; Last Update: July 28, 2011.
- 68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 [PDF Version]68Ga-DOTA-E-[c(RGDfK)]2Kam Leung.Created: February 20, 2011; Last Update: May 12, 2011.
- 68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-{Glu-[cyclo(Arg-Gly-Asp-d-Phe-Lys)]2}2 [PDF Version]68Ga-DOTA-E-{E-[c(RGDfK)]2}2Kam Leung.Created: February 19, 2011; Last Update: May 12, 2011.
- 68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-cyclo(Arg-Gly-Asp-D-Phe-Lys) [PDF Version]68Ga-DOTA-E-c(RGDfK)Kam Leung.Created: February 6, 2011; Last Update: May 12, 2011.
- 68Ga-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-d-Glu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 [PDF Version]68Ga-DOTA-MG0Kam Leung.Created: August 15, 2011; Last Update: November 10, 2011.
- 68Ga-Trastuzumab F(ab’) fragment [PDF Version]68Ga-DCHFThe MICAD Research Team.Created: May 18, 2007; Last Update: June 25, 2007.
- Gallium-68-dotamaleimide-Cys165-annexin A5 [PDF Version]68Ga-Cys165-AnxA5Liang Shan.Created: June 28, 2011; Last Update: August 10, 2011.
- Gallium-68-dotamaleimide-Cys2-annexin A5 [PDF Version]68Ga-Cys2-AnxA5Liang Shan.Created: June 28, 2011; Last Update: August 10, 2011.
- Gly-Ala-Cys-Leu-Arg-Ser-Gly-Arg-Gly-Cys-Gly-(PEG)3-DOTA-68Ga [PDF Version]68Ga-DOTA-TCTP-1Kam Leung.Created: December 20, 2010; Last Update: April 7, 2011.
- 67/68Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-1,2-diaminoethane-γ-folate [PDF Version]
- 74As
- [74As]-Labeled monoclonal antibody against anionic phospholipids [PDF Version]Arvind Chopra.Created: April 14, 2008; Last Update: May 27, 2008.
- [74As]-Labeled monoclonal antibody against anionic phospholipids [PDF Version]
- 76Br
- 4-[76Br]Bromophenyl-1,4-diazabicyclo(3.2.2) nonane-4-carboxylate [PDF Version][76Br]SSR180711Kam Leung.Created: December 12, 2008; Last Update: February 24, 2009.
- 5-[76Br]-N-(4-(3,4-Dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl)-2,3-dimethoxybenzamide [PDF Version][76Br]RHM-4Kam Leung.Created: October 5, 2006; Last Update: April 3, 2012.
- 76Br-Human recombinant anti-ED-B fibronectin L19-small immunoprotein [PDF Version]76Br-L19-SIPThe MICAD Research Team.Created: August 4, 2007; Last Update: August 27, 2007.
- 4-[76Br]Bromophenyl-1,4-diazabicyclo(3.2.2) nonane-4-carboxylate [PDF Version]
- 86Y
- 86Y-CHX-A''-Diethylenetriamine pentaacetic acid-bevacizumab [PDF Version]86Y-CHX-A''-DTPA-bevacizumabKam Leung.Created: December 17, 2010; Last Update: March 16, 2011.
- 86Y-CHX-A''-Diethylenetriamine pentaacetic acid-cetuximab [PDF Version]86Y-CHX-A''-DTPA-cetuximabKam Leung.Created: August 15, 2010; Last Update: November 11, 2010.
- 86Y-CHX-A''-diethylenetriamine pentaacetic acid-panitumumab [PDF Version]86Y-CHX-A''-DTPA-PanitumumabKam Leung.Created: August 25, 2011; Last Update: December 8, 2011.
- 86Y-CHX-A”-Rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13 [PDF Version]86Y-CHX-A”-ReCCMSH(Arg11)Kam Leung.Created: August 20, 2009; Last Update: September 8, 2010.
- 86Y-DOTA-[Pro1,Tyr4]-Bombesin[1-14] [PDF Version]86Y-MP2346Kenneth T. Cheng, Jason S. Lewis, and Gráinne B. Biddlecombe.Created: August 6, 2007; Last Update: January 8, 2008.
- 86Y-DOTA-rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13 [PDF Version]86Y-DOTA-ReCCMSH(Arg11)Kam Leung.Created: May 30, 2009; Last Update: July 14, 2009.
- 86Y-CHX-A''-Diethylenetriamine pentaacetic acid-bevacizumab [PDF Version]
- 89Zr
- 89Zr-Desferrioxamine-anti-CD105 TRC105 chimeric monoclonal antibody [PDF Version]89Zr-Df-TRC105Kam Leung.Created: November 1, 2011; Last Update: January 12, 2012.
- 89Zr-Desferrioxamine-anti-epithelial glycoprotein-1 hRS7 humanized monoclonal antibody [PDF Version]89Zr-Df-hRS7Kam Leung.Created: January 15, 2012; Last Update: April 19, 2012.
- 89Zr-Desferrioxamine B-7E11 anti-prostate-specific membrane antigen monoclonal antibody [PDF Version]89Zr-DFO-7E11Kam Leung.Created: November 22, 2011; Last Update: February 23, 2012.
- 89Zr-Desferrioxamine B-J591 anti-prostate-specific membrane antigen monoclonal antibody [PDF Version]89Zr-DFO-J591Kam Leung.Created: September 12, 2010; Last Update: November 18, 2010.
- 89Zr-Desferrioxamine B-Transferrin [PDF Version]89Zr-DFO-TransferrinKam Leung.Created: April 1, 2013; Last Update: June 6, 2013.
- 89Zr-Desferrioxamine p-isothiocyanatobenzyl-anti-EGFR nanobody 7D12 [PDF Version]89Zr-Df-Bz-NCS-7D12Kam Leung.Created: March 21, 2012; Last Update: June 7, 2012.
- 89Zr-Desferrioxamine p-isothiocyanatobenzyl-anti-hepatocyte growth factor nanobody 1E2 fused to albumin-binding nanobody Alb8 [PDF Version]89Zr-Df-Bz-NCS-1E2-Alb8Kam Leung.Created: May 17, 2012; Last Update: August 27, 2012.
- 89Zr-Desferrioxamine p-isothiocyanatobenzyl-anti-hepatocyte growth factor receptor 1-armed antibody onartuzumab [PDF Version]89Zr-Df-OnartuzumabKam Leung.Created: December 1, 2012; Last Update: March 14, 2013.
- 89Zr-Labeled fresolimumab (human anti-transforming growth factor-β monoclonal antibody) [PDF Version][89Zr]-FresolimumabArvind Chopra.Created: December 13, 2011; Last Update: January 26, 2012.
- 89Zr-Labeled N-succinyldesferrioxamine-ranibizumab [PDF Version][89Zr]-RanibizumabArvind Chopra.Created: January 26, 2011; Last Update: February 24, 2011.
- 89Zr-Labeled N-suc-desferrioxamine-conjugated anti-carbonic anhydrase IX chimeric monoclonal antibody cG250-F(ab’)2 fragments [PDF Version][89Zr]-cG250-F(ab')2Arvind Chopra.Created: August 2, 2010; Last Update: October 14, 2010.
- 89Zr-Labeled p-isothiocyanatobenzyl-desferrioxamine B (Df-Bz-NCS)–conjugated panitumumab, a fully human monoclonal antibody directed against the extracellular domain III of the epidermal growth factor receptor [PDF Version][89Zr]-PanitumumabArvind Chopra.Created: May 4, 2012; Last Update: June 21, 2012.
- 89Zr-Labeled trastuzumab, a humanized monoclonal antibody against epidermal growth factor receptor 2 [PDF Version]89Zr-TrastuzumabArvind Chopra.Created: January 5, 2010; Last Update: March 4, 2010.
- 89Zr-N-Succinyldesferal-anti-CD44v6 chimeric monoclonal antibody U36 [PDF Version]89Zr-N-SucDf-cMAb U36Kam Leung.Created: March 25, 2010; Last Update: April 22, 2010.
- 89Zr-N-Succinyldesferal-chimeric monoclonal antibody G250 [PDF Version]89Zr-Df-cG250Kam Leung.Created: April 22, 2010; Last Update: May 27, 2010.
- 89Zr-N-Succinyldesferal-human anti-insulin-like growth factor 1 receptor monoclonal antibody R1507 [PDF Version]89Zr-R1507Kam Leung.Created: December 20, 2010; Last Update: February 3, 2011.
- 89Zr-N-Succinyldesferrioxamine-bevacizumab [PDF Version]89Zr-BevacizumabKam Leung.Created: October 17, 2008; Last Update: December 16, 2008.
- 89Zr-N-Succinyldesferrioxamine-DN30 [PDF Version]89Zr-DN30Kam Leung.Created: November 17, 2007; Last Update: March 12, 2012.
- 89Zr-Desferrioxamine-anti-CD105 TRC105 chimeric monoclonal antibody [PDF Version]
- 11C
- SPECT
- 111In
- [111In]5-[(3aR,6S,6aS)-2-Oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-6-yl]pentanoic acid [PDF Version][111In]BiotinArvind Chopra.Created: May 1, 2008; Last Update: May 28, 2008.
- [111In]-DOTA-Aminohexanoyl-[D-Phe6,Leu-NHCH2CH2CH313,desMet14] BBN[6-14] [PDF Version][111In]BomproamideArvind Chopra.Created: May 20, 2010; Last Update: July 8, 2010.
- [111In]-Ethylenedicysteine-murine anti-phosphotyrosine antibody [PDF Version]111In-EC-APTArvind Chopra.Created: March 12, 2009; Last Update: April 6, 2009.
- [111In]Labeled-(NAc-dD-CHA-F-dS-dR-Y-L-W-S-βAla)2-K-K(DOTA) [PDF Version][111In]Anti-uPA peptideArvind Chopra.Created: April 1, 2010; Last Update: May 27, 2010.
- [111In]-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-heat-stable human Escherichia coli enterotoxin [PDF Version][111In]DOTA-F19-STh(1-19)Arvind Chopra.Created: May 16, 2008; Last Update: June 10, 2008.
- [111In]-Labeled chimeric monoclonal antibody cG250 directed against carbonic anhydrase IX [PDF Version][111In]-DOTA-cG250Arvind Chopra.Created: August 6, 2010; Last Update: September 2, 2010.
- [111In]-Labeled divalent Fab fragment of chimeric monoclonal antibody cG250 directed against carbonic anhydrase IX [PDF Version][111In]-DOTA-F(ab’)2-cG250Arvind Chopra.Created: August 11, 2010; Last Update: September 2, 2010.
- [111In]-Labeled monovalent Fab fragment of chimeric monoclonal antibody cG250 directed against carbonic anhydrase IX [PDF Version][111In]-DOTA-Fab-cG250Arvind Chopra.Created: August 11, 2010; Last Update: September 2, 2010.
- [111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Pro1,Tyr4]Bombesin [PDF Version][111In-DOTA-Pro1,Tyr4]BNKenneth T. Cheng.Created: October 23, 2007; Last Update: November 13, 2007.
- [111In-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-10-maleimidoethylacetamide-Cys61]-Affibody ZHER2:2395 [PDF Version][111In-MMA-NODAGA-Cys61]-ZHER2:2395Kam Leung.Created: May 20, 2012; Last Update: September 13, 2012.
- [111In-Diethylenetriamine pentaacetic acid-ACMpip5,Tha6,βAla11,Tha13,NIe14]bombesin(5-14) [PDF Version][111In-DTPA-ACMpip5,Tha6,βAla11,Tha13,NIe14]BN(5-14)Kenneth T. Cheng.Created: December 18, 2007; Last Update: January 14, 2008.
- [111In-Diethylenetriaminepentaacetic acid-Pro1,Tyr4]bombesin [PDF Version][111In-DTPA-Pro1,Tyr4]BNKenneth T. Cheng.Created: October 10, 2007; Last Update: November 7, 2007.
- 111In/125/131I-Labeled anti-mucin-1 murine, chimeric or humanized antibody hPAM4 [PDF Version][111In/125/131I]-hPAM4Arvind Chopra.Created: June 16, 2011; Last Update: July 26, 2011.
- 111In/125I/99mTc-Labeled N-terminus tri-(histidine-glutamate) (HE)3-tagged and N- or C-terminus hexahistidine (H6)-tagged anti-epidermal growth factor receptor Affibody ZHER2:342-C [PDF Version][111In/125I/99mTc]-(HE)3-ZHER2:342-C, [111In/125I/99mTc]-H6-ZHER2:342-C, and [111In/125I/99mTc]-ZHER2:342-H6-CArvind Chopra.Created: July 16, 2012; Last Update: August 9, 2012.
- 111In/86Y-Labeled F(ab')2 fragment of panitumumab, a fully human monoclonal antibody directed against the extracellular domain III of the epidermal growth factor receptor [PDF Version][111In/86Y]-CHX-A''-Panitumumab F(ab')2Arvind Chopra.Created: April 30, 2012; Last Update: June 21, 2012.
- 111In-(1-isothiocyanatobenzyl-3-methyldiethylenetriaminepentaaetic acid)-anti–TAG-72 humanized CH2 domain-deleted antibody [PDF Version]111In-(Mx-DTPA)-HuCC49ΔCH2 AbKenneth T. Cheng.Created: August 17, 2007; Last Update: February 12, 2008.
- 111In-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Ac-RWQPCPAESWT-Cha-CWDPGGGK-NH2 (FibPep) [PDF Version]111In-DOTA-FibPepKam Leung.Created: May 7, 2013; Last Update: May 30, 2013.
- 111In-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-anti-insulin-like growth factor 1 receptor Affibody ZIGF1R:4551 [PDF Version]111In-DOTA-ZIGF1R:4551Kam Leung.Created: January 20, 2012; Last Update: March 29, 2012.
- 111In-1,4,7,10-Tetraazacyclododecane-1,4,7,10-triacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 [PDF Version]111In-DOTA-8-Aoc-BBN[7-14]NH2Kam Leung.Created: June 20, 2012; Last Update: October 4, 2012.
- 111In-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-L-homoalanine [PDF Version]111In-DO3A-HKam Leung.Created: January 12, 2013; Last Update: March 28, 2013.
- 111In-1,4,7,10-tetraazacyclododecane-1,4,7-tris-acetic acid-10-maleimidoethylacetamide-Affibody ZHER2:2395-Cys [PDF Version]111In-[MMA-DOTA-Cys61]-Z2395-CKam Leung.Created: August 16, 2009; Last Update: November 19, 2009.
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-AB.Fab4D5 [PDF Version]111In-DOTA-AB.Fab4D5Kam Leung.Created: April 16, 2007; Last Update: November 8, 2007.
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid- Affibody ZHER2:342-pep2 [PDF Version]111In-DOTA-ZHER2:342-pep2Kam Leung.Created: April 16, 2007; Last Update: June 27, 2007.
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-cyclo(D-diaminobutyric acid-Arg-Phe-Phe-D-Trp-Lys-Thr-Phe) [PDF Version]111In-KE88Kam Leung.Created: September 1, 2009; Last Update: October 8, 2009.
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-LLP2A [PDF Version]111In-DOTA-LLP2AKam Leung.Created: June 10, 2009; Last Update: August 12, 2009.
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 diabody [PDF Version]111In-DOTA-T84.66 diabodyKam Leung.Created: February 2, 2008; Last Update: March 6, 2008.
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 minibody [PDF Version]111In-DOTA-T84.66 minibodyKam Leung.Created: February 2, 2008; Last Update: March 6, 2008.
- 111In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 scFv-human serum albumin [PDF Version]111In-DOTA-T84.66 scFv-HSAKam Leung.Created: July 2, 2008; Last Update: September 2, 2008.
- 111In-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-NDECELCVNVACTGCL [PDF Version]111In-DOTA-E3-uroguanylinKam Leung.Created: April 16, 2010; Last Update: June 25, 2010.
- 111In-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Glu-[cyclo(Arg-Gly-Asp-d-Phe-Lys)]2 [PDF Version]111In-NODAGA-E-[c(RGDfK)]2Kam Leung.Created: May 5, 2013; Last Update: June 13, 2013.
- 111In-2-(4,7,10-Tris(carboxymethyl)-1,4,7,10-tetracyclododecan-1-yl)pentanedioic acid-Trastuzumab [PDF Version]111In-DOTAGA-TrastuzumabKam Leung.Created: May 23, 2012; Last Update: September 13, 2012.
- 111In-2-(p-isothiocyanatobenzyl)-6-methyl-diethylenetriamine-N,N,N´,N´´,N´´-pentaacetic acid-trastuzumab [PDF Version]111In-1B4M-DTPA-humAb4D5-8Kenneth T. Cheng.Created: May 1, 2008; Last Update: June 4, 2008.
- 111In-Anti-CD105 MJ7/18 monoclonal antibody [PDF Version]111In-MJ7/18 MAbKenneth T. Cheng.Created: July 4, 2006; Last Update: December 21, 2007.
- 111In-Benzyl-diethylenetriamine pentaacetic acid-AMB8LK [PDF Version]111In-DTPA-AMB8LKKam Leung.Created: May 24, 2007; Last Update: February 1, 2007.
- 111In-Benzyl-diethylenetriaminepentaacetic acid-ZHER2:342 [PDF Version]111In-Benzyl-DTPA-ZHER2:342Kam Leung.Created: April 6, 2008; Last Update: May 30, 2008.
- 111In-Benzyl-tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-ZHER2:342 [PDF Version]111In-Benzyl-DOTA-ZHER2:342Kam Leung.Created: April 6, 2008; Last Update: May 29, 2008.
- 111In-BZ-Diethylenetriaminepentaacetic acid-ZEGFR:1907 [PDF Version]Kam Leung.Created: April 6, 2009; Last Update: June 24, 2009.
- 111In-Capromab pendetide [PDF Version]111In-CYT-356Kam Leung.Created: October 5, 2005; Last Update: May 24, 2008.
- 111In-CHX-A''-DTPA-anti-mindin/RG-1 monoclonal antibody 19G9 [PDF Version]111In-CHX-A''-DTPA-19G9Kam Leung.Created: November 16, 2009; Last Update: December 3, 2009.
- 111In-CHX-A”-diethylenepentaacetic acid-Affibody ZHER2:2395-Cys [PDF Version]111In-CHX-A’’-DTPA-Z2395-CKam Leung.Created: August 16, 2009; Last Update: November 19, 2009.
- 111In-CHX-A”-Diethylenetriamine pentaacetic acid-(ZEGFR:955)2 [PDF Version]111In-CHX-A”-DTPA-(ZEGFR:955)2Kam Leung.Created: June 6, 2008; Last Update: July 15, 2008.
- 111In-CHX-A”-Rhenium-cyclized-[Cys3,4,10,D-Phe7,Arg11]α-MSH3-13 [PDF Version]111In-CHX-A”-ReCCMSH(Arg11)Kam Leung.Created: August 20, 2009; Last Update: May 9, 2012.
- 111In conjugated to benzyl-diethylenetriaminepentaacetic acid-human epidermal growth factor [PDF Version][111In]Bz-DTPA-hEGFArvind Chopra.Created: February 4, 2009; Last Update: February 25, 2009.
- 111In-Diethylenetriaminepentaacetic acid-2-(p-isothiocyanatobenzyl)-6-methyl-B3 monoclonal antibody [PDF Version]111In-DTPA-1B4M-B3Kam Leung.Created: March 17, 2009; Last Update: May 13, 2009.
- 111In-Diethylenetriaminepentaacetic acid-2C5 monoclonal antibody [PDF Version]111In-DTPA-2C5Kam Leung.Created: May 17, 2009; Last Update: June 6, 2009.
- 111In-Diethylenetriaminepentaacetic acid-aminohexanoic acid-Lys40-exendin-4 [PDF Version]111In-DTPA-Ahx-Lys40-exendin-4Kam Leung.Created: January 17, 2007; Last Update: January 30, 2012.
- 111In-Diethylenetriamine pentaacetic acid-anti-epithelial glycoprotein-1 hRS7 humanized monoclonal antibody [PDF Version]111In-DTPA-hRS7Kam Leung.Created: January 12, 2012; Last Update: April 19, 2012.
- 111In-Diethylenetriamine pentaacetic acid-Anti-ligand–induced binding sites (LIBS) single-chain (scFv) antibody [PDF Version]111In-DTPA-LIBS-scFvKam Leung.Created: November 23, 2012; Last Update: January 31, 2013.
- 111In-Diethylenetriamine pentaacetic acid-bevacizumab [PDF Version]111In-DTPA-bevacizumabKam Leung.Created: October 17, 2008; Last Update: December 16, 2008.
- 111In-Diethylenetriaminepentaacetic acid-cyclo(CTTHWGFTLC) [PDF Version]111In-DTPA-CTTKam Leung.Created: January 17, 2007; Last Update: April 25, 2012.
- 111In-Diethylenetriamine pentaacetic acid-human anti-insulin-like growth factor 1 receptor monoclonal antibody R1507 [PDF Version]111In-DTPA-R1507Kam Leung.Created: December 20, 2010; Last Update: February 3, 2011.
- 111In-Diethylenetriamine pentaacetic acid-human epidermal growth factor [PDF Version]111In-DTPA-hEGFArvind Chopra.Created: December 4, 2007; Last Update: January 22, 2008.
- 111In-Diethylenetriamine pentaacetic acid-IC2 rat monoclonal autoantibody to pancreatic β-cell surface antigen [PDF Version]111In-DTPA-IC2Kam Leung.Created: November 3, 2011; Last Update: February 2, 2012.
- 111In-Diethylenetriaminepentaacetic acid-Lys40-exendin-3 [PDF Version]111In-DTPA-Lys40-exendin-3Kam Leung.Created: August 20, 2010; Last Update: November 3, 2010.
- 111In-Diethylenetriamine pentaacetic acid-NAVPNLRGDLQVLAQKVART [PDF Version]111In-DTPA-A20FMDV2Kam Leung.Created: September 6, 2012; Last Update: November 29, 2012.
- 111In-Diethylenetriamine pentaacetic acid-pertuzumab [PDF Version]111In-DTPA-pertuzumabKam Leung.Created: December 6, 2009; Last Update: January 21, 2010.
- 111In-Diethylenetriaminepentaacetic acid-polyethylene glycol-annexin V [PDF Version]111In-DTPA-PEG-Anx5Kenneth T. Cheng.Created: September 28, 2006; Last Update: January 9, 2008.
- 111In-Diethylenetriamine
pentaacetic acid-QKYGNQWAVGHLM-NH2 [PDF Version]111In-[DTPA1-Lys3,Tyr4]-BNKam Leung.Created: April 21, 2010; Last Update: June 25, 2010.
- 111In-Diethylenetriamine pentaacetic acid-single-walled nanotubes [PDF Version]111In-DTPA-SWNTsKam Leung.Created: September 26, 2008; Last Update: November 17, 2008.
- 111In-Diethylenetriaminepentaacetic acid-trastuzumab [PDF Version]111In-DTPA-humAb4D5-8Kenneth T. Cheng.Created: March 1, 2006; Last Update: June 4, 2008.
- 111Indium-diethylenetriaminepentaacetic acid-d-phenylalanine-octreotide [PDF Version]111In-DTPA-OCThe MICAD Research Team.Created: January 23, 2005; Last Update: August 25, 2005.
- 111Indium-diethylenetriaminepentaacetic acid-folate [PDF Version]111In-DTPA-folateKam Leung.Created: April 1, 2005; Last Update: January 29, 2011.
- 111In-DOTA-4-amino-1-carboxymethyl-piperidine-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 [PDF Version]111In-RM2Kam Leung.Created: February 5, 2011; Last Update: May 4, 2011.
- 111In-DOTA-Gly-benzoyl-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 [PDF Version]111In-RM1Kam Leung.Created: November 5, 2009; Last Update: January 30, 2011.
- 111In-DOTA-Re(Cys3,4,10,d-Phe7,Arg11)αMSH3-13 [PDF Version]111In-DOTA-Re(Arg11)CCMSHKenneth T. Cheng, Zhen Cheng, and Thomas P. Quinn.Created: September 1, 2007; Last Update: December 17, 2007.
- 111In-DPC11870 [PDF Version]111In-DPC11870Arvind Chopra.Created: March 7, 2007; Last Update: December 19, 2008.
- 111In-DTPA-Poly(ethylene glycol)-anti-epidermal growth factor receptor antibody C225 [PDF Version]111In-DTPA-PEG-C225The MICAD Research Team.Created: June 7, 2007; Last Update: July 2, 2007.
- 111In-Ibritumomab tiuxetan [PDF Version]111In-2B8 MAbThe MICAD Research Team.Created: November 22, 2005; Last Update: September 26, 2007.
- 111In-Labeled (7S)-26-(4-((1-((1-carboxy-5-(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)pentyl)amino)-1-oxo-6-(1-((7S)-1,3,7,22-tetracarboxy-5,13,20-trioxo-4,6,12,21-tetraazahexacosan-26-yl)-1H-1,2,3-triazole-4-carboxamido)hexan-2-yl)carbamoyl)-1H-1,2,3-triazol-5-yl)-5,13,20-trioxo-4,6,12,21-tetraazahexacosane-1,3,7,22-tetracarboxylic acid [PDF Version][111In]3Liang Shan.Created: October 31, 2012; Last Update: December 19, 2012.
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated dimeric [Tyr3]octreotide [PDF Version]111In-Dimeric [Tyr3]octreotideLiang Shan.Created: November 14, 2010; Last Update: December 28, 2010.
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated monomeric [Tyr3]octreotide [PDF Version]111In-Monomeric [Tyr3]octreotideLiang Shan.Created: November 14, 2010; Last Update: December 28, 2010.
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-d-Phe-Lys)]4 [PDF Version]111In-DOTA-RAFT-RGDLiang Shan.Created: July 17, 2012; Last Update: August 29, 2012.
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH2 with a disulfide bridge between the two homoC [PDF Version]111In-DOTA-MUT-DSLiang Shan.Created: November 15, 2011; Last Update: December 21, 2011.
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,7,10,13-tetraoxapentadecanoic acid) [PDF Version]111In(DOTA-2P4G-RGD4)Liang Shan.Created: February 23, 2012; Last Update: March 22, 2012.
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)]-cyclo(Lys(PEG4)-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,7,10,13-tetraoxapentadecanoic acid) [PDF Version]111In(DOTA-6P-RGD4)Liang Shan.Created: February 23, 2012; Last Update: March 22, 2012.
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)}-{PEG4-Glu[cyclo(Lys-Arg-Gly-Asp-d-Phe)]-cyclo(Lys-Arg-Gly-Asp-d-Phe)} (PEG4 = 15 amino-4,710,13-tetraoxapentadecanoic acid) [PDF Version]111In(DOTA-2P-RGD4)Liang Shan.Created: February 23, 2012; Last Update: March 22, 2012.
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-d-Tyr-d-Lys(HSG)-d-Glu-d-Lys(HSG)-NH2 (IMP-288) [PDF Version][111In]-IMP-288Arvind Chopra.Created: June 29, 2011; Last Update: August 25, 2011.
- 111In-Labeled 1,4,7,10-tetraazacyclododecane-N,N’,N”,N’”-tetraacetic acid-GSC(succinimidopropionyl-EAYGWNleDF-NH2)-EAYGWNleDF-NH2 [PDF Version]111In-MGD5Arvind Chopra.Created: January 8, 2010; Last Update: February 18, 2010.
- 111In-Labeled Ac-Phe-Lys(DTPA)-Tyr-Lys(DTPA)-NH2 (IMP-156) [PDF Version][111In]-IMP-156Arvind Chopra.Created: June 27, 2011; Last Update: July 27, 2011.
- 111In-Labeled affibody ABY-025 targeting epidermal growth factor receptor 2 [PDF Version][111In]-ABY-025Arvind Chopra.Created: July 27, 2010; Last Update: August 27, 2010.
- 111In-Labeled anti-CD44v6 chimeric monoclonal antibody U36 [PDF Version]111In-cMAb U36Arvind Chopra.Created: July 22, 2008; Last Update: August 14, 2008.
- 111In-Labeled anti-epidermal growth factor receptor Affibody PEP09239 [PDF Version][111In]PEP09239Arvind Chopra.Created: March 28, 2013; Last Update: May 2, 2013.
- 111In-Labeled anti-epidermal growth factor receptor human monoclonal antibody 048-006 [PDF Version][111In]-048-006Arvind Chopra.Created: October 10, 2012; Last Update: November 8, 2012.
- 111In-Labeled chimeric monoclonal antibody, ch806, targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII) [PDF Version][111In]-ch806Arvind Chopra.Created: July 6, 2010; Last Update: August 26, 2010.
- 111In-Labeled CHX-A''-DTPA–conjugated MORAb-009, a chimeric monoclonal antibody directed against mesothelin [PDF Version][111In]MORAb-009Arvind Chopra.Created: January 10, 2012; Last Update: February 2, 2012.
- 111In-Labeled CHX-A”-DTPA conjugated monoclonal antibody (mAb) 806 targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII) [PDF Version][111In]-mAb806Arvind Chopra.Created: July 1, 2010; Last Update: August 5, 2010.
- 111In-Labeled diethylenetriamine-pentaacetic acid-Ac-TZ14011 [PDF Version][111In]Ac-TZ14011Arvind Chopra.Created: June 10, 2009; Last Update: July 7, 2009.
- 111In-Labeled DOTA-conjugated 6-aminohexanoic linker-containing variant of anti-epidermal growth factor receptor 2 Affibody ZHER2:342 (ABY-003) [PDF Version][111In]-ABY-003Arvind Chopra.Created: July 8, 2011; Last Update: August 23, 2011.
- 111In-Labeled DOTA-conjugated sCCK8[Phe2(p-CH2SO3H),Nle3,6], a sulfated cholecystokinin 8 (sCCK8) peptide derivative [PDF Version][111In]sCCK8[Phe2(p-CH2SO3H),Nle3,6Arvind Chopra.Created: January 7, 2013; Last Update: January 31, 2013.
- 111In-Labeled DTPA conjugated anti-c-kit monoclonal antibody 12A8 Fab fragment [PDF Version][111In]12A8 FabArvind Chopra.Created: June 9, 2011; Last Update: June 30, 2011.
- 111In-Labeled DTPA conjugated monoclonal antibody 12A8 that targets the c-kit receptor [PDF Version][111In]12A8Arvind Chopra.Created: June 9, 2011; Last Update: June 30, 2011.
- 111In-Labeled DTPA-conjugated Tat-linked anti-phosphorylated histone protein H2AX antibody [PDF Version][111In]-DTPA-anti-γH2AX-TatArvind Chopra.Created: July 28, 2011; Last Update: August 25, 2011.
- 111In-Labeled human serum albumin–conjugated Affibody ZHER2:342 that targets the human epidermal growth factor receptor 2 (HER2) [PDF Version][111In]-DOTA-HSA-ZHER2:342Arvind Chopra.Created: May 19, 2011; Last Update: June 1, 2011.
- 111In-Labeled lexatumumab [PDF Version]111ln-EC-HGS-ETR2Arvind Chopra.Created: March 19, 2009; Last Update: May 20, 2009.
- 111In-Labeled mapatumumab [PDF Version]111In-EC-HGS-ETR1Arvind Chopra.Created: March 16, 2009; Last Update: May 20, 2009.
- 111In-Labeled MLS128 anti-Tn murine monoclonal antibody [PDF Version]111In-MLS128Liang Shan.Created: July 21, 2009; Last Update: August 25, 2009.
- 111In-Labeled panitumumab, a fully human monoclonal antibody directed against the extracellular domain III of the epidermal growth factor receptor [PDF Version][111In]-PanitumumabArvind Chopra.Created: April 24, 2012; Last Update: June 21, 2012.
- 111In-Labeled recombinant gelonin toxin-B lymphocyte stimulator protein fusion protein [PDF Version][111In]-DTPA-rGel/BLySArvind Chopra.Created: February 22, 2011; Last Update: March 31, 2011.
- 111In-p-Benzyl isothiocyanate-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-14C5 monoclonal antibody [PDF Version]111In-p-SCN-Bz-DOTA-14C5Kam Leung.Created: April 20, 2013; Last Update: May 16, 2013.
- 111In-Streptavidin-biotinylated α-melanocyte-stimulating hormone 2.0 bacteriophage [PDF Version]111In-SA-α-MSH2.0 phageKenneth T. Cheng.Created: March 28, 2007; Last Update: May 5, 2008.
- 111In-TA138 [PDF Version]RP748Kam Leung.Created: October 17, 2005; Last Update: March 11, 2011.
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-c(D-Cys-Phe-Tyr-D-AgI8(Me,2-naphthoyl)-Lys-Thr-Phe-Cys)-OH [PDF Version]111In-DOTA-sst3-ODN-8Kam Leung.Created: August 5, 2009; Last Update: October 15, 2009.
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 [PDF Version]111In-DOTA-E-[c(RGDfK)]2Kam Leung.Created: August 20, 2007; Last Update: September 15, 2007.
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-{Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2}2 [PDF Version]111In-DOTA-E-{E-[c(RGDfK)]2}2Kam Leung.Created: August 19, 2007; Last Update: September 15, 2007.
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Glu-cyclo(Arg-Gly-Asp-D-Phe-Lys) [PDF Version]111In-DOTA-E-c(RGDfK)Kam Leung.Created: August 6, 2007; Last Update: September 17, 2007.
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-MEDI-522 [PDF Version]111In-DOTA-MEDI-522Kam Leung.Created: June 6, 2011; Last Update: June 30, 2011.
- 111In-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Phe(4-NO2)-cyclo(D-Cys-Tyr-D-Trp-Lys-Thr-Cys)-D-Tyr-NH2 [PDF Version]111In-DOTA-sst2-ANTKam Leung.Created: September 5, 2009; Last Update: October 15, 2009.
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-(GSG)-ANTPCGPYTHDCPVKR [PDF Version]111In-DOTA(GSG)-G3-C12Kam Leung.Created: April 17, 2009.
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-Asp–Tyr(SO3H)–Met–Gly–Trp–Met–Asp–Phe–NH2 [PDF Version]111In-DOTA-sCCK8Kam Leung.Created: December 17, 2007; Last Update: February 28, 2008.
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid- d-Glu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 [PDF Version]111In-DOTA-minigastrinKam Leung.Created: February 17, 2008; Last Update: May 8, 2008.
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-dihistidine-norleucine peptide analog [PDF Version]111In-DOTA-H2-NleKenneth T. Cheng.Created: August 8, 2007; Last Update: December 11, 2007.
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-HHEAYGWMDF-NH2 peptide [PDF Version]111In-DOTA-H2-MetKenneth T. Cheng.Created: April 23, 2007; Last Update: April 3, 2008.
- 111In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-HHHHHH-EAYGWMDF-NH2 peptide [PDF Version]111In-DOTA-H6-MetKenneth T. Cheng.Created: April 23, 2007; Last Update: April 3, 2008.
- 111In-Tetrameric Plectin-1 targeting peptide (4(βAKTLLPTP-GGS(PEG5000))KKK-111In-DOTA-βA-NH2) [PDF Version]111In-tPTPKam Leung.Created: January 28, 2011; Last Update: April 27, 2011.
- 111In-Trastuzumab Fab [PDF Version]111In-humAb4D5-8 FabThe MICAD Research Team.Created: March 13, 2006; Last Update: April 18, 2006.
- 4-[2-(3,4,5,6-Tetrahydropyrimidin-2-ylamino)ethyloxy]benzoyl-2-(S)-[N-3-amino-(SCN-Bz-DOTA-111In)-neopenta-1-carbamyl)]-aminoethylsulfonylamino-β-alanine [PDF Version]IAC-SCN-Bz-DOTA-111InKenneth T. Cheng, Chang H. Paik, and Narasimhan Danthi.Created: July 9, 2007; Last Update: December 18, 2007.
- Anti-mouse monoclonal antibody immunoglobulin G conjugated to GRKKRRQRRRPPQGYG-diethylenetriamine pentaacetic acid-[111In] [PDF Version][111In]mIgG-tat peptideArvind Chopra.Created: January 16, 2008; Last Update: February 20, 2008.
- Biotinylated anti-Tn MLS128 monoclonal antibody-streptavidin-111In-DTPA-biotin [PDF Version]Bt-MLS128-SA-111In-biotinLiang Shan.Created: July 21, 2009; Last Update: September 17, 2009.
- Lys-cys-cys-tyr-ser-leu-(gly-ser-gly)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-111In [PDF Version]111In-DOTA-(GSG)-KCCYSLArvind Chopra.Created: November 8, 2007; Last Update: December 12, 2007.
- Single-walled carbon nanotubes-111In-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-rituximab [PDF Version]CNT-([111In]DOTA)(Rituximab)Kenneth T. Cheng, Michael R. McDevitt, and David A. Scheinberg.Created: August 21, 2007; Last Update: December 21, 2007.
- TA138-conjugated 111In nanoparticles [PDF Version]αvβ3-targeted 111In/NPArvind Chopra.Created: October 22, 2007; Last Update: November 13, 2007.
- [111In]5-[(3aR,6S,6aS)-2-Oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-6-yl]pentanoic acid [PDF Version]
- 123I
- (1-Butyl-4-piperidinylmethyl)-8-amino-7-[123I]iodo-1,4-benzodioxan-5-carboxylate [PDF Version][123I]SB207710Kam Leung.Created: April 22, 2009; Last Update: June 5, 2009.
- [123I]-2-Iodo-2-amino-3-phenylpropanoic acid [PDF Version]2-[123I]I-L-PAArvind Chopra.Created: June 3, 2008; Last Update: July 3, 2008.
- [123I]Iomazenil [PDF Version][123I]IMZThe MICAD Research Team.Created: March 22, 2005; Last Update: October 5, 2005.
- [123I]Vascular endothelial growth factor [PDF Version][123I]VEGF165Kam Leung.Created: April 18, 2005; Last Update: August 16, 2005.
- [123I]-β-Methyl iodophenyl-pentadecanoic acid [PDF Version][123I]-BMIPPArvind Chopra.Created: February 12, 2008; Last Update: December 19, 2008.
- 1-(2,4-Dichlorophenyl)-5-(4-[123I]iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid N',N'-dimethyl-hydrazide [PDF Version][123I]Me2PyrKam Leung.Created: March 5, 2007; Last Update: March 13, 2007.
- 1(trans-[123I]Iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]piperidine [PDF Version][123I]TPCNEKenneth T. Cheng.Created: January 5, 2007; Last Update: June 2, 2008.
- 123/131I-Fab and F(ab')2 fragments of anti-integrin αvβ5 monoclonal antibody 14C5 [PDF Version]123/131I-Fab/F(ab')2-14C5Kam Leung.Created: March 20, 2013; Last Update: May 23, 2013.
- 123I-Annexin V [PDF Version]123I-Anx5Kenneth T. Cheng.Created: August 15, 2006; Last Update: December 18, 2007.
- 123I-Anti-vascular cell adhesion molecule monoclonal antibody 5F10 [PDF Version]123I-5F10Kam Leung.Created: September 27, 2007; Last Update: October 29, 2007.
- 123I-Arg-Glu-Asn-Leu-Arg-Ile-Ala-Leu-Arg-Tyr [PDF Version]123I-B2702-pKam Leung.Created: September 6, 2007; Last Update: November 15, 2007.
- 123I-c(RGDfK)-human serum albumin-tissue inhibitor of matrix metalloproteinase 2 fusion protein [PDF Version]123I-RGD-HSA-TIMP2Kam Leung.Created: February 10, 2012; Last Update: May 24, 2012.
- 123I-Interleukin-2 [PDF Version]123I-IL-2Kam Leung.Created: April 29, 2005; Last Update: August 16, 2005.
- 123I-Labeled (S)-2-(3-((S)-1-carboxy-5-(3-(4-iodophenyl) ureido)pentyl)ureido)pentanedoic acid [PDF Version][123I]MIP-1095Arvind Chopra.Created: September 29, 2009; Last Update: November 24, 2009.
- 123I-Labeled (S)-2-(3-((S)-1-carboxy-5-(4-iodobenzylamino)pentyl)ureido)pentanedoic acid [PDF Version][123I]MIP-1072Arvind Chopra.Created: September 29, 2009; Last Update: November 24, 2009.
- 2-(2-(4-(4-[123I]Iodobenzyl)piperazin-1-yl)-2-oxoethyl)isoindoline-1,3-dione [PDF Version][123I]MEL037Kenneth T. Cheng and Andrew Katsifis.Created: July 31, 2007; Last Update: January 31, 2008.
- 2β-Carbomethoxy-3β-(4´-((Z)-2-[123I]iodoethenyl)phenyl)nortropane [PDF Version][123I]pZIENTJeffrey Stehouwer and Arvind Chopra.Created: January 31, 2011; Last Update: March 31, 2011.
- 5-[123I]Iodo-3-[2(S)-2-azetidinylmethoxy]pyridine [PDF Version]5-[123I]IAKam Leung.Created: July 7, 2006; Last Update: July 24, 2006.
- 6-Chloro-2-(4'-[123I]iodophenyl)-3-(N,N-diethyl)imidazo[1,2-a]pyridine-3-acetamide [PDF Version][123I]CLINDEKam Leung.Created: January 12, 2008; Last Update: February 18, 2008.
- 7-(2-(4-(2-Fluoro-4-[123I]iodophenyl)piperazin-1-yl)ethyl)-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine [PDF Version][123I]MNI-420Arvind Chopra.Created: April 22, 2013; Last Update: June 27, 2013.
- 8-[123I]Iodo-L-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid [PDF Version][123I]ITICKam Leung.Created: February 22, 2007; Last Update: May 12, 2008.
- Mono-[123I]Iodohypericin [PDF Version][123I]MIHArvind Chopra.Created: February 6, 2008; Last Update: March 12, 2008.
- Mono-[123I]iodohypericine monocarboxylic acid [PDF Version][123I]MIHAArvind Chopra.Created: February 21, 2008; Last Update: June 2, 2008.
- N-(2-(Diethylamino)ethyl)-5-[123I]iodonicotinamide [PDF Version][123I]MEL008Kam Leung.Created: October 7, 2009; Last Update: March 4, 2010.
- N-(3-Fluoropropyl)-2β-carbomethoxy-3β-(4-[123I]iodophenyl)nortropane [PDF Version][123I]FP-CITKam Leung.Created: December 16, 2004; Last Update: February 1, 2011.
- N-(Morpholin-4-yl)-5-(4-[123I]iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide [PDF Version][123I]AM281Kam Leung.Created: December 5, 2006; Last Update: January 31, 2008.
- (1-Butyl-4-piperidinylmethyl)-8-amino-7-[123I]iodo-1,4-benzodioxan-5-carboxylate [PDF Version]
- 123I,125I
- [123I/125I]6-Iodo-2-(4´-dimethylamino)-phenyl-imidazo[1,2-a]pyridine [PDF Version][123,125I]IMPYThe MICAD Research Team.Created: April 18, 2005; Last Update: May 12, 2006.
- 125I-Labeled chimeric monoclonal antibody, ch806, targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII) [PDF Version][125I]-ch806Arvind Chopra.Created: July 6, 2010; Last Update: August 26, 2010.
- 125I-Labeled monoclonal antibody (mAb) 806 targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII) [PDF Version][125I]-mAb806Arvind Chopra.Created: July 1, 2010; Last Update: August 5, 2010.
- 2-((2-((Dimethylamino)methyl)phenyl)thio)-5-[123I]iodophenylamine [PDF Version]Radioiodinated ADAMThe MICAD Research Team.Created: August 6, 2007; Last Update: September 6, 2007.
- Radioiodinated N-(2-diethylaminoethyl)-6-iodoquinoxaline-2-carboxamide dihydrochloride salt [PDF Version][125I]ICF01012Liang Shan.Created: August 5, 2011; Last Update: September 28, 2011.
- [123I/125I]6-Iodo-2-(4´-dimethylamino)-phenyl-imidazo[1,2-a]pyridine [PDF Version]
- 123I, 131I
- 123/131I-Anti-cellular adhesion molecule monoclonal antibody 14C5 [PDF Version]123/131I-mAb 14C5Kam Leung.Created: June 11, 2007; Last Update: February 20, 2013.
- 131I-Labeled arginine-arginine-leucine (RRL)-containing cyclic peptide (YCGGRRLGGC) for imaging prostate carcinoma [PDF Version]131I-Labeled RRL peptideLiang Shan.Created: January 6, 2010; Last Update: February 16, 2010.
- 123/131I-Anti-cellular adhesion molecule monoclonal antibody 14C5 [PDF Version]
- 123I/125I/131I
- Meta-[radioiodinated]iodobenzylguanidine [PDF Version][123I/125I/131I]MIBGThe MICAD Research Team.Created: May 3, 2007; Last Update: July 3, 2007.
- Meta-[radioiodinated]iodobenzylguanidine [PDF Version]
- 125I
- (2S,αS)-2-(α-(2-[125I]Iodophenoxy)benzyl)morpholine [PDF Version][125I]IPBMKam Leung.Created: February 19, 2009; Last Update: May 15, 2009.
- [125I](E)-N-1-(3'-iodoallyl)-N'-4-(3'',4''-dimethoxyphenethyl)-piperazine [PDF Version][125I]E-1Liang Shan.Created: August 16, 2012; Last Update: September 25, 2012.
- [125I]2-Iodo-N-[(S)-{(S)-1-methylpiperidin-2-yl}(phenyl)methyl]3-trifluoromethyl-benzamide [PDF Version][125I]5Liang Shan.Created: April 10, 2012; Last Update: May 30, 2012.
- [125I]Anti-claudin 4 monoclonal antibody [PDF Version][125I]Anti-claudin 4The MICAD Research Team.Created: June 28, 2007; Last Update: August 2, 2007.
- [125I]Anti-prostate stem cell antigen antibody [PDF Version][125I]Anti-PSCA antibodyThe MICAD Research Team.Created: June 29, 2007; Last Update: August 2, 2007.
- [125I]-Labeled monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII) [PDF Version][125I]SGMIB-L8A4Arvind Chopra.Created: December 24, 2010; Last Update: February 17, 2011.
- [125I]N-(4-Dipropylaminobutyl)-4-iodobenzamide [PDF Version][125I]BZ18Liang Shan.Created: August 5, 2011; Last Update: August 20, 2011.
- [125I]N-[2-[N-Ethyl-N-[2-(2-fluoropyridin-3-yloxy)ethyl]amino]ethyl]-6-iodoquinoxaline-2-carboxamide dihydrochloride salt [PDF Version][125I]56Liang Shan.Created: August 5, 2011; Last Update: August 20, 2011.
- 125I-Anti-malondialdehyde-modified low-density lipoprotein monoclonal antibody [PDF Version]125I-MDA2Kam Leung.Created: August 15, 2009; Last Update: October 22, 2009.
- 125I-Hydroxylated-single-walled nanotubes [PDF Version]125I-SWNTolsKam Leung.Created: September 26, 2008; Last Update: November 17, 2008.
- 125I-Labeled anti-epidermal growth factor receptor human Fab antibody fragment [PDF Version]125I-FabKam Leung.Created: April 6, 2010; Last Update: June 18, 2010.
- 125I-Labeled anti-mucin 1 bispecific antibody bsPAM4 [PDF Version][125I]-bsPAM4Arvind Chopra.Created: June 22, 2011; Last Update: July 26, 2011.
- 125I-Labeled heparin-binding peptides that target heparan sulfate proteoglycans for the in vivo imaging of peripheral amyloidosis [PDF Version][125I]-PeptidesArvind Chopra.Created: November 2, 2011; Last Update: December 1, 2011.
- 125I Labeled-mesenchymal-epithelial transition factor binding peptide [PDF Version][125I]-cMBPArvind Chopra.Created: July 28, 2009; Last Update: September 10, 2009.
- 125I-Labeled mesenchymal-epithelial transition factor binding peptide-8-aminooctanoic acid [PDF Version][125I]-cMBP-AOCArvind Chopra.Created: July 30, 2009; Last Update: September 10, 2009.
- 125I-Labeled mesenchymal-epithelial transition factor binding peptide-Gly-Gly-Gly [PDF Version][125I]cMBP-GGGArvind Chopra.Created: July 30, 2009; Last Update: September 10, 2009.
- 125I-Labeled monoclonal antibody, mAb RM2, targeting the RM2 antigen [PDF Version][125I]-mAb RM2Arvind Chopra.Created: September 12, 2012; Last Update: October 11, 2012.
- 125I-Labeled monoclonal antibody PSA30 [PDF Version]125I-PSA30Liang Shan.Created: November 9, 2012; Last Update: December 5, 2012.
- 125I-Labeled mouse anti-human carbonic anhydrase IX monoclonal antibody [PDF Version]125I-MAbLiang Shan.Created: May 3, 2012; Last Update: May 30, 2012.
- 125I-Labeled murine anti-CD20 antigen monoclonal antibody NuB2 conjugated to one or three octaarginine (maleimide-(6-aminocaproic acid)2-(D-Arg)8-(D-Tyr)) peptide chains [PDF Version][125I]SIB-NuB2i and [125I]SIB-NuB2iiiArvind Chopra.Created: December 8, 2010; Last Update: December 28, 2010.
- 125I-Labeled single-chain monoclonal antibody, NS4F5, that targets the GlcNS6S-IdoA2S motif of heparan sulfate proteoglycans for the in vivo imaging of peripheral amyloidosis [PDF Version][125I]-NS4F5Arvind Chopra.Created: November 4, 2011; Last Update: December 1, 2011.
- 125I-Labeled trivalent, bispecific monoclonal antibody construct TF10 that targets mucin-1 and is reactive against a histamine-succinyl-glycine hapten IMP-288 [PDF Version][125I]-TP10Arvind Chopra.Created: June 29, 2011; Last Update: August 25, 2011.
- 125I-Radioiodinated tyrosine-folate and tyrosine-click-folate [PDF Version][125I]-2 and [125I]-4Liang Shan.Created: May 20, 2012; Last Update: June 27, 2012.
- 125I-Single-chain antibody B1 targeting a pancreatic β-cell surface antigen [PDF Version]125I-SCA B1Kam Leung.Created: February 2, 2012; Last Update: May 17, 2012.
- 125I-Single-chain antibody B5 targeting a pancreatic β-cell surface antigen [PDF Version]125I-SCA B5Kam Leung.Created: February 2, 2012; Last Update: May 17, 2012.
- 125I-T84.66 scFv-human serum albumin [PDF Version]125I-T84.66 scFv-HSAKam Leung.Created: July 2, 2008; Last Update: September 2, 2008.
- 125I-Vascular endothelial growth factor-121 [PDF Version]125I-VEGF121Kam Leung.Created: June 6, 2007; Last Update: July 6, 2007.
- 2-(4'-Dimethylaminophenyl)-6-[125I]iodobenzothiazole [PDF Version][125I]TZDMThe MICAD Research Team.Created: January 8, 2007; Last Update: January 18, 2007.
- 2-{[4-(4-[125I]Iodobenzyl)piperidin-1-yl]methyl}benzimidazol-5-ol [PDF Version][125I]8Arvind Chopra.Created: January 31, 2011; Last Update: March 31, 2011.
- 3-(4-Hydroxy-3-[125I]iodophenyl)propionate-exendin(9-39) [PDF Version][125I]-BH-Exendin(9-39)Kam Leung.Created: April 6, 2010; Last Update: June 18, 2010.
- Biotinylated anti-Tn MLS128 monoclonal antibody-125I-streptavidin [PDF Version]Bt-MLS128-125I-SALiang Shan.Created: July 21, 2009; Last Update: September 17, 2009.
- Fluorinated and iodinated (Z)-2-(4-(2-fluoroethoxy)benzylidene)-5-iodobenzofuran-3(2H)-one [PDF Version][18F/125I]3Liang Shan.Created: November 30, 2011; Last Update: December 28, 2011.
- N,N-Diethyl-2-(2-(3-[125I]iodo-4-methyoxyphenyl)-5,7-dimethyl-pyrazolo(1,5-a)pyrimidin-3-yl)-acetamide [PDF Version][125I]-IodoDPA-713Kam Leung.Created: April 16, 2010; Last Update: June 3, 2010.
- N-{2-[4-(4-[125I]Iodobenzyl)-piperidin-1-ylmethyl]benzoimidazol-5-yl}-methanesulfonamide [PDF Version][125I]9Arvind Chopra.Created: January 31, 2011; Last Update: March 31, 2011.
- N1,N1-diethyl-N4-(7-[125I]iodoquinolin-4-yl)pentane-1,4-diamine [PDF Version]125I IQLiang Shan.Created: March 19, 2012; Last Update: May 2, 2012.
- Radioiodinated (1E,4E)-1-(4-aminophenyl)-5-(4-iodophenyl)penta-1,4-dien-3-one and (1E,4E)-1-(4-iodophenyl)-5-(4-(methylamino)phenyl)penta-1,4-dien-3-one [PDF Version][125I]70, [125I]71Liang Shan.Created: December 12, 2011; Last Update: February 7, 2012.
- Radioiodinated (Z)-2-(4-(2-hydroxyethoxy)benzylidene)-5-iodobenzofuran-3(2H)-one [PDF Version][125I]15Liang Shan.Created: November 30, 2011; Last Update: December 28, 2011.
- Radioiodinated anti-CD105 MAEND3 monoclonal antibody [PDF Version]125I-MAEND3 MAbKenneth T. Cheng.Created: April 5, 2006; Last Update: January 9, 2008.
- Radioiodinated anti–TAG-72 CC49 Fab’ antibody fragment [PDF Version]125I-CC49 Fab’Kenneth T. Cheng.Created: March 10, 2008; Last Update: April 9, 2008.
- Radioiodinated-anti–TAG-72 covalently linked CC49 divalent single-chain Fv antibody [PDF Version]125I-CC49 sc(Fv)2 AbKenneth T. Cheng.Created: September 25, 2007; Last Update: October 30, 2007.
- Radiolabeled (hetero)aromatic analogs of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and therapy of melanoma [PDF Version][125I]5a-ILiang Shan.Created: November 19, 2009; Last Update: December 30, 2009.
- (2S,αS)-2-(α-(2-[125I]Iodophenoxy)benzyl)morpholine [PDF Version]
- 125I/131I
- Radioiodinated anti-TAG-72 CC49 tetravalent single-chain Fv antibody [PDF Version]125I/131I-CC49 [sc(Fv)2]2 AbKenneth T. Cheng.Created: July 23, 2007; Last Update: January 22, 2008.
- Radioiodinated anti-TAG-72 humanized CH2 domain-deleted antibody [PDF Version]Radioiodinated HuCC49ΔCH2 AbKenneth T. Cheng.Created: August 30, 2007; Last Update: November 14, 2007.
- Radioiodinated anti–TAG-72 non-covalently linked CC49 divalent single-chain Fv antibody [PDF Version]125I/131I-CC49 (scFv)2 AbKenneth T. Cheng.Created: December 5, 2007; Last Update: January 7, 2008.
- Radioiodinated humanized monoclonal antibody A33 [PDF Version]Radioiodinated-huA33 mAbArvind Chopra.Created: September 16, 2007; Last Update: October 22, 2007.
- Radioiodinated MLS128 anti-Tn murine monoclonal antibody [PDF Version]Radioiodinated-MLS128Liang Shan.Created: July 21, 2009; Last Update: August 25, 2009.
- Radioiodinated anti-TAG-72 CC49 tetravalent single-chain Fv antibody [PDF Version]
- 125mTe
- Cd125mTe/ZnS Nanoparticles coupled with anti-thrombomodulin monoclonal antibody 201B [PDF Version]Cd125mTe/ZnS-201BKam Leung.Created: September 26, 2009; Last Update: December 24, 2009.
- Cd125mTe/ZnS Nanoparticles coupled with anti-thrombomodulin monoclonal antibody 201B [PDF Version]
- 131I
- [131I]N-(6-amino-2,2,4-trimethylhexyl)-2-[(5-iodo(3-pyridyl))carbonylamino]-3-(2-napthyl)propanamide [PDF Version][131I]IPC-β-AL3Arvind Chopra.Created: June 22, 2009; Last Update: August 4, 2009.
- 131I-Chlorotoxin [PDF Version]131I-TM-601The MICAD Research Team.Created: July 17, 2007; Last Update: August 8, 2007.
- 131I-Human recombinant anti-ED-B fibronectin antibody small immunoprotein [PDF Version]131I-L19-SIPKam Leung.Created: April 17, 2007; Last Update: July 6, 2007.
- 131I-Labeled [Z]-2-[4-(1,2-diphenyl-1-di-butenyl)-phenoxy]-N,N-dimethylethanamine [PDF Version]131I-TAMLiang Shan.Created: July 6, 2009; Last Update: August 18, 2009.
- 131I-Labeled anti-α folate receptor human antibody fragment AFRA-DMF5.3 dimer [PDF Version][131I]-AFRA-DFM5.3Arvind Chopra.Created: December 9, 2011; Last Update: December 26, 2011.
- 131I-Labeled recombinant anti-glycoprotein A33 antibody single chain variable fragment fused to cytosine deaminase [PDF Version][131I]A33scFv::CDyArvind Chopra.Created: July 8, 2009; Last Update: August 12, 2009.
- 131I-NP-4 anti-CEA monoclonal antibody [PDF Version]131I-NP-4 MAbKenneth T. Cheng.Created: December 27, 2005; Last Update: March 11, 2008.
- 131I-Tositumomab [PDF Version]131I-B1 MAbKenneth T. Cheng.Created: October 19, 2005; Last Update: June 2, 2008.
- 3'-(E)-(2-[123/131I]Iodovinyl)uridine [PDF Version][123/131I]IV-14Kam Leung.Created: March 17, 2010; Last Update: April 22, 2010.
- N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[131I]iodo-5-methoxybenzyl)acetamide [PDF Version][131I]PBR3aKam Leung.Created: August 6, 2007; Last Update: September 12, 2007.
- N(ε)-(3-[131I]Iodobenzoyl)-Lys5-N(α)-maleimido-Gly1-GEEEK-anti-HER2 nanobody 5F7GGC [PDF Version][131I]IB-Mal-D-GEEEK-NbKam Leung.Created: January 15, 2013; Last Update: March 28, 2013.
- R-2-[131I]Iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1H-indol-3-yl)methanone [PDF Version]R-[131I]AM2233Kam Leung.Created: December 12, 2006; Last Update: February 12, 2008.
- Radioiodinated anti-DNA-histone 1 complex chimeric tumor necrosis therapy (TNT) monoclonal antibody 1 [PDF Version][125/131I]-chTNT-1/BArvind Chopra.Created: September 17, 2011; Last Update: December 1, 2011.
- [131I]N-(6-amino-2,2,4-trimethylhexyl)-2-[(5-iodo(3-pyridyl))carbonylamino]-3-(2-napthyl)propanamide [PDF Version]
- 131I, 123I, 125I
- Radioiodinated anti-CEA monoclonal antibody NP-4 F(ab´)2 fragment [PDF Version]123I/131I/125I-NP-4 F(ab´)2Kenneth T. Cheng.Created: March 23, 2006; Last Update: April 10, 2008.
- Radioiodinated anti-CEA monoclonal antibody NP-4 F(ab´)2 fragment [PDF Version]
- 131I, 125I
- Radioiodinated anti–TAG-72 CC49 (Fab’)2 antibody fragment [PDF Version]131I/125I-CC49 (Fab’)2Kenneth T. Cheng.Created: November 5, 2007; Last Update: January 9, 2008.
- Radioiodinated anti–TAG-72 CC49 (Fab’)2 antibody fragment [PDF Version]
- 170Tm
- [170Tm]-Labeled ethylenediamine tetramethylene phosphonic acid [PDF Version][170Tm]-EDTMPArvind Chopra.Created: April 27, 2011; Last Update: May 26, 2011.
- [170Tm]-Labeled ethylenediamine tetramethylene phosphonic acid [PDF Version]
- 177Lu
- [177Lu]-Labeled (S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-tetraacetic acid (C-DOTA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII) [PDF Version][177Lu]C-DOTA-L8A4Arvind Chopra.Created: December 24, 2010; Last Update: February 17, 2011.
- [177Lu]-Labeled [(R)-2-amino-3-(4-isothiocyanatophenyl)propyl]-trans-(S,S)-cyclohexane-1,2-diamine-pentaacetic acid (CHX-A″-DTPA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII) [PDF Version][177Lu]CHX-A''-DTPA-L8A4Arvind Chopra.Created: December 24, 2010; Last Update: February 17, 2011.
- [177Lu]-Labeled 2-(4-isothiocyanatobenzyl)-6-methyldiethylene-triaminepentaacetic acid (1B4M-DTPA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII) [PDF Version][177Lu]1B4M-DTPA-L8A4Arvind Chopra.Created: December 24, 2010; Last Update: February 17, 2011.
- [177Lu]-Labeled α-(5-isothiocyanato-2-methoxyphenyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (MeO-DOTA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII) [PDF Version][177Lu]MeO-DOTA-L8A4Arvind Chopra.Created: December 24, 2010; Last Update: February 17, 2011.
- 177Lu-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-human serum albumin-Ac-Cys-ZEGFR:1907 [PDF Version]177Lu-DO3A-HSA-ZEGFR:1907Kam Leung.Created: June 25, 2012; Last Update: November 15, 2012.
- 177Lu-Benzyl-diethylenetriamine pentaacetic acid-anti-carbonic anhydrase IX small immunoprotein A3 [PDF Version]177Lu-Bn-DTPA-SIP-A3Kam Leung.Created: December 2, 2009; Last Update: January 12, 2010.
- 177Lu-CHX-A''-DTPA-ABD-Affibody (ZHER2:342)2 [PDF Version]177Lu-ABD-(ZHER2:342)2Huiming Zhang.Created: July 25, 2008; Last Update: August 27, 2008.
- 177Lu-DOTA-Gly-4-aminobenzoyl-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 [PDF Version][177Lu]-AMBAHuiming Zhang.Created: October 1, 2008; Last Update: November 17, 2008.
- 177Lu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-d-Trp-Lys-Thr-Cys)) [PDF Version]177Lu-AM3Liang Shan.Created: December 10, 2010; Last Update: January 18, 2011.
- 177Lu-Labeled aglycosylated anti-L1-CAM monoclonal antibody chCE7 [PDF Version][177Lu]-chCE7aglArvind Chopra.Created: June 26, 2012; Last Update: July 26, 2012.
- 177Lu-Labeled DOTA-conjugated AE105 peptide (Asp-Cha-Phe-(d)Ser-(d)Arg-Tyr-Leu-Trp-Ser-CONH2) [PDF Version][177Lu]-DOTA-AE105Arvind Chopra.Created: September 13, 2012; Last Update: November 8, 2012.
- 177Lu-Labeled ethylenediamine tetramethylene phosphonic acid [PDF Version][177Lu]-EDTMPArvind Chopra.Created: April 28, 2011; Last Update: May 26, 2011.
- 177Lu-Labeled h-R3 (nimotuzumab), a humanized monoclonal antibody targeting the external domain of the epidermal growth factor receptor [PDF Version][177Lu]-h-R3Arvind Chopra.Created: January 4, 2012; Last Update: February 2, 2012.
- 177Lu-Labeled humanized monoclonal antibody against human epidermal growth factor receptor 2 [PDF Version][177Lu]PertuzumabArvind Chopra.Created: November 17, 2008; Last Update: December 17, 2008.
- 177Lu-Labeled methylene diphosphonate [PDF Version][177Lu]-MDPArvind Chopra.Created: May 24, 2011; Last Update: June 30, 2011.
- 177Lu-Labeled sodium pyrophosphate [PDF Version]177Lu-PYPLiang Shan.Created: November 27, 2012; Last Update: December 19, 2012.
- [177Lu]-Labeled (S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-tetraacetic acid (C-DOTA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII) [PDF Version]
- 186Re
- 186Re-Labeled [N-[2[[3-(3,3-diphosphonopropylcarbamoyl)propyl]-2-thioethylamino]acetyl]-2-aminoethylenethiolate] oxorhenium (V) [PDF Version][186Re]MAMA-BPArvind Chopra.Created: November 6, 2009; Last Update: June 3, 2010.
- 186Re-Labeled [N-[2-[[4-[(4-hydroxy-4,4-diphosphonobutyl)amino]-4-oxobutyl]-2-thioethylamino]acetyl]-2-aminoethanethiolate] oxorhenium (V) [PDF Version][186Re]MAMA-HBPArvind Chopra.Created: November 6, 2009; Last Update: June 3, 2010.
- 186Re-Labeled [N-[2[[3-(3,3-diphosphonopropylcarbamoyl)propyl]-2-thioethylamino]acetyl]-2-aminoethylenethiolate] oxorhenium (V) [PDF Version]
- 188Re
- 188Re-Labeled humanized monoclonal anti-epidermal growth factor receptor antibody [PDF Version]188Re-NimotuzumabArvind Chopra.Created: August 4, 2008; Last Update: September 2, 2008.
- 188Re-Labeled humanized monoclonal anti-epidermal growth factor receptor antibody [PDF Version]
- 211At
- 213Bi/211At-Labeled MX35, an anti–sodium-dependent phosphate transport protein 2b (NaPi2b) murine monoclonal antibody [PDF Version][213Bi]MX35 and [211At]MX35Arvind Chopra.Created: February 27, 2012; Last Update: May 31, 2012.
- 213Bi/211At-Labeled MX35, an anti–sodium-dependent phosphate transport protein 2b (NaPi2b) murine monoclonal antibody [PDF Version]
- 67Ga
- 67Ga-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-Gly-Glu-c[Lys-Nlc-Glu-His-d-Phe-Arg-Trp-Gly-Arg-Pro-Val-Asp] [PDF Version]67Ga-DOTA-GlyGlu-CycMSHKam Leung.Created: April 28, 2010; Last Update: June 3, 2010.
- 67Ga labeled cyclic diethylenetriamine pentaacetic acid Insulin [PDF Version][67Ga]-insulinArvind Chopra.Created: May 22, 2008; Last Update: July 14, 2008.
- 67Ga-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-3-{2-[2-(3-amino-propoxy)-ethoxy]-ethoxy}-propylamine-γ-folate [PDF Version]67Ga-P1254Kam Leung.Created: February 14, 2011; Last Update: May 26, 2011.
- 67Ga-1,4,7,10-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-Gly-Glu-c[Lys-Nlc-Glu-His-d-Phe-Arg-Trp-Gly-Arg-Pro-Val-Asp] [PDF Version]
- 99mTc
- [2[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]-oct-2-yl]-methyl](2-mercaptoethyl)amino]ethyl]amino]ethanethiolato(3-)-N2,N2’,S2,S2]oxo-[1R-exo-exo)])- [99mTc]-technetium [PDF Version]99mTc-TRODAT-1Arvind Chopra.Created: April 24, 2007; Last Update: December 20, 2007.
- [99mTc/90Y]-1,4,7,10 Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid phenylalanine derivative conjugated to anti-epidermal growth factor receptor antibody ior egf/r3 [PDF Version][99mTc/90Y]DOTA-Ph-Al-ior egf/r3Puja Panwar, Normando Iznaga-Escobar, Pushpa Mishra, Vibha Srivastava, Rakesh Sharma, Ramesh Chandra, Anil Mishra, and Arvind Chopra.Created: August 27, 2009; Last Update: October 15, 2009.
- [99mTc(CO)3]+-Labeled anti-epidermal growth
factor receptor (HER2) affibody ZHER2:342 with a hexa-histidine tag
(H6) on the C-terminal [PDF Version][99mTc(CO)3]+-ZHER2:342-H6Arvind Chopra.Created: December 20, 2010; Last Update: January 20, 2011.
- [99mTc(CO)3]+-Labeled anti-epidermal growth
factor receptor (HER2) affibody ZHER2:342 with a hexa-histidine tag
(H6) on the N-terminal [PDF Version][99mTc(CO)3]+-H6-ZHER2:342Arvind Chopra.Created: December 16, 2010; Last Update: January 20, 2011.
- [99mTc(CO)3]+-Labeled anti-epidermal growth
factor receptor (HER2) affibody ZHER2:342 with a
tri-(histidine-glutamate) peptide tag (HE)3 on the N-terminal [PDF Version][99mTc(CO)3]+-(HE)3-ZHER2:342Arvind Chopra.Created: December 21, 2010; Last Update: January 20, 2011.
- [99mTc(N)(NS-Cys-Gly-CCK-8)(PNP3)]+ [PDF Version]99mTc(N)(PNP3)-CCK-8The MICAD Research Team.Created: April 30, 2007; Last Update: May 30, 2007.
- [99mTc](CO)3N-(pyridin-2-yl-methyl)-N[2-(4-sulfamoylphenyl)-ethyl]aminoethyl acetate [PDF Version][99mTc]5Arvind Chopra.Created: August 25, 2010; Last Update: October 28, 2010.
- [99mTc]1,4,7,10-tetraazacyclododecane-N, N’, N’’, N’’’-tetraacetic acid-Phe-Lys-histamine-succinyl-Gly-D-Tyr-Lys- histamine-succinyl-Gly-thiosemicarbazonyl-glyoxyl-cysteine [PDF Version][99mTc]IMP-245Arvind Chopra.Created: March 13, 2008; Last Update: May 22, 2008.
- [99mTc]-1,4,7,10-Tetraazacyclododecane tetramethylenephosphonic acid [PDF Version]Anupama Datta, Puja Panwar, Krishna Chuttani, Anil Kumar Mishra, and Arvind Chopra.Created: March 31, 2009; Last Update: June 9, 2009.
- [99mTc]4-Dithiocarbamato-N-benzylpiperidine [PDF Version][[99mTc]N(PNP)Pip-DTC]+Drishty Satpati, Ketaki Bapat, Haladhar Deb Sarma, Kanchan Kothari, Meera Venkatesh, Sharmila Banerjee, and Arvind Chopra.Created: April 3, 2008; Last Update: May 14, 2008.
- [99mTc]-Acetyl-arg-arg-arg-arg-arg-cys-gly-cys-gly-gly-pro-leu-tyr-arg-arg-ile-ile-arg-arg-leu-leu-glu-ser-dermatan sulfate [PDF Version]99mTc-P1827DSArvind Chopra.Created: November 19, 2007; Last Update: December 19, 2007.
- [99mTc]Anti-CD3 monoclonal antibody [PDF Version][99mTc]Anti-CD3 mAbArvind Chopra.Created: January 28, 2008; Last Update: March 10, 2008.
- [99mTc]Cyclo(L-homocysteinyl-N-methyl-L-phenylalanyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl), (1‡1´)-sulfide with 3-[(mercaptoacetyl)amino]-L-alanyl-L-lysyl-L-cysteinyl-L-lysinamide [PDF Version][99mTc]DepreotideArvind Chopra.Created: March 27, 2008; Last Update: May 27, 2008.
- [99mTc]-diethylenetriaminepentaacetic acid-galactosyl human serum albumin [PDF Version]99mTc-GSAArvind Chopra.Created: April 24, 2007; Last Update: June 12, 2007.
- [99mTc]Epidermal growth factor receptor–specific nanobody [PDF Version][99mTc]EGFR nanobodyArvind Chopra.Created: April 22, 2008; Last Update: May 13, 2008.
- [99mTc]Human telomerase reverse-transcriptase antisense mRNA oligonucleotide [PDF Version][99mTc]MAG3-ASONArvind Chopra.Created: May 7, 2008; Last Update: May 27, 2008.
- [99mTc]-Mercaptoacetyldiglycyl-1,5-diaminopentylene hypericincarboxamide [PDF Version][99mTc]-HypericinArvind Chopra.Created: February 26, 2008; Last Update: March 25, 2008.
- [99mTc]-Pentavalent dimercaptosuccinic acid [PDF Version][99mTc]-(V)DMSAArvind Chopra.Created: June 11, 2010; Last Update: July 29, 2010.
- [99mTc]Vasoactive intestinal peptide-aminobutyric acid-Gly-Gly-(D)-Ala-Gly [PDF Version][99mTc]TP3654Arvind Chopra.Created: March 7, 2008; Last Update: April 17, 2008.
- [99mTc-Gly-Gly-Cys]-Ornithine-ornithine-ornithine-cyclo(Arg-Gly-Asp-d-Phe-Lys) [PDF Version][99mTc-GGC]-(Orn)3-c(RGDfK)Kam Leung.Created: February 16, 2013; Last Update: April 18, 2013.
- [99mTc-N40-1-bzlg0,D-Phe6,Leu-NHEt13,des-Met14]Bombesin(6–14) [PDF Version][99mTc]Demobesin 1Liang Shan.Created: August 30, 2009; Last Update: October 28, 2009.
- 99mTc/111In-Labeled DTPA-succinyl polylysine [PDF Version][99mTc/111In]-DSPLArvind Chopra.Created: October 16, 2012; Last Update: November 21, 2012.
- 99mTc/188Re-Labeled dipicolylamine-alendronate [PDF Version][99mTc/188Re]DPA-alendronateArvind Chopra.Created: April 21, 2010; Last Update: May 24, 2010.
- 99mTc-(3Z)-4-{4-[2-(Dimethylamino)ethoxy]phenyl}-3,4-diphenylbut-3-en-1-ylN,N-bis[2-(2,6-dioxomorpholin-4-yl)ethyl]glycinate [PDF Version]99mTc-DTPA-TORKam Leung.Created: May 25, 2010; Last Update: July 7, 2010.
- 99mTc(CO)3-((S-Pyridin-2-ylmethyl)-Cys)-Nle-Asp-His-d-Phe-Arg-Trp-Gly-Lys-NH2 [PDF Version]Kam Leung.Created: January 28, 2013; Last Update: April 18, 2013.
- 99mTc(CO)3-Anti-carcinoembryonic antigen (CEA) humanized CEA5 graft nanobody [PDF Version]99mTc-Humanized CEA5 graftKam Leung.Created: April 11, 2012; Last Update: July 26, 2012.
- 99mTc(CO)3-Anti-epidermal growth factor receptor nanobody 8B6 [PDF Version]99mTc(CO)3-8B6Kam Leung.Created: April 11, 2012; Last Update: July 12, 2012.
- 99mTc(CO)3-Anti-vascular cell adhesion molecule-1 nanobody cAbVCAM1-5 [PDF Version]99mTc-cAbVCAM1-5Kam Leung.Created: April 5, 2012; Last Update: July 26, 2012.
- 99mTc(CO)3-Bipyridine-cyclo-(Arg-Gly-Asp-D-Tyr-Lys) [PDF Version]99mTc(CO)3-BPy-c(RGDyK)Kam Leung.Created: June 14, 2007; Last Update: August 14, 2007.
- 99mTc(CO)3-Pyrazolyl-cyclo(Arg-Gly-Asp-D-Tyr-Lys) [PDF Version]99mTc(CO)3-PZ-c(RGDyK)Kam Leung.Created: July 9, 2007; Last Update: August 27, 2007.
- 99mTc-(Hydrazinonicotinic acid-duramycin)(tricine)(TPPTS) [PDF Version]99mTc-DuramycinKam Leung.Created: October 25, 2008; Last Update: January 2, 2009.
- 99mTc-(Hydrazinonicotinic acid-β-Ala-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2)(tricine)(TPPTS) [PDF Version]99mTc-(HYNIC-ABN)(tricine)(TPPTS)Kam Leung.Created: October 25, 2008; Last Update: December 12, 2008.
- 99mTc-(NαHis)Ac-(Arg-N-CH3)-Arg-Pro-(dimethyl-Tyr)-(tertary-Leu)-Leu [PDF Version]99mTc-NT-XIXKam Leung.Created: August 5, 2009; Last Update: September 18, 2009.
- 99mTc-(RR,SS)-4,8-diaza-3,6,6,9-tetramethylundecane-2,10-dione bisoxime [PDF Version]99mTc-HMPAOArvind Chopra.Created: May 14, 2007; Last Update: June 5, 2009.
- 99mTc(v)O-Gly-Gly-Cys-Orn-Orn-Orn-Bombesin[2-14] [PDF Version]99mTc-N3S-X-BN[2-14]Liang Shan.Created: August 19, 2009; Last Update: September 23, 2009.
- 99mTc-[Ac-CCEHdFRWCKPV-NH2] [PDF Version]99mTc-CCMSHKenneth T Cheng.Created: April 7, 2008; Last Update: April 30, 2008.
- 99mTc-[Cys3,4,10,d-Phe7,Arg11]α-MSH3-13 [PDF Version]99mTc-(Arg11)CCMSHKenneth T Cheng and Thomas P Quinn.Created: January 26, 2007; Last Update: January 22, 2008.
- 99mTc-1,4,7-Tris(carboxymethyl)-10-(4-aminoethyl)-1,4,7,10-tetraazacyclododecane-Folate [PDF Version]99mTc-DO3A-EA-FolateKam Leung.Created: November 22, 2012; Last Update: January 31, 2013.
- 99mTc-2-[Bis-(2-mercaptoethyl)]aminoethanethiol-4-isocyano-N-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]butanamide [PDF Version]99mTc-NS3M1Liang Shan.Created: May 16, 2012; Last Update: July 10, 2012.
- 99mTc-2-Methoxyisobutylisonitrile [PDF Version]99mTc-MIBIKam Leung.Created: October 5, 2004; Last Update: December 8, 2004.
- 99mTc-Acetyl-Asn-Gln-Glu-Gln-Val-Ser-Pro-3-iodo-Tyr-Thr-Leu-Leu-Lys-Gly-NC100194 [PDF Version]99mTc-NC100668Kam Leung.Created: May 7, 2007; Last Update: February 11, 2008.
- 99mTc-Ac-Lys(DTPA)-Tyr-Lys(DTPA)-Lys(thiosemicarbazonyl-glyoxyl-cysteinyl-)-NH2 (IMP-192) [PDF Version][99mTc]-IMP-192Arvind Chopra.Created: June 27, 2011; Last Update: July 26, 2011.
- 99mTc-Affibody ZHER2:2395-Cys [PDF Version]99mTc-Z2395-CKam Leung.Created: September 16, 2009; Last Update: November 19, 2009.
- 99mTc-Anti-CD105 E9 monoclonal antibody [PDF Version]99mTc-CD105 E9 MAbKenneth T. Cheng.Created: July 14, 2007; Last Update: December 10, 2007.
- 99mTc-Anti-ED-B fibronectin L19-(Gy)3-Cys-Ala scFv antibody fragment [PDF Version]99mTc-AP39Kenneth T. Cheng.Created: February 6, 2007; Last Update: January 14, 2008.
- 99mTc-Anti-ED-B fibronectin single-chain antibody fragment L19-Hi20 [PDF Version]99mTc-L19-Hi20Kenneth T. Cheng.Created: February 26, 2007; Last Update: January 15, 2008.
- 99mTc-Anti-ED-B fibronectin single-chain antibody fragment L19-His [PDF Version]99mTc-L19-HisKenneth T. Cheng.Created: February 12, 2007; Last Update: January 16, 2008.
- 99mTc- anti-EGFR monoclonal antibody h-R3 [PDF Version]99mTc-hR3The MICAD Research Team.Created: May 22, 2007; Last Update: June 25, 2007.
- 99mTc-Arcitumomab [PDF Version]99mTc-IMMU-4Kenneth T. Cheng.Created: December 11, 2005; Last Update: March 17, 2008.
- 99mTc-Bis-amino-bis-thiol-conjugated 6-(3-bromopropoxy)-2-(4-(dimethylamino)phenyl)-4H-chromen-4-one and (Z)-5-(3-bromopropoxy)-2-(4-(dimethylamino)benzylidene)benzofuran-3(2H)-one [PDF Version][99mTc]BAT-FL, [99mTc]BAT-ARLiang Shan.Created: November 30, 2011; Last Update: December 28, 2011.
- 99mTc-CCND1-PNA-IGF1 Chimeras [PDF Version]99mTc-WT4185Kenneth T Cheng, Eric Wickstrom, Xiaobing Tian, Mohan R Aruva, Wenyi Qin, Weizhu Zhu, Kevin T Duffy, Edward R Sauter, and Mathew L Thakur.Created: November 1, 2006; Last Update: January 16, 2008.
- 99mTc-Cys-Gly-Gly-Affibody ZHER2:342 [PDF Version]99mTc-CGG-ZHER2:342Kam Leung.Created: February 16, 2008; Last Update: April 7, 2008.
- 99mTc-Diamine dioxime-Lys-Cys-Arg-Gly-Asp-Cyc-Phe-Cys-polyethylene glycol [PDF Version]99mTc-NC100692Kam Leung.Created: April 9, 2010; Last Update: May 20, 2010.
- 99mTc-Diethylenetriaminepentaacetate-deoxyglucose [PDF Version]99mTc-DTPA-DGKenneth T. Cheng.Created: March 6, 2007; Last Update: March 12, 2008.
- 99mTc-Diethylenetriamine pentaacetic acid–lactosyl human serum albumin [PDF Version]99mTc-LACTALLiang Shan.Created: August 23, 2010; Last Update: October 1, 2010.
- 99mTc-Diethylenetriaminepentaacetic acid-mannosyl-dextran [PDF Version]99mTc-DTPA-Mannosyl-dextranKenneth T. Cheng, David R. Vera, Anne M. Wallace, Carl K Hoh, Jeanette Mendez, and Kam Leung.Created: October 23, 2007; Last Update: March 2, 2011.
- 99mTc-Diethylenetriamine pentaacetic acid superparamagnetic iron oxide nanoparticles conjugated with lactobionic acid [PDF Version]99mTc-DTPA-SPION-LBAKam Leung.Created: April 28, 2010; Last Update: May 20, 2010.
- 99mTc-Ethylenediaminediacetic acid/hydrazinonicotinamide-[dGlu1]minigastrin [PDF Version]99mTc-EDDA/HYNIC-MG0Kenneth T. Cheng.Created: May 2, 2007; Last Update: January 28, 2008.
- 99mTc-Ethylenediaminediacetic acid/hydrazinonicotinic acid-[dGlu1, desGlu2–6]minigastrin [PDF Version]99mTc-EDDA/HYNIC-MG11The MICAD Research Team.Created: May 4, 2007; Last Update: June 7, 2007.
- 99mTc-Ethylenediaminediacetic acid/hydrazinonicotinic acid-cyclo(Arg-Gly-Asp-D-Try-Lys) [PDF Version]99mTc-EDDA/HYNIC-c(RGDyK)Kam Leung.Created: July 15, 2007; Last Update: August 27, 2007.
- 99mTc-ethylenediamine N,N’-diacetic acid/hydrazinonicotinamide-Tyr3-octreotide [PDF Version]99mTc-HYNIC-TOCArvind Chopra.Created: October 12, 2007; Last Update: November 7, 2007.
- 99mTc-Ethylenedicysteine-C225 [PDF Version]99mTc-EC-C225Kam Leung.Created: April 22, 2005; Last Update: December 29, 2011.
- 99mTc-Ethylenedicysteine-deoxyglucose [PDF Version]99mTc-EC-DGKam Leung.Created: October 17, 2009; Last Update: February 16, 2010.
- 99mTc-Ethylenedicysteine-endostatin [PDF Version]99mTc-EC-endostatinKam Leung.Created: March 3, 2005; Last Update: December 14, 2011.
- 99mTc-Ethylenedicysteine-folate [PDF Version]99mTc-EC-folateKam Leung.Created: April 18, 2005; Last Update: January 9, 2011.
- 99mTc-Ethylenedicysteine-guanine [PDF Version]99mTc-EC-GuanThe MICAD Research Team.Created: August 17, 2007; Last Update: September 19, 2007.
- 99mTc-Ethylenenediamine-N,N'-diacetic acid/hydrazinonicotinamide[Lys3]-bombesin [PDF Version]99mTc-EDDA/HYNIC-[Lys3]-BNKenneth T. Cheng, Guillermina Ferro-Flores, and Consuelo Arteaga de Murphy.Created: August 15, 2007; Last Update: September 19, 2007.
- 99mTc-Fucoidan, a polysaccharidic ligand of P-selectin [PDF Version]99mTc-FucoidanKam Leung.Created: January 18, 2012; Last Update: April 12, 2012.
- 99mTc-Galactosyl-methylated chitosan [PDF Version]99mTc-GMCKam Leung.Created: September 15, 2009; Last Update: December 2, 2009.
- 99mTc-Glucosamine-multiwall carbon nanotubes [PDF Version]99mTc-MWNT-GKenneth T. Cheng, Jinxue. Guo, and Xiao Zhang.Created: October 2, 2007; Last Update: November 5, 2007.
- 99mTc-Glucosamino-Asp-cyclo(Arg-Gly-Asp-D-Phe-Lys) [PDF Version]Glucosamino 99mTc-D-c(RGDfK)Kam Leung.Created: August 15, 2007; Last Update: September 25, 2007.
- 99mTc-glutamate peptide 3-aminoethyl estradiol [PDF Version]99mTc-GAP-EDLArvind Chopra.Created: August 27, 2007; Last Update: September 24, 2007.
- 99mTc-Gly-Gly-Cys-(Arg)3-bombesin(2-14)-NH2 [PDF Version]99mTc-BN-ALiang Shan.Created: December 6, 2012; Last Update: January 29, 2013.
- 99mTc-Hexamethylpropyleneamine oxime-blue-biotin-liposomes [PDF Version]99mTc-HMPAO-BBLHuiming Zhang.Created: March 11, 2008; Last Update: April 22, 2008.
- 99mTc-Hexamethylpropyleneamine oxime pH-sensitive liposomes [PDF Version]99mTc-SpHLVildete Carmo, Mônica De Oliveira, Valbert Cardoso, and Arvind Chopra.Created: July 2, 2008; Last Update: August 7, 2008.
- 99mTc-Human β-defensin-3 [PDF Version]99mTc-HBD-3Kam Leung.Created: August 25, 2009; Last Update: November 19, 2009.
- 99mTc-Hydrazinonicotinamide/tricine-eighteen-nucleotide RIα mRNA antisense small interfering oligoribonucleotides [PDF Version]99mTc-HYNIC/tricine-18-nt-RIα-mRNA-AS siRNAsKenneth T. Cheng.Created: September 21, 2007; Last Update: October 23, 2007.
- 99mTc-Hydrazinonicotinamide-aminohexanoic acid-Lys40-exendin-4 [PDF Version][Lys40(Ahx-HYNIC-99mTc)NH2]-exendin-4Kam Leung.Created: January 20, 2012; Last Update: April 26, 2012.
- 99mTc-Hydrazinonicotinamide-annexin V [PDF Version]99mTc-HYNIC-annexin VKam Leung.Created: February 28, 2006; Last Update: April 6, 2008.
- 99mTc-Hydrazinonicotinamide-anti-TAG-72 CC49 divalent single-chain Fv monoclonal antibody [PDF Version]99mTc-HYNIC-CC49 sc(Fv)2 MAbKenneth T. Cheng.Created: June 19, 2007; Last Update: January 28, 2008.
- 99mTc-Hydrazinonicotinamide-anti-TAG-72 CC49 tetravalent single-chain Fv monoclonal antibody [PDF Version]99mTc-HYNIC-CC49 [sc(Fv)2]2 MAbKenneth T. Cheng.Created: June 26, 2007; Last Update: December 28, 2007.
- 99mTc-Hydrazinonicotinamide-chitosan-anti-vascular endothelial growth factor receptor 2 monoclonal antibody DC101 [PDF Version]99mTc-HYNIC-chitosan-DC101Kam Leung.Created: September 15, 2009; Last Update: December 24, 2009.
- 99mTc-Hydrazinonicotinamide-epidermal growth factor [PDF Version]99mTc-HYNIC-EGFKam Leung.Created: June 3, 2005; Last Update: January 11, 2012.
- 99mTc-Hydrazinonicotinamide-galactosyl-chitosan [PDF Version]99mTc-HGCKam Leung.Created: September 15, 2009; Last Update: December 2, 2009.
- 99mTc-Hydrazinonicotinamide-interleukin-8 [PDF Version]99mTc-HYNIC-IL-8Kam Leung.Created: March 9, 2007; Last Update: March 27, 2007.
- 99mTc-Hydrazinonicotinic acid-bitistatin [PDF Version]99mTc-HYNIC-bitistatinKam Leung.Created: July 7, 2007; Last Update: April 25, 2012.
- 99mTc-Hydrazinonicotinic acid-cyclo[γ-d-Glu-Ala-Tyr-d-Lys]-Trp-Met-Phe-NH2 [PDF Version]99mTc-HYNIC-cyclo-MG1Kam Leung.Created: February 17, 2010; Last Update: March 25, 2010.
- 99mTc-Hydrazinonicotinic acid-Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 [PDF Version]99mTc-HYNIC-E-[c(RGDfK)]2Kam Leung.Created: August 15, 2007; Last Update: September 25, 2007.
- 99mTc-Hydrazinonicotinic acid-Glu-{Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2}2 [PDF Version]99mTc-HYNIC-E{E[c(RGDfK)]2}2Kam Leung.Created: July 15, 2007; Last Update: August 31, 2007.
- 99mTc-Hydrazinonicotinic acid-single-chain Cys-tagged vascular endothelial growth factor-121 [PDF Version]99mTc-HYNIC-scVEGF121Kam Leung.Created: February 17, 2008; Last Update: March 31, 2008.
- 99mTc-Hydrazinonicotinyl(tricine)(TPPTS)-Glu-c(RGDyK)-bombesin[7-14]NH2 [PDF Version]99mTc-HYNIC-RGD-BBNKam Leung.Created: August 16, 2012; Last Update: November 8, 2012.
- 99mTc-Interleukin-18-binding protein-Fc-interlukin-1 receptor antagonist [PDF Version]99mTc-IL-18bp-Fc-IL-1raKam Leung.Created: May 2, 2013; Last Update: May 30, 2013.
- 99mTc-Interleukin-2 [PDF Version]99mTc-IL-2Kam Leung.Created: September 15, 2006; Last Update: October 12, 2006.
- 99mTc-Labeled, PEGylated (NαHis)Ac-β3hLys-βAla-βAla-Gln7-Trp8-Ala9-Val10-Gly11-His12-Cha13-Nle14-NH2 [PDF Version]99mTc-PEGx-Lys-BNLiang Shan.Created: March 12, 2012; Last Update: April 11, 2012.
- 99mTc-Labeled (1S,3S)-3-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-α-l-lyxo-hexopyranoside [PDF Version][99mTc]DaunorubicinArvind Chopra.Created: February 1, 2013; Last Update: February 28, 2013.
- 99mTc-labeled [N40,Pro1,Tyr4]bombesin [PDF Version][99mTc]Demobesin 3Liang Shan.Created: September 20, 2009; Last Update: October 28, 2009.
- 99mTc-Labeled 13,13’[oxybis[methylene(2,5-dioxo-1,3-pyrrolidinediyl)]]bis[N-(mercaptoacetyl)-D-tyrosyl-S-(3-aminopropyl)-L-cysteinylglycyl-L-α-aspartyl-L-cysteinylglycylglycyl-S-[(acetylamino)methyl]-L-cysteinylglycyl-S-[(acetylamino)methyl-L-cysteinylglycylglycyl-L-cysteinamide],cyclic(1→5),(1’→5’),-bis(sulfide) [PDF Version]99mTc-apcitideArvind Chopra.Created: December 19, 2008; Last Update: January 14, 2009.
- 99mTc-Labeled 1-hydroxy-2-(2-ethyl-4-methyl-1H-imidazol-1-yl)ethane-1,1-diyldiphosphonic acid [PDF Version][99mTc]-EMIDPArvind Chopra.Created: July 13, 2010; Last Update: July 29, 2010.
- 99mTc-Labeled 1-hydroxy-2-(2-isopropyl-1H-imidazole-1-yl)ethylidene-1,1-bisphosphonic acid [PDF Version][99mTc]-iPIDPArvind Chopra.Created: October 24, 2011; Last Update: November 1, 2011.
- 99mTc-Labeled 1-hydroxy-3-(1H-imidazol-1-yl)propane-1,1-diyldiphosphonic acid (IPrDP) [PDF Version][99mTc]-IPrDPArvind Chopra.Created: July 7, 2011; Last Update: September 8, 2011.
- 99mTc-Labeled 5-amino-1,3-bis(ethylamine-(N,N-dimethyl diphosphonic acid)acetamido)benzene [PDF Version][99mTc]IPTMPPuja Panwar, Sweta Singh, Nitin Kumar, Harish Rawat, Anil Kumar Mishra, and Arvind Chopra.Created: July 10, 2009; Last Update: October 1, 2009.
- 99mTc-Labeled 6-hydrazinopyridine-3-carboxylic acid (HYNIC)–conjugated murine anti-MUC1 monoclonal antibody PR81 [PDF Version][99mTc]-PR81Arvind Chopra.Created: May 26, 2010; Last Update: June 29, 2010.
- 99mTc-Labeled 6-hydrazinopyridine-3-carboxylic acid conjugated to hydroxy-bisphosphonate [PDF Version][99mTc]HYNIC-HBPArvind Chopra.Created: November 6, 2009; Last Update: December 9, 2009.
- 99mTc-Labeled acetylated dendrimer poly(amido)-amine generation 5-folic acid-2-(p-isothiocyanatobenzyl)-6-methyl-diethylenetriamine pentaacetic acid conjugate [PDF Version]99mTc-G5-Ac-FA-DTPALiang Shan.Created: March 15, 2011; Last Update: April 21, 2011.
- 99mTc-Labeled acetylated dendrimer poly(amido)-amine generation 5-PEGylated folic acid-2-(p-isothiocyanatobenzyl)-6-methyl-diethylenetriamine pentaacetic acid conjugate [PDF Version]99mTc-G5-Ac-pegFA-DTPALiang Shan.Created: March 15, 2011; Last Update: April 21, 2011.
- 99mTc-Labeled anti-carcinoembryonic antigen monoclonal antibody CL-58 [PDF Version]99mTc-Anti-CEA CL-58Arvind Chopra.Created: July 28, 2008; Last Update: August 27, 2008.
- 99mTc-Labeled anti-macrophage mannose receptor (MMR; CD206) nanobody [PDF Version][99mTc]MMR NbArvind Chopra.Created: September 4, 2012; Last Update: September 27, 2012.
- 99mTc-Labeled anti-receptor for advanced glycation endproducts monoclonal antibody F(ab’)2 fragments [PDF Version]99mTc-anti-RAGE mF(ab’)2Liang Shan.Created: July 16, 2010; Last Update: August 16, 2010.
- 99mTc-Labeled anti-receptor for advanced glycation endproducts polyclonal antibody F(ab’)2 fragments [PDF Version]99mTc-anti-RAGE pF(ab’)2Liang Shan.Created: July 16, 2010; Last Update: August 16, 2010.
- 99mTc-labeled anti-tumor necrosis factor-alpha monoclonal antibody [PDF Version]99mTc-anti-TNF-α mAbArvind Chopra.Created: September 25, 2007; Last Update: October 22, 2007.
- 99mTc-Labeled citric acid-folate conjugate [PDF Version]99mTc-Citro-folateLiang Shan.Created: March 15, 2011; Last Update: April 19, 2011.
- 99mTc-Labeled cysteine-tagged dimeric epidermal growth factor [PDF Version][99mTc]Cys-dEGFArvind Chopra.Created: May 18, 2009; Last Update: July 15, 2009.
- 99mTc-Labeled cysteine-tagged epidermal growth factor [PDF Version][99mTc]Cys-EGFArvind Chopra.Created: May 18, 2009; Last Update: July 15, 2009.
- 99mTc-Labeled doxorubicin [PDF Version]99mTc-doxorubicinLiang Shan.Created: December 3, 2012; Last Update: January 2, 2013.
- 99mTc-Labeled hydrazinonicotinamide-cysteine-annexin A5 [PDF Version]99mTc-HYNIC-cys-Annexin A5Arvind Chopra.Created: January 13, 2010; Last Update: March 4, 2010.
- 99mTc-Labeled imine 6-(pyridine-2-methylimine)-4-[(3-bromophenyl)amino]quinazoline [PDF Version][99mTc]Complex 7Arvind Chopra.Created: June 18, 2009; Last Update: August 4, 2009.
- 99mTc-labeled ior-egf/r3 monoclonal antibody against epidermal growth factor receptor [PDF Version]99mTc-ior-egf/r3 MAbArvind Chopra.Created: June 11, 2007; Last Update: December 19, 2008.
- 99mTc-Labeled lexatumumab [PDF Version]99mTc-EC-HGS-ETR2Arvind Chopra.Created: March 19, 2009; Last Update: May 20, 2009.
- 99mTc-Labeled mannosylated dextran DCM20 [PDF Version]99mTc(CO)3-DCM20Liang Shan.Created: May 16, 2012; Last Update: July 17, 2012.
- 99mTc-Labeled mapatumumab [PDF Version]99mTc-EC-HGS-ETR1Arvind Chopra.Created: March 16, 2009; Last Update: May 20, 2009.
- 99mTc-Labeled mercaptoacetylglycylglycylglycine conjugated to hydroxy-bisphosphonate [PDF Version][99mTc]MAG3-HBPArvind Chopra.Created: November 6, 2009; Last Update: December 9, 2009.
- 99mTc-Labeled murine IgM monoclonal antibody, fanolesomab, that targets the CD15 glycoprotein antigen [PDF Version]99mTc-FanolesomabArvind Chopra.Created: September 19, 2011; Last Update: October 28, 2011.
- 99mTc-Labeled N-(triethylammonium)-3-propyl-[15]ane-N5 [PDF Version][99mTc]NTP 15-5Arvind Chopra.Created: September 18, 2009; Last Update: December 17, 2009.
- 99mTc-Labeled Nε49 mercaptoacetyl derivatives of affibody ZHER2:342 targeting the human epidermal growth factor receptor [PDF Version][99mTc]-Nε49-maGGG-ZHER2:342; [99mTc]-Nε49-maSSS-ZHER2:342; [99mTc]-Nε49-maESE-ZHER2:342Arvind Chopra.Created: January 19, 2010; Last Update: March 4, 2010.
- 99mTc-Labeled O-[3-(1,4,8,11-tetraazabicyclohexadecane)-propyl]-α-methyl tyrosine [PDF Version][99mTc]-N4-AMTArvind Chopra.Created: October 26, 2011; Last Update: December 1, 2011.
- 99mTc-Labeled peptide derivative of folic acid [PDF Version]99mTc-EC20Arvind Chopra.Created: September 11, 2009; Last Update: November 12, 2009.
- 99mTc-Labeled poly(ethyleneglycol)–N-(N-(3-diphenylphosphinopropionyl)glycyl)-S-tritylcysteine (PEG-PN2S)-linked ubiquicidin (UBI) [PDF Version][99mTc]-PEG-PN2S-UBI29-41Arvind Chopra.Created: September 26, 2011; Last Update: October 28, 2011.
- 99mTc-Labeled pyridyl benzofuran derivatives to target β-amyloid plaques [PDF Version][99mTc]BAT-bp-1, [99mTc]BAT-bp-2, and [99mTc]BAT-bp-3Arvind Chopra.Created: July 11, 2012; Last Update: August 16, 2012.
- 99mTc-Labeled rituximab, a chimeric murine/human anti-CD20 monoclonal antibody [PDF Version][99mTc]RituximabArvind Chopra.Created: September 20, 2012; Last Update: October 25, 2012.
- 99mTc-Labeled S-benzoylmercaptoacetyl triglycine d-galactose [PDF Version][99mTc]SBz-MAG3-GaArvind Chopra.Created: April 21, 2010; Last Update: May 11, 2010.
- 99mTc-Labeled S-benzoylmercaptoacetyl triglycine d-glucose [PDF Version][99mTc]SBz-MAG3-GlArvind Chopra.Created: April 21, 2010; Last Update: May 13, 2010.
- 99mTc-Labeled S-benzoylmercaptoacetyl triglycine n-acetylglucosamine [PDF Version][99mTc]SBz-MAG3-NGArvind Chopra.Created: April 21, 2010; Last Update: May 13, 2010.
- 99mTc-Labeled succinimidyl-6-hydrazinonicotinate hydrochloride (SHNH)-conjugated visilizumab [PDF Version]99mTc-SHNH-visilizumabLiang Shan.Created: December 7, 2009; Last Update: January 12, 2010.
- 99mTc-Labeled tetraethylenepentamine-folate [PDF Version]99mTc-TEPA-FolatePuja Panwar, Vibha Srivastava, Vibha Tandon, Pushpa Mishra, Krishna Chuttani, Rakesh Sharma, Ramesh Chandra, Anil Mishra, and Arvind Chopra.Created: August 25, 2009; Last Update: October 1, 2009.
- 99mTc-Labeled trans-1,2-cyclohexyldinitrilo tetramethylene phosphonic acid [PDF Version][99mTc]CDTMPPuja Panwar, Krishna Chuttani, Pushpa Mishra, Rajnish Sharma, Anupam Mondal, Anil Kumar Mishra, and Arvind Chopra.Created: August 19, 2009; Last Update: October 15, 2009.
- 99mTc-Labeled tumor-associated glycoprotein 72 binding peptides A2-6 and A3-10 [PDF Version][99mTc]-A2-6 and [99mTc]-A3-10Arvind Chopra.Created: September 13, 2011; Last Update: October 27, 2011.
- 99mTc-Labeled tumor-associated glycoprotein 72 binding peptides G3-15 and T3-15 [PDF Version][99mTc]-G3-15 and [99mTc]-T3-15Arvind Chopra.Created: September 13, 2011; Last Update: October 27, 2011.
- 99mTc-Mercaptoacetyl-Glu-Glu-aptamer specific for tenascin-C [PDF Version]99mTc-TTA1Huiming Zhang.Created: July 17, 2008; Last Update: August 12, 2008.
- 99mTc-Mercaptoacetyl-Glu-Glu-Glu-Affibody ZHER2:342 [PDF Version]99mTc-MaEEE-ZHER2:342Kam Leung.Created: March 16, 2008; Last Update: April 7, 2008.
- 99mTc-Mercaptoacetyl-Gly-Gly-Gly-Affibody ZHER2:342 [PDF Version]99mTc-MAG3-ZHER2:342Kam Leung.Created: January 6, 2008; Last Update: April 5, 2008.
- 99mTc-Mercaptoacetyl-Gly-Gly-Gly-PAP-1 [PDF Version]99mTc-MAG3-PAP-1Kam Leung.Created: August 8, 2008; Last Update: August 15, 2008.
- 99mTc-Mercaptoacetyl-Ser-Ser-Ser-Affibody ZHER2:342 [PDF Version]99mTc-MaSSS-ZHER2:342Kam Leung.Created: March 11, 2008; Last Update: May 5, 2008.
- 99mTc-Methyl diphosphonate [PDF Version]99mTc-MDPArvind Chopra.Created: March 29, 2007; Last Update: August 24, 2009.
- 99mTc-Monocyte chemoattractant protein-1 [PDF Version]99mTc-MCP-1Dagmar Hartung, Artiom Petrov, Kenneth T. Cheng, and Jagat Narula.Created: February 2, 2008; Last Update: March 26, 2008.
- 99mTc-N,N'-Bis(S-benzoyl-thioglycoloyl)diamidopropanoyl-KRAS-PNA-d(Cys-Ser-Lys-Cys) [PDF Version]99mTc-WT4351Kenneth T. Cheng, Atis Chakrabarti, Mohan R. Aruva, Mathew L. Thakur, and Eric Wickstrom.Created: August 9, 2007; Last Update: January 3, 2008.
- 99mTc-N2S2-Tat(49-57)-Lys3-bombesin [PDF Version]99mTc-Tat-BNLiang Shan.Created: August 10, 2009; Last Update: September 23, 2009.
- 99mTc-Nicotinic acid/tricine/hydrazinonicotinamide-nonsulfated cholecystokinin-8 [PDF Version]99mTc-NA/tricine/HYNIC-nsCCK-8Kenneth T. Cheng and Peter Laverman.Created: August 31, 2007; Last Update: September 25, 2007.
- 99mTc-Nicotinic acid/tricine/hydrazinonicotinamide-sulfated cholecystokinin-8 [PDF Version]99mTc-NA/tricine/HYNIC-sCCK-8Kenneth T. Cheng and Peter Laverman.Created: August 18, 2007; Last Update: September 13, 2007.
- 99mTcO-N,N-Dimethylglycyl-l-lysinyl-l-cysteinylamide-8-amino-3,6-dioxaoctanoic-probestin [PDF Version]99mTcO-N3S-PEG2-probestinKam Leung.Created: January 15, 2012; Last Update: April 12, 2012.
- 99mTc-pGlu-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2 [PDF Version]99mTc-LitorinKam Leung.Created: October 1, 2007; Last Update: December 24, 2007.
- 99mTc-Regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-d-Phe-Lys)]4 [PDF Version]99mTc-RAFT-c(-RGDfK-)4Kam Leung.Created: February 9, 2008; Last Update: May 8, 2008.
- 99mTc-S-acetylmercaptoacetyltriserine-stromal-derived factor 1α [PDF Version]99mTc-MAS3-SDF-1αArvind Chopra.Created: June 11, 2008; Last Update: July 22, 2008.
- 99mTc-succinimidyl-6-hydrazinopyridine-3-carboxylate-interleukin 12 [PDF Version]99mTc-IL-12Arvind Chopra.Created: October 5, 2007; Last Update: November 13, 2007.
- 99mTc-Tricarbonyl-His6-annexin A5 [PDF Version]99mTc(CO)3-His-A5Kam Leung.Created: April 19, 2012; Last Update: July 19, 2012.
- 99mTc-Tricarbonyl-K-H-K-H-cholecystokinin 8 [PDF Version][99mTc](KH)2CCK8Arvind Chopra.Created: July 14, 2008; Last Update: August 27, 2008.
- 99mTc-Tricarbonyl–labeled aspartic-N-monoacetic acid (ASMA) [PDF Version][99mTc](CO)3(ASMA)Arvind Chopra.Created: August 2, 2012; Last Update: September 13, 2012.
- 99mTc-Type II tumor necrosis receptor-Fc-interlukin-1 receptor antagonist fusion protein [PDF Version]99mTc-TNFR2-Fc-IL-1raKam Leung.Created: May 1, 2013; Last Update: May 30, 2013.
- 99mTc-Ubiquicidin29-41 [PDF Version]99mTc-UBI29-41The MICAD Research Team.Created: July 31, 2007; Last Update: September 6, 2007.
- 99mTc≡Nitrido(diphosphine)-Cys-β-Ala-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 [PDF Version]99mTcN(PNP6)-Cys-β-Ala-BBN(7-14)NH2Kam Leung.Created: December 5, 2008; Last Update: January 16, 2009.
- Acetyl-lys-lys-lys-lys-lys-cys-gly-cys-gly-gly-pro-leu-tyr-lys-lys-ile-ile-lys-lys-leu-leu-glu-ser-heparin-[99mTc] [PDF Version]P483H-99mTcArvind Chopra.Created: November 14, 2007; Last Update: December 20, 2007.
- N-[2-(N-(2-mercaptoethyl)) amino ethyl]-N-(2-mercaptoethyl)-3,5-dimethylacetamide amantadine-technetium [PDF Version]99mTc-NCAMLiang Shan.Created: June 12, 2012; Last Update: July 17, 2012.
- Tricarbonyl[99mTc]technetium(I)-((S)-6-(8-(bis(pyridin-2-ylmethyl)amino)octanamido)-2-((S)-1-carboxy-3-phenylpropylamino)hexanoyl)pyrrolidine-2-carboxylic acid [PDF Version]99mTc-(CO)3D(C8)lisinoprilArvind Chopra.Created: June 25, 2008; Last Update: July 29, 2008.
- Tri-methoxy-tris-pyrazolyl-99mTc-(CO)3 [PDF Version]99mTc-TMEOPLiang Shan.Created: March 27, 2012; Last Update: April 25, 2012.
- [2[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]-oct-2-yl]-methyl](2-mercaptoethyl)amino]ethyl]amino]ethanethiolato(3-)-N2,N2’,S2,S2]oxo-[1R-exo-exo)])- [99mTc]-technetium [PDF Version]
- 111In
- Ultrasound
- Dye
- 3,7-bis(dimethylamino)-phenothiazin-5-ium chloride [PDF Version]Methylene blueArvind Chopra.Created: April 5, 2011; Last Update: April 29, 2011.
- 3,7-bis(dimethylamino)-phenothiazin-5-ium chloride [PDF Version]
- Gold
- Gold nanocages [PDF Version]Au nanocagesKam Leung.Created: March 19, 2011; Last Update: June 2, 2011.
- Poly(ethylene glycol)-coated gold nanocages [PDF Version]PEG-AuNCsKam Leung.Created: March 19, 2011; Last Update: June 2, 2011.
- Poly(ethylene glycol)-coated gold nanocages bioconjugated with [Nle4,d-Phe7]-α-melanotropin-stimulating hormone [PDF Version][Nle4,d-Phe7]-α-MSH-PEG-AuNCsKam Leung.Created: May 29, 2011; Last Update: July 14, 2011.
- Polyethylene glycol–coated (PEG5000) gold nanoparticles [PDF Version]PEGylated gold nanoparticlesLiang Shan.Created: June 17, 2010; Last Update: November 17, 2010.
- Gold nanocages [PDF Version]
- ICG
- Indocyanine green–enhanced, cyclic Arg-Gly-Asp–conjugated, PEGylated single-walled carbon nanotubes [PDF Version]SWNT-ICG-RGDLiang Shan.Created: June 2, 2010; Last Update: July 12, 2010.
- Indocyanine green–enhanced, cyclic Arg-Gly-Asp–conjugated, PEGylated single-walled carbon nanotubes [PDF Version]
- Microbubbles
- Abciximab microbubbles [PDF Version]MBAbcKam Leung.Created: April 26, 2007; Last Update: February 26, 2008.
- Air-filled, cross-linked, human serum albumin microcapsules [PDF Version]Air-filled HSA microcapsulesKenneth T. Cheng.Created: July 6, 2006; Last Update: May 8, 2008.
- Anti-ligand–induced binding sites (LIBS) single-chain antibody conjugated to microbubbles [PDF Version]LIBS-MBsKam Leung.Created: October 21, 2012; Last Update: February 28, 2013.
- Anti-vascular cell adhesion molecule-1 monoclonal antibody M/K-2.7 microbubbles [PDF Version]MBVCAM-1Kam Leung.Created: November 20, 2007; Last Update: January 15, 2008.
- Buried cyclo(Arg-Gly-Tyr(Me)-Lys-Glu) microbubbles [PDF Version]bRGD-MBsHuiming Zhang.Created: June 2, 2008; Last Update: July 21, 2008.
- Magnetic microbubbles conjugated with anti-vascular cell adhesion molecule-1 monoclonal antibody 429 [PDF Version]MBvMKam Leung.Created: February 27, 2012; Last Update: June 14, 2012.
- Microbubble-conjugated vascular endothelial growth factor receptor 2 binding peptide [PDF Version]BR55Adrian Nunn, Sibylle Pochon, Isabelle Tardy, Francois Tranquart, and Arvind Chopra.Created: February 14, 2012; Last Update: July 11, 2012.
- Microbubble-conjugated vascular endothelial growth factor receptor 2 monoclonal antibody [PDF Version]Arvind Chopra.Created: November 5, 2007; Last Update: December 12, 2007.
- Microbubbles coated with antibody to intracellular adhesion molecule-1 [PDF Version]MBICAM-1Kam Leung.Created: December 21, 2006; Last Update: April 17, 2012.
- Microbubbles coated with antibody to mucosal addressin cellular adhesion molecule-1 [PDF Version]MBMAdCAM-1Kam Leung.Created: February 9, 2007; Last Update: February 27, 2007.
- Microbubbles coated with anti-P-selectin antibody RB40.34 [PDF Version]MB-RB40.34Kam Leung.Created: December 21, 2006; Last Update: April 17, 2012.
- Microbubbles coated with biotinylated rabbit anti-mouse endoglin monoclonal antibody [PDF Version]MBendoglinArvind Chopra.Created: September 6, 2011; Last Update: September 29, 2011.
- Microbubbles coated with biotinylated rabbit anti-mouse vascular endothelial growth factor receptor 2 (VEGFR-2) monoclonal antibody [PDF Version]MBvegfr2Arvind Chopra.Created: September 12, 2011; Last Update: September 29, 2011.
- Microbubbles coated with biotinylated rabbit anti-mouse αVβ3 integrin monoclonal antibody [PDF Version]MBintegrinArvind Chopra.Created: September 12, 2011; Last Update: September 29, 2011.
- Microbubbles conjugated with anti-matrix metalloproteinase 2 mouse monoclonal antibody sc-13595 [PDF Version]MMP2-MBsKam Leung.Created: August 15, 2011; Last Update: November 17, 2011.
- Microbubbles conjugated with anti-vascular cell adhesion molecule-1 nanobody cAbVCAM1-5 [PDF Version]MB-cAbVCAM1-5Kam Leung.Created: March 3, 2012; Last Update: June 14, 2012.
- Microbubbles conjugated with cyclo(CGGRRLGGC) [PDF Version]MBRRLKam Leung.Created: June 30, 2008.
- Microbubbles conjugated with knottin 2.5D [PDF Version]MBKnottinKam Leung.Created: October 20, 2010; Last Update: December 9, 2010.
- Microbubbles conjugated with single-chain Cys-tagged vascular endothelial growth factor-121 [PDF Version]scVEGF-MBsKam Leung.Created: December 15, 2010; Last Update: February 24, 2011.
- Microbubbles-echistatin [PDF Version]MBEKam Leung.Created: February 18, 2005; Last Update: January 11, 2012.
- Microbubbles with a disteroylphosphatidylcholine, disteroylphosphatidylethanolamine-polyethyleneglycol (PEG) 2000-pyridyldithio propionate-PEG 40 stearate shell conjugated to cyclic arginine-glycine-aspartic acid-d-tyrosine-lysine (cRGD) pentapeptide [PDF Version]cRGD-MBArvind Chopra.Created: March 28, 2011; Last Update: April 28, 2011.
- Perflexane-Lipid Microspheres [PDF Version]AFO150Kenneth T. Cheng.Created: November 1, 2005; Last Update: May 13, 2008.
- Perflutren lipid microspheres [PDF Version]DMP 115Kenneth T. Cheng.Created: February 24, 2006; Last Update: November 21, 2007.
- Sonicated human serum microspheres [PDF Version]Sonicated HSMKenneth T. Cheng.Created: March 20, 2006; Last Update: May 27, 2008.
- Stabilized sulfur hexafluoride microbubbles [PDF Version]SF6 MicrobubblesKenneth T. Cheng.Created: September 21, 2006; Last Update: February 25, 2008.
- Abciximab microbubbles [PDF Version]
- Nanobubbles
- Perfluoropropane-filled, sorbitan monostearate– and polyoxyethylene 40 stearate–shelled nanobubbles [PDF Version]PFC-S60-PEG40S-NBLiang Shan.Created: August 2, 2010; Last Update: September 1, 2010.
- Perfluoropropane-filled, sorbitan monostearate– and polyoxyethylene 40 stearate–shelled nanobubbles [PDF Version]
- Dye
- X-Ray, CT
- Au
- Gold nanoparticles [PDF Version]AuNPsKam Leung.Created: October 26, 2006; Last Update: March 8, 2011.
- Polyethylene glycol-gold nanoparticles [PDF Version]PEG-AuNPsKam Leung.Created: May 26, 2008; Last Update: June 9, 2008.
- Gold nanoparticles [PDF Version]
- Bi
- Bismuth sulphide polyvinylpyrrolidone nanoparticles [PDF Version]BPNPsKam Leung.Created: October 26, 2006; Last Update: November 11, 2007.
- Bismuth sulphide polyvinylpyrrolidone nanoparticles [PDF Version]
- Iodine
- (S)-N,N’-bis[2-hydroxy-1-(hydroxymethyl)-ethyl-2,4,6-triiodo-5-lactamidoisophthalamide [PDF Version]IopamidolThe MICAD Research Team.Created: April 3, 2007; Last Update: April 17, 2007.
- 1,3-Bis-[7-(3-amino-2,4,6-triiodophenyl)-heptanoyl]-2-oleoyl glycerol [PDF Version]DHOGCynthia Burrascano, William C. Dow, and Arvind Chopra.Created: August 29, 2007; Last Update: December 18, 2007.
- 5-[3-Hydroxy-2-hydroxymethyl-propionamido)-N,N´-dimethyl-N,N´-bis-(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide [PDF Version]IobitridolKenneth T. Cheng.Created: May 16, 2006; Last Update: April 21, 2008.
- Ethyl-3,5-bis(acetylamino)-2,4,6-triiodobenzoate nanoparticles [PDF Version]N1177Huiming Zhang.Created: June 10, 2008; Last Update: July 30, 2008.
- Ioxilan carbonate particles [PDF Version]IX-C particlesKenneth T. Cheng.Created: September 1, 2007; Last Update: December 18, 2007.
- Lipiodol-loaded poly(oxyethylene)-block-poly(oxypropylene)-block-poly(oxyethylene) triblock copolymers/polyethylene glycol-nanoparticles [PDF Version]LPNCsKenneth T. Cheng.Created: January 9, 2008; Last Update: February 18, 2008.
- N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)-glycolamidol]-2,4,6-triiodoisophthalamide [PDF Version]IoversolKenneth T. Cheng.Created: February 7, 2006; Last Update: February 7, 2008.
- N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl-3-methoxypropyl)-acetamidol]-2,4,6-triiodoisophthalamide [PDF Version]IopentolKenneth T. Cheng.Created: March 6, 2006; Last Update: March 4, 2008.
- N-(2,3-Dihydroxypropyl)-N´-(2-hydroxyethyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodoisophthalamide [PDF Version]IoxilanThe MICAD Research Team.Created: July 12, 2006; Last Update: August 9, 2006.
- Sodium-2-[(3-butanoylamino-2,4,6-triiodo-phenyl)methyl]butanoate [PDF Version]Tyropanoate SodiumKenneth T. Cheng.Created: October 5, 2005; Last Update: June 30, 2008.
- (S)-N,N’-bis[2-hydroxy-1-(hydroxymethyl)-ethyl-2,4,6-triiodo-5-lactamidoisophthalamide [PDF Version]
- Au
- NLM CatalogRelated NLM Catalog Entries
- Review Molecular Imaging and Contrast Agent Database (MICAD): evolution and progress.[Mol Imaging Biol. 2012]Review Molecular Imaging and Contrast Agent Database (MICAD): evolution and progress.Chopra A, Shan L, Eckelman WC, Leung K, Latterner M, Bryant SH, Menkens A. Mol Imaging Biol. 2012 Feb; 14(1):4-13.
- Imaging tests for the detection of osteomyelitis: a systematic review.[Health Technol Assess. 2019]Imaging tests for the detection of osteomyelitis: a systematic review.Llewellyn A, Jones-Diette J, Kraft J, Holton C, Harden M, Simmonds M. Health Technol Assess. 2019 Oct; 23(61):1-128.
- Review Dementia -- Caring, Ethics, Ethnical and Economical Aspects: A Systematic Review[ 2008]Review Dementia -- Caring, Ethics, Ethnical and Economical Aspects: A Systematic ReviewSwedish Council on Health Technology Assessment. 2008 Jun
- Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.[Med J Aust. 2020]Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Osborne SR, Alston LV, Bolton KA, Whelan J, Reeve E, Wong Shee A, Browne J, Walker T, Versace VL, Allender S, et al. Med J Aust. 2020 Dec; 213 Suppl 11:S3-S32.e1.
- Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.[Ont Health Technol Assess Ser....]Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.Medical Advisory Secretariat. Ont Health Technol Assess Ser. 2010; 10(8):1-64. Epub 2010 Jun 1.
- Molecular Imaging and Contrast Agent Database (MICAD)Molecular Imaging and Contrast Agent Database (MICAD)
- Taxonomy Links for GEO Profiles (Select 119820239) (1)Taxonomy
- OMIM Links for GEO Profiles (Select 119820239) (1)OMIM
- PMC Links for GEO Profiles (Select 119820239) (30)PMC
Your browsing activity is empty.
Activity recording is turned off.
See more...